
<html lang="en"     class="pb-page"  data-request-id="8a4b909b-e7be-4b41-8b97-6aa771b9daf4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b01104;issue:issue:10.1021/jmcmar.2019.62.issue-21;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Chirality-Driven Mode of Binding of α-Aminophosphonic Acid-Based Allosteric Inhibitors of the Human Farnesyl Pyrophosphate Synthase (hFPPS)" /></meta><meta name="dc.Creator" content="Yuting  Feng" /></meta><meta name="dc.Creator" content="Jaeok  Park" /></meta><meta name="dc.Creator" content="Shi-Guang  Li" /></meta><meta name="dc.Creator" content="Rebecca  Boutin" /></meta><meta name="dc.Creator" content="Peter  Viereck" /></meta><meta name="dc.Creator" content="Matthew A.  Schilling" /></meta><meta name="dc.Creator" content="Albert M.  Berghuis" /></meta><meta name="dc.Creator" content="Youla S.  Tsantrizos" /></meta><meta name="dc.Description" content="Thienopyrimidine-based allosteric inhibitors of the human farnesyl pyrophosphate synthase (hFPPS), characterized by a chiral α-aminophosphonic acid moiety, were synthesized as enantiomerically enri..." /></meta><meta name="Description" content="Thienopyrimidine-based allosteric inhibitors of the human farnesyl pyrophosphate synthase (hFPPS), characterized by a chiral α-aminophosphonic acid moiety, were synthesized as enantiomerically enri..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 2, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01104" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01104" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01104" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01104" /></link>
        
    
    

<title>Chirality-Driven Mode of Binding of α-Aminophosphonic Acid-Based Allosteric Inhibitors of the Human Farnesyl Pyrophosphate Synthase (hFPPS) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01104" /></meta><meta property="og:title" content="Chirality-Driven Mode of Binding of α-Aminophosphonic Acid-Based Allosteric Inhibitors of the Human Farnesyl Pyrophosphate Synthase (hFPPS)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0006.jpeg" /></meta><meta property="og:description" content="Thienopyrimidine-based allosteric inhibitors of the human farnesyl pyrophosphate synthase (hFPPS), characterized by a chiral α-aminophosphonic acid moiety, were synthesized as enantiomerically enriched pairs, and their binding mode was investigated by X-ray crystallography. A general consensus in the binding orientation of all (R)- and (S)-enantiomers was revealed. This finding is a prerequisite for establishing a reliable structure–activity relationship (SAR) model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01104"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01104">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01104&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01104&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01104&amp;href=/doi/10.1021/acs.jmedchem.9b01104" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9691-9702</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01091" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01131" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Chirality-Driven Mode of Binding of α-Aminophosphonic Acid-Based Allosteric Inhibitors of the Human Farnesyl Pyrophosphate Synthase (hFPPS)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yuting Feng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuting Feng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuting++Feng">Yuting Feng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jaeok Park</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jaeok Park</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</div><div class="loa-info-affiliations-info">Department of Biochemistry, McGill University, 3649 Promenade Sir William Osler, Montreal, Quebeck H3G 0B1, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jaeok++Park">Jaeok Park</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8180-3950" title="Orcid link">http://orcid.org/0000-0002-8180-3950</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shi-Guang Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shi-Guang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shi-Guang++Li">Shi-Guang Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rebecca Boutin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rebecca Boutin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca++Boutin">Rebecca Boutin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter Viereck</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter Viereck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Viereck">Peter Viereck</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthew A. Schilling</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthew A. Schilling</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, McGill University, 3649 Promenade Sir William Osler, Montreal, Quebeck H3G 0B1, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+A.++Schilling">Matthew A. Schilling</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Albert M. Berghuis</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Albert M. Berghuis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, McGill University, 3649 Promenade Sir William Osler, Montreal, Quebeck H3G 0B1, Canada</div></div><span class="conrtib-corresp"><strong>*</strong>For A.M.B.: E-mail, <a href="/cdn-cgi/l/email-protection#2f6e434d4a5d5b014d4a5d48475a465c6f424c48464343014c4e"><span class="__cf_email__" data-cfemail="e4a58886819690ca868196838c918d97a48987838d8888ca8785">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Albert+M.++Berghuis">Albert M. Berghuis</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Youla S. Tsantrizos</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Youla S. Tsantrizos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</div><div class="loa-info-affiliations-info">Department of Biochemistry, McGill University, 3649 Promenade Sir William Osler, Montreal, Quebeck H3G 0B1, Canada</div></div><span class="conrtib-corresp"><strong>*</strong>For Y.S.T.: phone, 514-398-3638; E-mail, <a href="/cdn-cgi/l/email-protection#cb92a4bea7aae5bfb8aaa5bfb9a2b1a4b88ba6a8aca2a7a7e5a8aa"><span class="__cf_email__" data-cfemail="0f56607a636e217b7c6e617b7d6675607c4f626c68666363216c6e">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Youla+S.++Tsantrizos">Youla S. Tsantrizos</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6231-7498" title="Orcid link">http://orcid.org/0000-0002-6231-7498</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01104&amp;href=/doi/10.1021%2Facs.jmedchem.9b01104" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9691–9702</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 2, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 July 2019</li><li><span class="item_label"><b>Published</b> online</span>2 October 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 November 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01104" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01104</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9691%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYuting%2BFeng%252C%2BJaeok%2BPark%252C%2BShi-Guang%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D21%26contentID%3Dacs.jmedchem.9b01104%26title%3DChirality-Driven%2BMode%2Bof%2BBinding%2Bof%2B%25CE%25B1-Aminophosphonic%2BAcid-Based%2BAllosteric%2BInhibitors%2Bof%2Bthe%2BHuman%2BFarnesyl%2BPyrophosphate%2BSynthase%2B%2528hFPPS%2529%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9702%26publicationDate%3DNovember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01104"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">857</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01104" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Chirality-Driven Mode of Binding of α-Aminophosphonic Acid-Based Allosteric Inhibitors of the Human Farnesyl Pyrophosphate Synthase (hFPPS)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yuting&quot;,&quot;last_name&quot;:&quot;Feng&quot;},{&quot;first_name&quot;:&quot;Jaeok&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;Shi-Guang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;Boutin&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Viereck&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;A. Schilling&quot;},{&quot;first_name&quot;:&quot;Albert&quot;,&quot;last_name&quot;:&quot;M. Berghuis&quot;},{&quot;first_name&quot;:&quot;Youla&quot;,&quot;last_name&quot;:&quot;S. Tsantrizos&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;9691-9702&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01104&quot;},&quot;abstract&quot;:&quot;Thienopyrimidine-based allosteric inhibitors of the human farnesyl pyrophosphate synthase (hFPPS), characterized by a chiral α-aminophosphonic acid moiety, were synthesized as enantiomerically enriched pairs, and their binding mode was investigated by X-ray crystallography. A general consensus in the binding orientation of all (R)- and (S)-enantiomers was revealed. This finding is a prerequisite for establishing a reliable structure–activity relationship (SAR) model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01104&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01104" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01104&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01104" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01104&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01104" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01104&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01104&amp;href=/doi/10.1021/acs.jmedchem.9b01104" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01104" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01104" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01104%26sid%3Dliteratum%253Aachs%26pmid%3D31577901%26genre%3Darticle%26aulast%3DFeng%26date%3D2019%26atitle%3DChirality-Driven%2BMode%2Bof%2BBinding%2Bof%2B%25CE%25B1-Aminophosphonic%2BAcid-Based%2BAllosteric%2BInhibitors%2Bof%2Bthe%2BHuman%2BFarnesyl%2BPyrophosphate%2BSynthase%2B%2528hFPPS%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D21%26spage%3D9691%26epage%3D9702%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291157" title="Organophosphorus compounds">Organophosphorus compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/jmcmar.2019.62.issue-21/20191114/jmcmar.2019.62.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Thienopyrimidine-based allosteric inhibitors of the human farnesyl pyrophosphate synthase (hFPPS), characterized by a chiral α-aminophosphonic acid moiety, were synthesized as enantiomerically enriched pairs, and their binding mode was investigated by X-ray crystallography. A general consensus in the binding orientation of all (<i>R</i>)- and (<i>S</i>)-enantiomers was revealed. This finding is a prerequisite for establishing a reliable structure–activity relationship (SAR) model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human farnesyl pyrophosphate synthase (hFPPS) is the gatekeeper of mammalian isoprenoid biosynthesis and a validated therapeutic target for bone-related diseases.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The catalytic product of hFPPS is the C-15 isoprenoid farnesyl pyrophosphate (FPP), which is formed from the successive condensation of two C-5 isopentenyl pyrophosphate (IPP) units with dimethyl allyl pyrophosphate (DMAPP). FPP is a key precursor to many essential metabolites, including geranylgeranyl pyrophosphate (GGPP). Blocking post-translational farnesylation or geranylgeranylation of small GTP-binding proteins (GTPases), particularly members of the RAS superfamily that are known drivers of oncogenesis, has been proposed as a potential novel mechanism for treating cancer.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> However, bona fide and clinically validated antitumor agents that selectively target hFPPS have not yet been identified. Currently, nitrogen-containing bisphosphonates (<i>N</i>-BPs; e.g., zoledronic acid <b>1</b>) are the only approved drugs that selectively target hFPPS. These inhibitors bind to the allylic subpocket of the active site and exhibit low nanomolar intrinsic potency (e.g., the IC<sub>50</sub> value of the most potent known inhibitor <b>1</b> is ∼2–4 nM).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> It has been assumed that the highly charged nature of the bisphosphonate pharmacophore of <i>N</i>-BPs, which exists as the trianion under physiological conditions, limits their cell membrane permeability, systemic circulation, and exposure to nonskeletal tissues. Nonetheless, clinical data obtained from patients treated with <b>1</b>, in addition to standard chemotherapy, suggest that this compound may have some therapeutic value in the treatment of cancers such as multiple myeloma<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and breast cancer.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Consequently, the identification of more “drug-like” (in the classical sense) inhibitors of hFPPS has attracted significant attention in recent years.</div><div class="NLM_p">The discovery of a catalytically relevant, allosteric pocket near the IPP binding subpocket of the active site<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> has fueled interest in the discovery of nonbisphosphonate inhibitors that can bind to this pocket and may exhibit superior biopharmaceutical properties than those of <i>N</i>-BPs. This allosteric pocket was found to play a critical role in the feedback mechanism of the enzyme, which is Nature’s way of controlling the intracellular concentrations of FPP.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> To date, many nonbisphosphonate, allosteric inhibitors of hFPPS have been reported; some examples are shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of active site (<b>1</b>) and allosteric inhibitors (<b>2</b>–<b>7</b>) of hFPPS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In the course of our own investigations, we discovered a new chemotype of allosteric inhibitors, the C6-substituted thienopyrimidine-based monophosphonate (C<sup>6</sup>–ThP-MP) analogues <b>6</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). These analogues are characterized by a chiral α-aminophosphonic acid moiety, which was previously shown to adopt two different binding orientations.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> A general consensus in the binding mode of all analogues within a structural class of inhibitors is a prerequisite for establishing a reliable structure–activity relationship (SAR) model. A predictive SAR model is the hallmark of medicinal chemistry and drug discovery. Therefore, we embarked on an investigation into the role of the α-aminophosphonic acid in controlling the binding orientation of this class of inhibitors. In this report, we describe the synthesis of several enantiomeric pairs of <b>6</b> and demonstrate that their chirality controls the binding orientation and interactions of these inhibitors with the hFPPS allosteric pocket.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The asymmetric synthesis of α-aminophosphonic acids is of considerable interest in drug discovery.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> These bioisosteres of amino acids are useful building blocks in the design of potential therapeutic agents, including HCV protease inhibitors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> A number of methodologies for their asymmetric synthesis have been previously reported. Recent examples include metal-catalyzed asymmetric hydrogenation of α,β-dehydroaminophosphonates,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> α-iminophosphonates,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and α-hydrazono phosphates,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> asymmetric hydrophosphonylation of imines,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> [3 + 2] cycloaddition of dehydroaminophosphonates and <i>N</i>-tosylhydrazones,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and other enantioselective C–C bond forming reactions that can lead to the formation of chiral quaternary Cα centers, as well as the asymmetric three component Kabachnik–Fields condensations.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">In this study, we adopted the asymmetric 1,4-addition of aryltrifluoroborates to dehydroaminophosphonate catalyzed by a Rh-Difluorphos complex for the preparation of the (<i>R</i>)<i>-</i>α-aminophosphonates with a benzylic side chain as previously reported by Darses (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, path A).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Preparation of various (<i>R</i>)-acetamido phosphonate esters <b>10</b> was initiated with the preparation of diethyl (1-acetamidovinyl)phosphonate <b>8</b>, following the protocol previously reported.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The subsequent 1,4-addition of various aryltrifluoroborates or boronic acids (<b>9</b>) to <b>8</b> proceeded to give the desired products (<i>R</i>)-<b>10</b> in 70–75% isolated yields and 85–90% enantiomeric excess (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, path A). Because the (<i>R</i>)-Difluorphos ligand is not commercially available, we decided to screen several other commonly used phosphorus-based ligands (e.g., BINAP, SEGPHOS, and many others) for the preparation of intermediates (<i>S</i>)-<b>10</b>. However, all of the ligands tested led to significantly lower enantiomeric purity of the (<i>S</i>)-<b>10</b> products. For example, only 55% ee was observed with both (<i>S</i>)-BINAP and (<i>S</i>)-SEGPHOS in the synthesis of analogue (<i>S</i>)-<b>10a</b>. Recently, a site-selective and enantioselective modification of an amino acid moiety in the natural product thiostrepton was reported by Key and Miller.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In this transformation, 1,4-addition of an arylboronic acids to an olefinic moiety was catalyzed by [Rh(nbd)<sub>2</sub>]BF<sub>4</sub> in the presence of (<i>S</i>,<i>S</i>)-Chiraphos as the ligand. We adopted this method and successfully synthesized various (<i>S</i>)-<b>10</b> building blocks in good yield (∼70%) and enantiomeric purity (70–80% ee; <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, path B).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Asymmetric Synthesis of α-Aminophosphonic Acid hFPPS Allosteric Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) [Rh(C<sub>2</sub>H<sub>4</sub>)<sub>2</sub>Cl]<sub>2</sub> (1.5 mol %), (<i>S</i>)-Difluorphos (3.3 mol %), NaHCO<sub>3</sub> (2 equiv), <i>i</i>PrOH, 90°C, 18 h (70–80% yield); (b) Rh(nbd)<sub>2</sub>BF<sub>4</sub> (7.5 mol %), (<i>S</i>,<i>S</i>)-Chiraphos (8 mol %), Na<sub>2</sub>CO<sub>3</sub> (1 equiv), MeOH (8 equiv), dioxane/H<sub>2</sub>O, 70°C, 20 h (60–70% yield); (c) (i) Boc<sub>2</sub>O, DMAP (cat.), THF, 80°C, 4 h, (ii) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O (2:1), RT, 20 h, (iii) HCl (4M in dioxane), DCM, RT, 3 h (50%); (d) Et<sub>3</sub>N, DMSO, 100°C, 2 h (50–80%); (e) TMSBr/MeOH, RT, 24 h (40–80% yield); (f) HPO(OEt)<sub>2</sub>, (<i>R</i>,<i>R</i>)- or (<i>S</i>,<i>S</i>)-ProPhenol/Et<sub>2</sub>Zn (10 mol %) toluene, 0 °C, 0.5 h (30% yield); (g) [Rh(cod)<sub>2</sub>]BF<sub>4</sub> (3 mol %), (<i>S</i>)-BINAP (6 mol %), guaiacol (1 equiv), toluene, 110 °C, 16 h (50% yield).</p></p></figure><div class="NLM_p">Unfortunately, neither of the above methods (i.e., paths A or B) were successful in the preparation of analogues <b>10</b> with an alkyl side chain (e.g., cyclohexyl derivative <b>10c</b>; <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, path C). Such analogues were prepared by asymmetric phosphorylation of the <i>N</i>-acylimine intermediate <b>11</b> catalyzed by diethyl zinc in the presence of Trost’s (<i>S</i>,<i>S</i>)- or (<i>R</i>,<i>R</i>)- ProPhenol ligands,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> as previously reported by Wang.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Although both the (<i>R</i>)- and (<i>S</i>)-<b>10c</b> were obtained in high enantiomeric purity (∼95% ee), the isolated yields were low (∼30%). Isomerization of imine <b>11</b> to the corresponding enamide <b>12</b> was observed as the main side product and the likely reason for the low yields. This isomerization has been previously observed with other similar systems<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and suggests that this methodology (i.e., <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, path C) would likely be even more problematic for the preparation of benzylic analogues, such as <b>10a</b> and <b>10b</b>.</div><div class="NLM_p">The subsequent removal of the <i>N</i>-acyl or <i>N</i>-benzoyl protecting groups of all intermediates <b>10</b> was achieved under mild conditions using a 3-step protocol, which involves the amide-to-carbamate transformation originally reported by Burk and Allen.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The Boc group was cleaved under standard acidic conditions to liberate the free amine intermediates <b>13</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Nucleophilic addition of amines <b>13</b> to the 4-fluoro-6-(<i>p</i>-tolyl)thieno[2,3-<i>d</i>]pyrimidine scaffold <b>14a</b>,<b>b</b> via S<sub>N</sub>Ar, followed by deprotection of the phosphonate ethyl esters, as previously reported,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> gave the final C<sup>6</sup>–ThP-MP inhibitors (<i>R</i>)- and (<i>S</i>)-<b>6d</b>–<b>6h</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><div class="NLM_p">To probe the binding contributions of the phosphonate group, we also synthesized the α-amino acid derivative of our most potent inhibitor <b>6g</b>. The synthesis of the amino acid (<i>S</i>)-<b>17</b> was achieved starting with 1,4-addition of aryltrifluoroborate <b>9d</b> to commercially available methyl 2-acetamidoacrylate (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), followed by deprotection of both the amine and the carboxylic acid moieties using the same protocol as for the conversion of the α-aminophosphonates <b>10</b>–<b>13</b>. For the synthesis of (<i>R</i>)-<b>17</b>, the best enantiomeric purity was achieved using the rhodium-catalyzed 1,4-addition of <b>9d</b> in the presence of (<i>S</i>)-BINAP and guaiacol, as previously reported by Darses.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Previously, in an effort to expedite optimization of our initial hit compound <b>6a</b> and establish SAR, a library of C<sup>6</sup>–ThP-MP analogues was prepared in racemic mixtures (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In this approach, a presumption was made that the potency observed with the racemic compounds would be mainly due to one enantiomer. In addition, it was assumed that the potent (<i>or more potent</i>) enantiomer was more likely to bind and cocrystallize with the enzyme. However, when enantiomerically enriched inhibitors (<i>R</i>)- and (<i>S</i>)-<b>6</b> were prepared, to our surprise, only a 2–3-fold difference in potency was observed, suggesting that more than one binding mode was possible for this class of compounds. This assumption was confirmed by the cocrystal structures of several analogues, including those of inhibitors <b>6a</b>, <b>6b</b>, and <b>6g</b>, which bound to the hFPPS allosteric pocket in two distinct orientations (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>; cocrystallizations were carried out with the racemic mixtures of the inhibitors).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Interestingly, the aromatic 6-tolyl thienopyrimidine core was the only part of these molecules that adopted consistent binding interactions with the protein, engaging in an edge-to-face π-stacking interaction with the side chain of Phe239 and a sandwich of π-stacking interactions with the side chains of Phe206 and Asn59. In contrast, the entire molecule <b>6g</b> was flipped by approximately 180° as compared to <b>6a</b> and <b>6b</b>, and consequently, the α-aminophosphonate moiety of each compound adopted a completely different orientation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). For example, in analogue <b>6a</b>, the phosphonate moiety was bound facing the active site and close to the guanidinium ion of Arg60 (from here on referred to as the “up orientation”; <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a), whereas in analogue <b>6g</b>, the phosphonate was bound nearly in the opposite direction and toward the solvent-exposed surface of the cavity (from here on referred to as the “down orientation”; <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Previously determined cocrystal structures of C<sup>6</sup>–ThP-MP inhibitors <b>6</b> (racemic samples of inhibitors <b>6b</b> and <b>6g</b> were used):<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (a) <b>6a</b>, (b) <b>6b</b>, and (c) <b>6g</b> bound in the allosteric pocket of hFPPS. For clarity, protein residues are only labeled in (a).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In this study, we reinvestigated the molecular interactions between hFPPS and several pairs of (<i>R</i>)- and (<i>S</i>)-enantiomers of the C<sup>6</sup>–ThP-MP inhibitors (<b>6</b>) by X-ray crystallography. A general consensus in the binding orientation for all (<i>S</i>)-<b>6</b>/enzyme complexes (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a,c,e) and a different consensus in binding for all the (<i>R</i>)-<b>6</b>/enzyme complexes (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b,d,f) were observed. Regardless of the presence of a substituent on the C-6 tolyl moiety attached to the thienopyrimidine core and/or a substituent on the Cα benzyl moiety of the α-aminophosphonate moiety (i.e., R<sup>1</sup>), all of the inhibitors with the (<i>S</i>)-stereochemistry were found to bind with the phosphonate in the “up-orientation” (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a,c,e), whereas all the (<i>R</i>)-enantiomers bound with the phosphonate in the “down-orientation” (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b,d,f). It should be noted that all crystals were obtained under slightly basic conditions (i.e., pH ∼ 7.5–8.5) to ensure (<i>inasmuch as it is possible</i>) that the phosphonate moiety of the enzyme-bound inhibitors were fully deprotonated; reported p<i>K</i><sub>a</sub>s of α-aminophosphonates are in the range of 2.3 (1st p<i>K</i><sub>a</sub>) to 6.0 (2nd p<i>K</i><sub>a</sub>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> It is noteworthy that inhibitor (<i>R</i>)-<b>6b</b>, which has a larger aromatic substituent directly attached to the Cα carbon, displays a different binding orientation (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). As we previously reported,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> this is likely due to anticipated steric clashes between the dihydrobenzofuran moiety and residues of the α<sub>H</sub> and α<sub>J</sub> helices of the protein, which prevent this compound from binding in the “down orientation”. Such unfavorable interactions may also induce an unusual microenvironment protonation of the D243 carboxylate side chain, which is found to bind close to the phosphonate moiety of the inhibitor. However, because inhibitors with an aromatic moiety directly attached to the Cα carbon are less potent that the benzylic analogues, we did not explore these analogues any further.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cocrystal structures of inhibitor/hFPPS complexes. Inhibitors: (a) (<i>S</i>)-<b>6d</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Z">6N7Z</a>), (b) (<i>R</i>)-<b>6d</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Y">6N7Y</a>), (c) (<i>S</i>)-<b>6f</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAG">6OAG</a>), (d) (<i>R</i>)-<b>6f</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAH">6OAH</a>), (e) (<i>S</i>)-<b>6g</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N82">6N82</a>), and (f) (<i>R</i>)-<b>6g</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N83">6N83</a>). The red spheres represent water molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We further examined the effects of the 3-chloro substituent on the C-6 tolyl moiety, which was previously found to improve the in vitro potency of these compounds. The cocrystal structures of inhibitors (<i>R</i>)-<b>6f</b> and (<i>R</i>)-<b>6g</b> (parts d and f of <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, respectively), which bind in the “down orientation”, revealed that the 3-chloro moiety contributed to the binding affinity of these inhibitors by making the entire tolyl side chain occupy the allosteric pocket more tightly (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b,c vs a). Additionally, the binding of the chlorine substituent induced some movement to the scaffold, which led to either a direct (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>d) or a water-mediated H-bond between the exocyclic C-4 nitrogen of the thienopyrimidine core and the carbonyl oxygen of Lys347 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>f). In contrast, with inhibitors (<i>S</i>)-<b>6f</b> and (<i>S</i>)-<b>6g</b> (parts c and e of <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, respectively), which bind in the “up orientation”, the 3-chloro moiety pushed the scaffold upward by ∼1 Å, causing the loss of several water-mediated interactions between the phosphonate moiety and the protein (e.g., to Asn59 and Arg60; <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a). These water-mediated interactions were previously observed with several analogues, including our initial hit, compound <b>6a</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a), and presumed to contribute to the binding affinity of these inhibitors.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Sideview of (<i>R</i>)-enantiomeric C<sup>6</sup>–ThP-MP inhibitor binding in space-filling representation. (a) (<i>R</i>)-<b>6d</b>, (b) (<i>R</i>)-<b>6f</b>, and (c) (<i>R</i>)-<b>6g</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Substitution on the Cα benzyl (i.e., <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>; inhibitor <b>6</b>, R<sup>1</sup>) of the α-aminophosphonate also played a significant role in the inhibitor/enzyme complex formation. For example, the 3-fluorobenzyl substituent in analogues <b>6e</b> and <b>6g</b> introduced additional binding interactions with the protein. The fluorine atom in (<i>S</i>)-<b>6g</b> formed water-mediated H-bonds with the carbonyl of Phe239 and Gln242 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>e), whereas in the (<i>R</i>)-enantiomer of <b>6g</b>, the fluorobenzyl moiety packed more tightly against the protein surface engaging in stronger van der Waals interactions, and the benzyl ring made a stacking interaction with the side chain of Phe239 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>f). Additionally, the fluorine atom appeared to form a direct nonclassical H-bond with the NH amide of Gln242. These interactions pushed the thienopyrimidine scaffold significantly toward the active site while burying the 3-chlorotolyl group deeper into the allosteric pocket (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>c) and contributed to the formation of the water-mediated H-bond between the exocyclic C-4 NH of the thienopyrimidine and the carbonyl oxygen of Lys347, mentioned above (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>f). Although the position of the phosphonate group was also shifted, the interaction with the water molecule bound to Asn59 was retained (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>f). Interestingly, all hFPPS inhibitors having the (<i>R</i>)-absolute stereochemistry and a 3-chloro substituent on the C-6 tolyl moiety were found to be more potent than their corresponding (<i>S</i>)-enantiomers in our in vitro hFPPS inhibition assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). These results are consistent with the more extensive network of inhibitor/protein interactions observed by X-ray crystallography.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzyme Inhibition (IC<sub>50</sub>) of Representative Allosteric hFPPS Inhibitors<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hFPPS IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">% ee</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="center">1.3<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="center">5.0</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>6d</b></td><td class="colsep0 rowsep0" align="center">2.8</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">71<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>6d</b></td><td class="colsep0 rowsep0" align="center">7.7</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">90<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>6e</b></td><td class="colsep0 rowsep0" align="center">1.2</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">86<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>6e</b></td><td class="colsep0 rowsep0" align="center">2.8</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">80<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(<i>S</i>)</b>-<b>6f</b></td><td class="colsep0 rowsep0" align="center"><b>3.7</b></td><td class="colsep0 rowsep0" align="center"><b>Cl</b></td><td class="colsep0 rowsep0" align="center"><b>71</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(<i>R</i>)</b>-<b>6f</b></td><td class="colsep0 rowsep0" align="center"><b>1.5</b></td><td class="colsep0 rowsep0" align="center"><b>Cl</b></td><td class="colsep0 rowsep0" align="center"><b>92</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(<i>S</i>)</b>-<b>6g</b></td><td class="colsep0 rowsep0" align="center"><b>1.1</b></td><td class="colsep0 rowsep0" align="center"><b>Cl</b></td><td class="colsep0 rowsep0" align="center"><b>87</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(<i>R</i>)</b>-<b>6g</b></td><td class="colsep0 rowsep0" align="center"><b>0.54</b><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center"><b>Cl</b></td><td class="colsep0 rowsep0" align="center"><b>78</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(<i>S</i>)</b>-<b>6h</b></td><td class="colsep0 rowsep0" align="center"><b>8.1</b></td><td class="colsep0 rowsep0" align="center"><b>Cl</b></td><td class="colsep0 rowsep0" align="center"><b>91</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(<i>R</i>)</b>-<b>6h</b></td><td class="colsep0 rowsep0" align="center"><b>3.0</b></td><td class="colsep0 rowsep0" align="center"><b>Cl</b></td><td class="colsep0 rowsep0" align="center"><b>99</b><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-<b>7b</b></td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">Cl</td><td class="colsep0 rowsep0" align="center">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-<b>7b</b></td><td class="colsep0 rowsep0" align="center">1.0</td><td class="colsep0 rowsep0" align="center">Cl</td><td class="colsep0 rowsep0" align="center">80</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> values were determined with 10 min preincubation of the enzyme with each inhibitor; the values shown are average of <i>n</i> ≥ 3 determinations with standard deviation of ±5–10%. Inhibitor <b>2a</b> was used as the positive control in each assay.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Assays were run in parallel, average values of <i>n</i> = 6 determinations.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">The enantiomeric purity (% ee) of analogues <b>6</b> was estimated from the chiral HPLC data of their precursor diethyl esters <b>15</b>.</p></div></div></div><div class="NLM_p last">In our previous studies, we compared our initial hit, the α-aminophosphonate <b>6a</b>, with the corresponding carboxylic acid derivative <b>7a</b> and found the latter to be significantly less potent (IC<sub>50</sub> values of 4.5 μM and >20 μM for compounds <b>6a</b> and <b>7a</b>, respectively).<a onclick="showRef(event, 'cit8a'); return false;" href="javascript:void(0);" class="ref cit8a">(8a)</a> Although the carboxylic acid analogue (<i>R</i>)-<b>7b</b> was found to be considerably more potent (IC<sub>50</sub> value of 1 μM) than <b>7a</b>, the (<i>S</i>)-<b>7b</b> was essentially inactive at the highest concentration test of 10 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Unfortunately, we were not able to obtain a cocrystal structure of (<i>R</i>)-<b>7b</b> bound to hFPPS. In the absence of direct structural evidence, we cautiously rationalize that binding of (<i>R</i>)-<b>7b</b> should correspond to that of the phosphonate derivatives (<i>S</i>)-<b>6g</b> (i.e., binding in the “up orientation”), and because the phosphonate moiety of this analogue [i.e., (<i>S</i>)-<b>6g</b>] does not form any interactions with the protein, its replacement with a carboxylic acid should have negligible impact on potency. This hypothesis is consistent with the almost identical potency observed for the carboxylic acid analogue (<i>R</i>)-<b>7b</b> and the corresponding phosphonate derivative (<i>S</i>)-<b>6g</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>; IC<sub>50</sub> values of 1.1 vs 1.0 μM, respectively). By analogy, inhibitor (<i>S</i>)-<b>7b</b> would be expected to bind in the “down orientation” [analogous to (<i>R</i>)-<b>6g</b>], and the smaller electron density and size of the carboxylate moiety could lead to loss of the water-mediated H-bond that was previously observed between the phosphonate moiety and Asn59 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>f), leading to significant loss of potency. Currently, we cannot exclude the possibility that without the phosphonate group engaging in this interaction, the fluorobenzyl moiety may not be able to position itself correctly for optimal binding, leading to further loss in binding affinity [i.e., as seen with (<i>R</i>)-<b>6g</b>].</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we synthesized a cluster of enantiomerically enriched pairs of Cα-substituted aminophosphonate-based allosteric inhibitors <b>6</b> of the human FPPS and demonstrated that the binding mode of these compounds is driven primarily (<i>if not exclusively</i>) by their chirality. A general consensus in the binding mode of all (<i>S</i>)-enantiomers (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a,c,e) and all (<i>R</i>)-enantiomers (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>b,d,f) was observed. These results can guide our future efforts in establishing a reliable SAR model. Independent optimization of the (<i>R</i>)- and (<i>S</i>)-enantiomers, expected to lead to divergent SAR, could also lead to more potent and selective allosteric inhibitors of hFPPS that can be used in vivo to confirm hFPPS as a validated biological target for oncology.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56607" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56607" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> General Information</h3><div class="NLM_p last">All reactions were carried out under an atmosphere of dry argon unless otherwise specified. Completion of all reactions was monitored by TLC and/or LC-MS. Flash column chromatography was performed on silica gel (Sigma-Aldrich, 60 Å, 230–400 mesh, 40–63 μm) as the stationary phase. Thin layer chromatography (TLC) was performed on alumina plates precoated with silica gel (MilliporeSigma, 60 Å, F254) and visualized by UV fluorescence when applicable (λ<sub>max</sub> = 254 nm) and/or by staining with Seebach’s Magic Stain (acidic aqueous solution of polymolybdic acid and cerium(IV) sulfate), ninhydrin, or basic aqueous KMnO<sub>4</sub> solution. All compounds were fully characterized by <sup>1</sup>H, <sup>13</sup>C, <sup>19</sup>F, <sup>31</sup>P NMR, and HRMS. <sup>1</sup>H NMR were recorded at 400 or 500 MHz, and coupling constants (<i>J</i>) are reported to ±0.5 Hz. <sup>13</sup>C{<sup>1</sup>H} NMR were recorded at 125 MHz and <sup>31</sup>P{<sup>1</sup>H} NMR were recorded at 202 MHz, unless otherwise indicated. Chemical shifts (δ) are reported in ppm relative to the internal deuterated solvent. Enantiomeric purity of chiral compounds was determined by chiral HPLC using an Agilent 1100 series instrument and the column type and solvent system indicated. Enantiomeric purity (% ee) was determined at two stages: intermediates <b>10</b> and <b>15</b> for the α-aminophosphonate analogues, as well as <b>16</b> and final compound <b>7b</b> for the carboxylic acid inhibitor. The absolute stereochemistry of the major enantiomer in all new α-aminophosphonates and α-amino acids were assigned by analogy with previously reported compounds in the literature. These assignments were further confirmed from the cocrystal structures of inhibitors (<i>R</i>)- and (<i>S</i>)-<b>6d</b>, (<i>R</i>)- and (<i>S</i>)-<b>6f</b>, and (<i>R</i>)- and (<i>S</i>)-<b>6g</b>. The homogeneity of all final inhibitors, compounds (<i>R</i>)- and (<i>S</i>)-<b>6d</b>–<b>6h</b> and <b>7b</b> were confirmed to >95% by <sup>1</sup>H NMR and C18 reversed phase HPLC, using an Atlantis T3 OBD, 5 μm, 4.6 mm × 100 mm column and a linear gradient of H<sub>2</sub>O:MeCN from 95:5 to 5:95 in 13 min then 100% MeCN for 2 min at a flow rate of 1 mL/min (all solvents contained 0.1% formic acid). LRMS were obtained on a Waters LC-MS instrument with ESI ± modes. HRMS were obtained on a TOF instrument with ESI ± modes, and the quoted masses are accurate to ±5 ppm. The names of the molecules that appear in the following pages were generated using ChemBioDraw Ultra 12.0.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> General Procedure for the Preparation of Final Inhibitors <b>6</b></h3><div class="NLM_p">Synthesis of the thienopyrimidine scaffolds <b>14</b>, the S<sub>N</sub>Ar reaction between <b>13</b> and <b>14</b>, as well as the final deprotection of the phosphonate esters <b>15</b>, to obtain the phosphonic acid inhibitors <b>6</b> were previously reported.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> (<i>R</i>)- or (<i>S</i>)-(2-Phenyl-1-((6-(<i>p</i>-tolyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)phosphonic Acid [(<i>R</i>)- or (<i>S</i>)-<b>6d</b>]</h4><div class="NLM_p last">Both compounds were isolated as off-white solids: (<i>R</i>)-<b>6d</b>, 3 mg, 37% yield; (<i>S</i>)-<b>6d</b>, 15 mg, 90% yield (yields indicated are for the last deprotection step). <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O): δ 7.88 (s, 1H), 7.75 (s, 1H), 7.60 (d, <i>J</i> = 8.1 Hz, 2H), 7.34 (d, <i>J</i> = 7.2 Hz, 2H), 7.24 (d, <i>J</i> = 8.0 Hz, 2H), 7.13 (t, <i>J</i> = 7.4 Hz, 2H), 7.06 (t, <i>J</i> = 7.3 Hz, 1H), 4.59 (ddd, <i>J</i> = 15.2, 12.4, 3.0 Hz, 3H), 3.46 (d, <i>J</i> = 13.8 Hz, 1H), 2.92 (td, <i>J</i> = 13.1, 6.5 Hz, 1H), 2.37 (s, 3H). <sup>31</sup>P{<sup>1</sup>H}NMR (203 MHz, D<sub>2</sub>O): δ 15.84. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, D<sub>2</sub>O): δ 162.6, 156.7, 152.10, 140.1, 139.9 (d, <i>J</i> = 13.5 Hz), 138.7, 129.7, 129.6, 129.4, 128.1, 126.2, 125.3, 118.1, 112.9, 52.4 (d, <i>J</i> = 138.2 Hz), 38.1, 20.2. HRMS-ESI (<i>m</i>/<i>z</i>) [M – H<sup>+</sup>]<sup>−</sup> calcd for C<sub>21</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>PS: 424.0890, found 424.0878.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> (<i>R</i>)- or (<i>S</i>)-(2-(3-Fluorophenyl)-1-((6-(p-tolyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)phosphonic Acid [(<i>R</i>)- or (<i>S</i>)-<b>6e</b>]</h4><div class="NLM_p last">Both compounds were isolated as off-white solids: (<i>R</i>)-<b>6e</b>, 6 mg, 40% yield; (<i>S</i>)-<b>6e</b>, 5 mg, 45% yield (yields indicated are for the last deprotection step). <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O): δ 7.71 (s, 1H), 7.61 (s, 1H), 7.49 (d, <i>J</i> = 7.9 Hz, 2H), 7.14 (d, <i>J</i> = 7.7 Hz, 2H), 6.90 (dd, <i>J</i> = 16.5, 9.5 Hz, 3H), 6.60 (t, <i>J</i> = 8.4 Hz, 1H), 4.38 (ddd, <i>J</i> = 15.6, 12.1, 3.1 Hz, 1H), 3.27 (d, <i>J</i> = 13.6 Hz, 1H), 2.73 (td, <i>J</i> = 12.9, 6.5 Hz, 1H), 2.23 (s, 3H). <sup>19</sup>F{<sup>1</sup>H}NMR (471 MHz, D<sub>2</sub>O): δ −115.07. <sup>31</sup>P{<sup>1</sup>H}NMR (203 MHz, D<sub>2</sub>O): δ 15.62. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, D<sub>2</sub>O): δ 163.3, 162.1 (d, <i>J</i> = 187.3 Hz), 156.8, 152.2, 142.6 (d, <i>J</i> = 21.2 Hz), 140.3, 139.0, 129.8, 129.6 (d, <i>J</i> = 8.4 Hz), 129.5, 125.6, 125.5, 118.2, 116.2 (d, <i>J</i> = 21.0 Hz), 113.1, 112.7 (d, <i>J</i> = 20.6 Hz), 52.3 (d, <i>J</i> = 136.6 Hz), 38.0, 20.3. HRMS-ESI (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>20</sub>FN<sub>3</sub>O<sub>3</sub>PS: 444.0942, found 444.0949.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> (<i>R</i>)- or (<i>S</i>)-(1-((6-(3-Chloro-4-methylphenyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)amino)-2-phenylethyl)phosphonic Acid [(<i>R</i>)- or (<i>S</i>)-<b>6f</b>]</h4><div class="NLM_p last">Both compounds were isolated as off-white solids: (<i>R</i>)-<b>6f</b>, 18 mg, 90% yield; (<i>S</i>)-<b>6f</b>, 8 mg, 88% yield (yields indicated are for the last deprotection step). <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O): δ 7.84 (s, 1H), 7.65 (s, 1H), 7.50 (s, 1H), 7.34 (d, <i>J</i> = 7.5 Hz, 2H), 7.25 (d, <i>J</i> = 7.9 Hz, 1H), 7.12 (t, <i>J</i> = 7.5 Hz, 2H), 7.03 (t, <i>J</i> = 7.3 Hz, 1H), 6.92 (d, <i>J</i> = 8.0 Hz, 1H), 4.58 (t, <i>J</i> = 13.7 Hz, 1H), 3.44 (d, <i>J</i> = 13.8 Hz, 1H), 2.90 (td, <i>J</i> = 12.7, 6.1 Hz, 1H), 2.18 (s, 3H). <sup>31</sup>P{<sup>1</sup>H}NMR (203 MHz, D<sub>2</sub>O): δ 15.79. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, D<sub>2</sub>O): δ 162.9, 156.7, 152.5, 139.8 (d, <i>J</i> = 7.1 Hz), 138.4, 135.9, 134.0, 131.6, 131.0, 129.4, 128.1, 126.1, 125.3, 123.5, 117.9, 113.8, 52.3 (d, <i>J</i> = 143.0 Hz), 38.0, 18.8. HRMS-ESI (<i>m</i>/<i>z</i>) [M – H<sup>+</sup>]<sup>−</sup> calcd for C<sub>21</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>3</sub>PS: 458.0501, found 458.0489.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> (<i>R</i>)- or (<i>S</i>)-(1-((6-(3-Chloro-4-methylphenyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)amino)-2-(3-fluorophenyl)ethyl)phosphonic Acid [(<i>R</i>)- or (<i>S</i>)-<b>6g</b>]</h4><div class="NLM_p last">Both compounds were isolated as off-white solids: (<i>R</i>)-<b>6g</b>, 10 mg, 41% yield; (<i>S</i>)-<b>6g</b>, 5 mg, 50% yield (yields indicated are for the last deprotection step). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ 7.88 (s, 1H), 7.79 (d, <i>J</i> = 1.5 Hz, 2H), 7.58 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.37 (d, <i>J</i> = 8.0 Hz, 1H), 7.10–7.00 (m, 3H), 6.75 (t, <i>J</i> = 9.0 Hz, 1H), 4.53 (ddd, <i>J</i> = 15.6, 12.3, 3.0 Hz, 1H), 3.42 (dt, <i>J</i> = 13.3, 3.0 Hz, 1H), 2.88 (td, <i>J</i> = 13.3, 6.6 Hz, 1H), 2.41 (s, 3H). <sup>31</sup>P{<sup>1</sup>H}NMR (162 MHz, D<sub>2</sub>O): δ 15.31. <sup>19</sup>F{<sup>1</sup>H}NMR (377 MHz, D<sub>2</sub>O) δ −115.57. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, D<sub>2</sub>O): δ 163.0, 162.3 (d, <i>J</i> = 242.4 Hz), 156.9 (d, <i>J</i> = 6.6 Hz), 152.5, 142.6 (dd, <i>J</i> = 13.6, 7.2 Hz), 138.4, 136.3, 134.2, 131.9, 131.2, 129.5 (d, <i>J</i> = 8.5 Hz), 125.6, 125.6 (d, <i>J</i> = 2.4 Hz), 123.8, 117.9, 116.2 (d, <i>J</i> = 20.8 Hz), 114.1, 112.7 (d, <i>J</i> = 21.0 Hz), 52.2 (d, <i>J</i> = 138.4 Hz), 38.0, 18.8. HRMS-ESI (<i>m</i>/<i>z</i>) [M – H<sup>+</sup>]<sup>−</sup> calcd for C<sub>21</sub>H<sub>17</sub>ClFN<sub>3</sub>O<sub>3</sub>PS: 476.0406, found 476.0387.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> (<i>R</i>)- or (<i>S</i>)-(1-((6-(3-Chloro-4-methylphenyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)amino)-2-cyclohexylethyl)phosphonic Acid [(<i>R</i>)- or (<i>S</i>)-<b>6h</b>]</h4><div class="NLM_p last">Both compounds were isolated as off-white solids: (<i>R</i>)-<b>6h</b>, 3 mg, 50% yield; (<i>S</i>)-<b>6h</b>, 5 mg, 35% yield (yields indicated are for the last deprotection step). <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O): δ 8.21 (s, 1H), 7.59 (s, 1H), 7.47 (s, 1H), 7.34 (d, <i>J</i> = 7.9 Hz, 1H), 7.17 (d, <i>J</i> = 7.9 Hz, 1H), 4.43 (t, <i>J</i> = 13.7 Hz, 1H), 2.16 (s, 3H), 2.01 (d, <i>J</i> = 12.2 Hz, 1H), 1.81 (t, <i>J</i> = 12.4 Hz, 1H), 1.72–1.55 (m, 5H), 1.31 (d, <i>J</i> = 11.8 Hz, 1H), 1.22–1.01 (m, 4H), 0.92 (q, <i>J</i> = 11.8 Hz, 1H). <sup>31</sup>P{<sup>1</sup>H}NMR (202 MHz, D<sub>2</sub>O): δ 17.32. <sup>13</sup>C{<sup>1</sup>H}NMR (201 MHz, D<sub>2</sub>O): δ 163.1, 153.2, 138.2, 136.3, 134.3, 132.0, 131.3, 125.7, 123.9, 114.2, 48.5, 47.8, 39.5, 34.2, 32.1, 26.2, 25.9, 18.9. HRMS-ESI (<i>m</i>/<i>z</i>) [M – H<sup>+</sup>]<sup>−</sup> calcd for C<sub>21</sub>H<sub>25</sub>ClN<sub>3</sub>O<sub>3</sub>PS: 464.0970, found 464.0982.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> ((<i>R</i>)- or (<i>S</i>)-2-((6-(3-Chloro-4-methylphenyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)amino)-3-(3-fluorophenyl)propanoic Acid [(<i>R</i>)- or (<i>S</i>)-<b>7b</b>]</h4><div class="NLM_p last">The S<sub>N</sub>Ar reaction between α-amino acid <b>17</b> and <b>14b</b> was conducted based on a previously reported procedure with minor modifications.<a onclick="showRef(event, 'cit8a ref9'); return false;" href="javascript:void(0);" class="ref cit8a ref9">(8a,9)</a> To a stirred solution of <b>14b</b> (28 mg, 0.1 mmol, 1 equiv) in 1.6 mL of dioxane, HCl salt of <b>17</b> (33 mg, 0.15 mmol, 1.5 equiv) in dioxane:H<sub>2</sub>O mixture (1:1, 1.6 mL, pH = ∼8–9 adjusted with 2.5 equiv Na<sub>2</sub>CO<sub>3</sub>) was added. The mixture was stirred at 100 °C for 30 min and then acidified using 1 M HCl (10 mL). EtOAc (10 mL × 2) was used to extract organic compounds from the aqueous phase. The crude was concentrated under reduced pressure. First purification was done by flash chromatography on silica gel using a solvent gradiant from 20 to 50% EtOAc in hexane followed by 0–10% MeOH in Et<sub>2</sub>O. The concentrated polar fractions were repurified using semipreparative HPLC on a C18 reversed phase column (Atlantis T3 OBD Prep Column, 100 Å, 5 μm, 19 mm × 50 mm) to give both enantiomers as white solids: (<i>R</i>)-<b>7b</b> (6 mg) in 20% yield, 80% ee; (<i>S</i>)-<b>7b</b> (15 mg) 32% yield, 83% ee. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.29 (s, 1H), 8.15 (s, 1H), 8.01 (d, <i>J</i> = 7.8 Hz, 1H), 7.74 (d, <i>J</i> = 1.9 Hz, 1H), 7.55 (dd, <i>J</i> = 7.9, 1.9 Hz, 1H), 7.47 (d, <i>J</i> = 8.0 Hz, 1H), 7.26 (td, <i>J</i> = 8.0, 6.3 Hz, 1H), 7.16–7.09 (m, 2H), 7.00–6.92 (m, 1H), 4.86 (q, <i>J</i> = 8.8, 7.5 Hz, 1H), 3.13 (dd, <i>J</i> = 13.9, 9.3 Hz, 2H), 2.37 (s, 3H). <sup>19</sup>F{<sup>1</sup>H}NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>): δ −114.18. <sup>13</sup>C{<sup>1</sup>H}NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.5, 164.9, 161.9 (d, <i>J</i> = 242.3 Hz), 156.2, 154.0, 142.2 (d, <i>J</i> = 6.9 Hz), 136.1, 135.6, 134.1, 132.8, 132.0, 129.6 (d, <i>J</i> = 8.3 Hz), 125.4, 125.3 (d, <i>J</i> = 2.5 Hz), 124.3, 117.4, 116.0 (d, <i>J</i> = 10.8 Hz), 115.7, 112.6 (d, <i>J</i> = 20.8 Hz), 55.8, 36.9, 19.3. HRMS-ESI (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>17</sub>ClFN<sub>3</sub>O<sub>2</sub>S: 442.0787, found 442.0775. Chiral HPLC (UV abs 254 nm), Lux Cellulose-3 (250 mm × 4.6 mm), 60:40 MeCN:H<sub>2</sub>O (0.1% formic acid), 1 mL/min: (<i>R</i>)-enantiomer <i>t</i><sub>R</sub> = 6.43 min, (<i>S</i>)-enantiomer <i>t</i><sub>R</sub> = 6.81 min.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Diethyl (1-Acetamidovinyl)phosphonate (<b>8</b>)</h3><div class="NLM_p">The synthesis of compound <b>8</b> was achieved in two steps as previously reported.<a onclick="showRef(event, 'ref18 ref25'); return false;" href="javascript:void(0);" class="ref ref18 ref25">(18,25)</a></div><div class="NLM_p"><b>Step 1</b>: Triethyl phosphite (9.2 mL, 54 mmol) was slowly added to acetyl chloride (3.8 mL, 60 mmol) at 0 °C under Ar. The mixture was stirred for 18 h at RT and concentrated under reduced pressure to remove excessive starting material and byproduct. Diethyl acetylphosphonate was isolated as a colorless oil (9.25 g, 95% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 4.23 (p, <i>J</i> = 7.2 Hz, 4H), 2.48 (d, <i>J</i> = 5.1 Hz, 3H), 1.38 (t, <i>J</i> = 7.1 Hz, 6H). <sup>31</sup>P{<sup>1</sup>H}NMR (203 MHz, CDCl<sub>3</sub>): δ −2.89. NMR data consistent with those previously reported.</div><div class="NLM_p last"><b>Step 2</b>: In a 250 mL three-neck round-bottom flask connected to Dean–Stark apparatus with a condenser, cyclohexane (90 mL) was added to acetamide (4.35 g, 73.5 mmol, 1.5 equiv), pTsOH monohydrate (0.932 g, 4.9 mmol, 0.1 equiv), and <i>p</i>-methoxyphenol (6.1 mg, 0.049 mmol, 0.1 mol %) under Ar. The mixture was refluxed at 102 °C, and diethyl acetylphosphonate (9.29 g, 49 mmol) was added dropwise over 60 min with a syringe pump. After refluxing for another 2 h, the mixture was cooled to RT and concentrated. Water (100 mL) and EtOAc (50 mL) were added to the crude; the two phases were separated, and the aqueous phase was further extracted with EtOAc (50 mL × 2). The combined organic phase was dried over anhydrous MgSO<sub>4</sub> and concentrated. The crude pale-yellow oil was purified by flash chromatography using 20–85% EtOAc in hexane (desired product eluted at 60–70% EtOAc) to yield an off-white solid (1.6 g, 15% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.18 (s, 1H), 6.66 (d, <i>J</i> = 41.6 Hz, 1H), 5.50 (d, <i>J</i> = 19.4 Hz, 1H), 4.18–4.07 (m, 4H), 2.10 (s, 3H), 1.35 (t, <i>J</i> = 7.1 Hz, 6H). <sup>31</sup>P{<sup>1</sup>H}NMR (203 MHz, CDCl<sub>3</sub>): δ 12.63. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 169.5, 131.4 (d, <i>J</i> = 198.8 Hz), 113.3 (d, <i>J</i> = 9.2 Hz), 63.2 (d, <i>J</i> = 5.5 Hz), 24.8, 16.3 (d, <i>J</i> = 6.4 Hz). NMR data consistent with those previously reported. LRMS (ESI) <i>m</i>/<i>z</i>: 222.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Potassium 3-Fluorophenyl Trifluoroborate Salt (<b>9d</b>)</h3><div class="NLM_p">The synthesis of trifluoroborate salt <b>9d</b> was achieved using standard literature procedures.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p"><b>Step 1</b>: Anhydrous THF (15 mL) was added to an oven-dried 100 mL round-bottom flask under Ar, cooled to −78 °C, and <i>n</i>-BuLi (6 mL, 2.5 M in hexane, 20 mmol, 1.5 equiv) was added slowly. 3-Bromofluorobenzene (1.1 mL, 10 mmol, 1 equiv) was added dropwise, and the mixture was stirred for 30 min at −78 °C. Triisopropyl borate (4.6 mL, 20 mmol, 2 equiv) was added dropwise. Stirring was continued at −78 °C for an additional 20 min, and then the mixture was warmed up and stirred at RT for 30 min. HCl (1M, 15 mL) was subsequently added to hydrolyze the borate, and the mixture was stirred for 20 min. The aqueous phase was extracted with anhydrous Et<sub>2</sub>O (30 mL × 2). The combined organic phase was dried over anhydrous MgSO<sub>4</sub> and concentrated. The crude solid was washed with hexane to remove any byproducts, and 3-fluorophenylboronic acid was isolated as a white solid (1 g, 65% yield), which was used as such in the following step. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.00 (d, <i>J</i> = 7.3 Hz, 1H), 7.88 (dt, <i>J</i> = 9.0, 4.6 Hz, 1H), 7.52 (m, 1H), 7.31 (m, 1H). 4.79 (s, boronic acid). <sup>19</sup>F{<sup>1</sup>H}NMR (471 MHz, CDCl<sub>3</sub>): δ −113.53.</div><div class="NLM_p"><b>Step 2</b>: 3-Fluorophenylboronic acid (0.62 g, 4.5 mmol, 1 equiv) was dissolved in MeOH (1.5 mL), and an excess of saturated KHF<sub>2</sub> aqueous solution (0.88 g in 2.5 mL of Milli-Q water, ∼4.5 M, 11.3 mmol) was added slowly under vigorous stirring. After 30 min, the solvent was removed and the mixture was taken up in small quantity of MeCN and filtered to remove KHF<sub>2</sub>. The filtrate was concentrated to obtain a white solid (0.89 g, quantitative yield), which was used directly in next step. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.11 (t, <i>J</i> = 5.0 Hz, 2H), 6.96 (dd, <i>J</i> = 10.2, 2.5 Hz, 1H), 6.83–6.74 (m, 1H). <sup>19</sup>F{<sup>1</sup>H}NMR (377 MHz, DMSO-<i>d</i><sub>6</sub>): δ −116.38. <sup>13</sup>C{<sup>1</sup>H}NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 128.5 (d, <i>J</i> = 6.5 Hz), 127.5, 117.4 (d, <i>J</i> = 16.0 Hz), 111.8 (d, <i>J</i> = 20.8 Hz).</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Diethyl (<i>R</i>)-(1-Acetamido-2-phenylethyl)phosphonate [(<i>R</i>)-<b>10a</b>]</h4><div class="NLM_p last">The synthesis of (<i>R</i>)-<b>10a</b> was based on the procedure provided below for the preparation of (<i>R</i>)-<b>10b</b> with one modification; due to the poor solubility of potassium phenyl trifluoroborate in <i>i</i>PrOH, phenyl boronic acid was used instead. The desired product (<i>R</i>)-<b>10a</b> was isolated as a yellow oil (275 mg, 95% yield, 93% ee). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.34–7.25 (m, 4H), 7.24 (d, <i>J</i> = 6.8 Hz, 1H), 6.15 (d, <i>J</i> = 10.0 Hz, 1H), 4.79 (dtd, <i>J</i> = 16.3, 10.2, 4.9 Hz, 1H), 4.12 (m, 4H), 3.24 (ddd, <i>J</i> = 14.0, 8.7, 4.9 Hz, 1H), 2.93 (dt, <i>J</i> = 14.4, 10.5 Hz, 1H), 1.90 (d, <i>J</i> = 1.1 Hz, 3H), 1.31 (t × 2, <i>J</i> = 7.1 Hz, 6H). <sup>31</sup>P{<sup>1</sup>H}NMR (162 MHz, CDCl<sub>3</sub>): δ 24.21. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 169.6 (d, <i>J</i> = 5.2 Hz), 136.7 (d, <i>J</i> = 12.8 Hz), 129.2, 128.5, 126.9, 63.0 (d, <i>J</i> = 6.9 Hz), 62.6 (d, <i>J</i> = 6.8 Hz), 46.8, 45.5, 35.8 (d, <i>J</i> = 3.3 Hz), 23.0, 16.5 (d × 2, <i>J</i> = 6.2 Hz). LRMS (ESI) <i>m</i>/<i>z</i>: 300.6 [M + H]<sup>+</sup>. Chiral HPLC (UV abs 220 nm) condition: Chiralcel OD (250 mm × 4.6 mm), 95:5 hexane:iPrOH, 0.8 mL/min; <i>t</i><sub>R</sub> = 16.4 min (major), 18.6 min (minor).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Diethyl (<i>S</i>)-(1-Acetamido-2-phenylethyl)phosphonate [(<i>S</i>)-<b>10a</b>]</h4><div class="NLM_p last">Synthesis of (<i>S</i>)-<b>10a</b> was achieved using the procedure described below for the preparation of (<i>S</i>)-<b>10b</b>. The product was isolated as a yellow oil (115 mg) in 65% yield, 70% ee. <sup>1</sup>H/<sup>31</sup>P/<sup>13</sup>C NMR and LC-MS data were identical to those of the (<i>R</i>)-isomer. Chiral HPLC (UV abs. 220 nm) condition: Chiralcel OD (250 mm × 4.6 mm), 95:5 hexane:iPrOH, 0.8 mL/min; <i>t</i><sub>R</sub> = 16.7 min (minor), 18.4 min (major).</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Diethyl (<i>R</i>)-(1-Acetamido-2-(3-fluorophenyl)ethyl)phosphonate [(<i>R</i>)-<b>10b</b>]</h4><div class="NLM_p last">Diethyl (1-acetamido-vinyl) phosphonate <b>8</b> (335 mg, 1.5 mmol, 1 equiv), potassium 3-fluorophenyl trifluoroborate <b>9d</b> (576 mg, 2.85 mmol, 1.9 equiv), NaHCO<sub>3</sub> (252 mg, 3 mmol, 2 equiv), di-μ-chloro-tetraethylene dirhodium(I) (8.8 mg, 0.023 mmol, 1.5 mol %), and (<i>S</i>)-difluorphos (33.8 mg, 0.05 mmol, 3.3 mol %) were dissolved in anhydrous, degassed <i>i</i>PrOH (4 mL) under Ar in a microwave tube (Biotage), and the mixture was further degassed for 10 min with Ar. The resulting orange suspension was stirred at 90 °C for 20 h. After cooling to RT, saturated aqueous NH<sub>4</sub>Cl solution (10 mL) was added into the mixture. The aqueous phase was extracted with DCM (10 mL × 3); the combined organic phase was washed with brine and dried with anhydrous MgSO<sub>4</sub>. The solvent was evaporated to yield crude product as brown viscous oil, which was purified by flash column chromatography on silica gel (from 1:1 EtOAc:hexane to 9:1 EtOAc:MeOH) to give the desired product as a yellow oil (330 mg, 70% yield, 90% ee). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.25 (m, 1H), 7.00 (d, <i>J</i> = 7.7 Hz, 1H), 6.92 (m, 2H), 5.65 (d, <i>J</i> = 10.1 Hz, NH), 4.75 (dd, <i>J</i> = 16.8, 4.9 Hz, 1H), 4.13 (m, 4H), 3.20 (ddd, <i>J</i> = 14.4, 9.5, 4.9 Hz, 1H), 2.88 (dt, <i>J</i> = 14.6, 10.2 Hz, 1H), 1.91 (d, <i>J</i> = 0.8 Hz, 3H), 1.31 (t × 2, <i>J</i> = 7.1 Hz, 6H). <sup>19</sup>F{<sup>1</sup>H}NMR (471 MHz, CDCl<sub>3</sub>): δ −113.32. <sup>31</sup>P{<sup>1</sup>H}NMR (203 MHz, CDCl<sub>3</sub>): δ 23.80. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 169.4 (d, <i>J</i> = 5.0 Hz), 139.2 (d, <i>J</i> = 5.4 Hz), 130.0 (d, <i>J</i> = 8.3 Hz), 124.9, 116.4 (d, <i>J</i> = 21.4 Hz), 114.0 (d, <i>J</i> = 20.8 Hz), 63.0 (d, <i>J</i> = 7.1 Hz), 62.8 (d, <i>J</i> = 6.7 Hz), 46.6, 45.49, 35.7, 23.2, 16.5 (d × 2, <i>J</i> = 5.5 Hz). LRMS (ESI) <i>m</i>/<i>z</i>: 318.3 [M + H]<sup>+</sup>. Chiral HPLC (UV abs 220 nm) condition: Chiralcel OD (250 mm × 4.6 mm), 95:5 hexane:<i>i</i>PrOH, 1 mL/min; <i>t</i><sub>R</sub> = 12.3 min (major), 15.1 min (minor)</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Diethyl (<i>S</i>)-(1-Acetamido-2-(3-fluorophenyl)ethyl)phosphonate [(<i>S</i>)-<b>10b</b>].<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></h4><div class="NLM_p last">Diethyl (1-acetamido-vinyl) phosphonate <b>8</b> (223 mg, 1 mmol, 1 equiv), 3-fluorophenyl boronic acid (280 mg, 2 mmol, 2 equiv), and Na<sub>2</sub>CO<sub>3</sub> (106 mg, 1 mmol, 1 equiv) were mixed in dry and degassed dioxane (3 mL) under Ar in a microwave tube (Biotage). Bis(norbornadiene)rhodium(I) tetrafluoroborate (26 mg, 0.07 mmol, 7 mol %) and (<i>S</i>,<i>S</i>)-Chiraphos (32 mg, 0.075 mmol, 7.5 mol %) were premixed with degassed dioxane/water (0.9/0.45 mL) and injected into the microwave tube. The mixture was then further degassed for 10 min with Ar, and MeOH (0.32 mL, 8 equiv) was added dropwise. The orange suspension was heated to 70 °C for 20 h (monitored by TLC). After cooling to RT, solvent was removed under reduced pressure. The residue was redissolved in DCM, washed with water and brine, and dried over anhydrous MgSO<sub>4</sub> to give the crude product as a brown viscous oil, which was purified by flash column chromatography on silica gel (using a solvent gradient from 1:1 EtOAc:hexane to 9:1 EtOAc:MeOH). Compound (<i>S</i>)-<b>10b</b> was isolated as a yellow oil (0.23 g) 70% yield in 89% ee. <sup>1</sup>H/<sup>19</sup>F/<sup>31</sup>P/<sup>13</sup>C NMR and LC-MS data were identical to those of the (<i>R</i>)-enantiomer. Chiralcel OD (250 mm × 4.6 mm), 95:5 hexane:<i>i</i>PrOH, 1 mL/min; <i>t</i><sub>R</sub> = 12.7 min (minor), 14.9 min (major)</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Diethyl (<i>S</i>)- or (<i>R</i>)-(1-Benzamido-2-cyclohexylethyl)phosphonate [(<i>S</i>)- or (<i>R</i>)-<b>10c</b>].<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></h4><div class="NLM_p last">Diethylzinc (0.15 mL, 1.3 M in toluene, 0.2 mmol) was added slowly to a stirred solution of (<i>R</i>,<i>R</i>) or (<i>S</i>,<i>S</i>)-ProPhenol (ligand <b>L1</b>; 64 mg, 0.1 mmol) in toluene (1.85 mL) under Ar. The mixture was stirred at RT for 0.5 h to generate zinc catalyst (0.05 M). The resulting catalyst solution (1 mL, 0.05 mmol) was added in one portion to freshly made <b>11</b> (120 mg, 0.5 mmol, ca. 80% purity) and diethyl phosphite (0.05 mL, 0.6 mmol, 1.2 equiv) in toluene (4 mL) at 0 °C under Ar. After stirring for 30 min, the reaction was quenched with saturated aqueous NH<sub>4</sub>Cl solution. After extraction with anhydrous Et<sub>2</sub>O (20 mL × 2), the combined organic phase was washed with brine, dried over anhydrous MgSO<sub>4</sub>, and concentrated under reduced pressure. The crude mixture was purified by flash column chromatography on silica gel using 20%–70% EtOAc in hexane to obtain (<i>R</i>)-<b>10c</b> or (<i>S</i>)-<b>10c</b> as a white solids (50 mg, 30% yield for both enantiomers) with >95% ee (after recrystallization using DCM-pentane at −20 °C) and side product <b>12</b> (due to isomerization of starting material <b>11</b>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.81–7.74 (m, 2H), 7.57–7.49 (m, 1H), 7.49–7.41 (m, 2H), 6.10 (d, <i>J</i> = 10.1 Hz, 1H), 4.86–4.71 (m, 1H), 4.24–4.03 (m, 4H), 1.94 (d, <i>J</i> = 12.9 Hz, 1H), 1.84–1.67 (m, 1H), 1.66 (m, 6H), 1.44–1.35 (m, 1H), 1.35 (s, 1H), 1.35–1.24 (m, 6H), 1.17 (m, 2H), 1.09–0.94 (m, 1H), 0.89 (t, <i>J</i> = 11.9 Hz, 1H). <sup>31</sup>P {<sup>1</sup>H} NMR (202 MHz, CDCl<sub>3</sub>): δ 25.55. <sup>13</sup>C {<sup>1</sup>H} NMR (126 MHz, CDCl<sub>3</sub>): δ 167.0, 134.3, 131.9, 128.9, 127.1, 62.8 (dd, <i>J</i> = 19.2, 6.8 Hz), 42.9, 37.4, 34.1 (d, <i>J</i> = 12.7 Hz), 26.6, 26.1, 16.6 (d × 2, <i>J</i> = 5.8 Hz). LRMS (ESI) <i>m</i>/<i>z</i>: 368.3 [M + H]<sup>+</sup>. HPLC (UV abs. 220 nm) condition: Chiralcel OD (250 mm × 4.6 mm), 98:2 hexane:iPrOH, 0.8 mL/min; (<i>R</i>)-enantiomer <i>t</i><sub>R</sub> = 10.3 min (major), 12.9 min (minor); (<i>S</i>)-enantiomer <i>t</i><sub>R</sub> = 9.9 min (minor), 12.0 min (major).</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>E</i>)-<i>N</i>-(2-Cyclohexylethylidene)benzamide (<b>11</b>)</h3><div class="NLM_p">The synthesis of <b>11</b> was achieved in three steps using the procedure recently reported by Lupton<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> with minor modifications.</div><div class="NLM_p"><b>Step 1:</b> Pyridinium chlorochromate (3.23 g, 15 mmol, 1.5 equiv) was added in one portion to cyclohexylethanol (1.4 mL, 10 mmol) in DCM (50 mL), and the mixture was stirred at RT for 2 h. Silica gel (3.75 g) and anhydrous diethyl ether (50 mL) were subsequently added and stirring was continued for an additional 1 h. The mixture was concentrated, and the solid residue was loaded directly onto a silica gel column and eluted using 0%–25% EtOAc in hexane to yield the 2-cyclohexylacetaldehyde as a colorless oil (0.83 g, 63% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 9.75 (t, <i>J</i> = 2.4 Hz, 1H), 2.28 (dd, <i>J</i> = 6.8, 2.4 Hz, 2H), 1.88 (m, 1H), 1.71 (m, 5H), 1.29 (m, 2H), 1.17 (m, 1H), 1.00 (m, 2H). <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 203.2, 51.5, 33.4, 32.8, 26.2.</div><div class="NLM_p"><b>Step 2</b>: Benzenesulfinic acid sodium salt (2.73 g, 15 mmol, 1.5 equiv) and benzamide (1.82 g, 15 mmol, 1.5 equiv) were mixed with acetonitrile (100 mL) under Ar. After purging Ar for 15 min, 2-cyclohexylacetaldehyde (1.41 g, 10 mmol) was added to the slurry in one portion. The suspension was cooled to 0 °C, and chlorotrimethylsilane (2.68 mL, 20 mmol, 2 equiv) was added slowly. The reaction was warmed up to RT and stirred for 16 h. Water (80 mL) was added to the suspension, and the mixture was stirred for 30 min. <i>N</i>-(2-Cyclohexyl-1-tosylethyl)benzamide precipitated as fine white solid and collected by filtration. The product was used in the next step without further purification (3.0 g, 80% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.79–7.72 (m, 2H), 7.61–7.55 (m, 2H), 7.55–7.50 (m, 1H), 7.46–7.38 (m, 2H), 7.25–7.23 (m, 1H), 6.35 (d, <i>J</i> = 10.5 Hz, 1H), 5.52 (ddd, <i>J</i> = 11.7, 10.5, 3.1 Hz, 1H), 2.39 (s, 3H), 2.19 (ddd, <i>J</i> = 14.2, 9.8, 3.1 Hz, 1H), 1.89–1.78 (m, 2H), 1.69 (d, <i>J</i> = 11.0 Hz, 3H), 1.62 (d, <i>J</i> = 6.9 Hz, 1H), 1.41 (dddt, <i>J</i> = 14.4, 10.8, 7.2, 3.7 Hz, 1H), 1.29–1.00 (m, 4H), 0.95 (tt, <i>J</i> = 12.0, 5.9 Hz, 1H). <sup>13</sup>C{<sup>1</sup>H}NMR (101 MHz, CDCl<sub>3</sub>): δ 166.4, 145.3, 133.8, 133.2, 132.4, 129.9, 129.2, 128.9, 127.1, 67.6, 34.2, 34.0, 33.9, 32.0, 26.4, 26.3, 26.0, 21.9. LRMS (ESI) <i>m</i>/<i>z</i>: 408.3 [M + Na]<sup>+</sup>.</div><div class="NLM_p last"><b>Step 3</b>: Cs<sub>2</sub>CO<sub>3</sub> (2.45 g,7.5 mmol) and Na<sub>2</sub>SO<sub>4</sub> (1.06 g, 7.5 mmol) were flame-dried under high vacuum, cooled under Ar, and mixed with anhydrous DCM (20 mL). <i>N</i>-(2-Cyclohexyl-1-tosylethyl)benzamide (577 mg, 1.5 mmol) was added as DCM solution (5 mL). The reaction mixture was stirred vigorously (>1000 rpm) at RT for 4 h. Pentane (40 mL) was added to the mixture, and the solid was filtered. The solution was concentrated under reduced pressure at 20 °C to obtain <b>11</b> as colorless oil, which was used directly in the next step without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.12 (t, <i>J</i> = 5.0 Hz, 1H), 8.06–7.98 (m, 2H), 7.61–7.54 (m, 1H), 7.46 (dd, <i>J</i> = 8.4, 7.0 Hz, 2H), 2.35 (dd, <i>J</i> = 6.5, 5.0 Hz, 2H), 1.86–1.59 (m, 7H), 1.36–1.13 (m, 3H), 1.11–0.98 (m, 2H). <sup>13</sup>C{<sup>1</sup>H}NMR (101 MHz, CDCl<sub>3</sub>): δ 180.9, 169.7, 133.5, 132.9, 130.0, 128.6, 77.5, 77.2, 76.8, 44.1, 35.3, 33.4, 26.3, 26.2. LRMS (ESI) <i>m</i>/<i>z</i>: 230.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>E</i>)-<i>N</i>-(2-Cyclohexylvinyl)benzamide (<b>12</b>)</h3><div class="NLM_p last">Compound <b>12</b> was isolated as a white solid as major byproduct in the preparation of <b>10c</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.92–7.72 (m, 2H), 7.61 (d, <i>J</i> = 9.8 Hz, 1H), 7.58–7.47 (m, 1H), 7.44–7.38 (m, 2H), 6.94 (ddd, <i>J</i> = 14.4, 10.5, 1.3 Hz, 1H), 5.27 (dd, <i>J</i> = 14.4, 7.1 Hz, 1H), 2.04 (qdd, <i>J</i> = 8.1, 4.2, 1.2 Hz, 1H), 1.79–1.72 (m, 5H), 1.66 (dddt, <i>J</i> = 12.9, 5.1, 3.4, 1.6 Hz, 2H), 1.28 (tt, <i>J</i> = 12.7, 3.2 Hz, 2H), 1.23–1.16 (m, 1H), 1.16–1.08 (m, 2H).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure for the Synthesis of α-Aminophosphonate Diethyl Esters <b>13</b></h3><div class="NLM_p">A typical procedure for the <i>N</i>-deacetylation of intermediate <b>10</b> (regardless stereochemistry) at 1 mmol scale was achieved in three steps according to literature procedure.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p"><b>Step 1</b>: Intermediate <b>10</b> in anhydrous THF (4.5 mL) was transferred to a 10 mL microwave tube loaded with Boc<sub>2</sub>O (437 mg, 2 mmol, 2 equiv) and DMAP (24 mg, 0.2 mmol, 0.2 equiv) under Ar. The tube was sealed, and the reaction mixture was stirred for 4 h at 80 °C. After cooling to RT, the solvent was removed under reduced pressure, and the crude product was redissolved in DCM. The organic phase was washed with saturated aqueous NH<sub>4</sub>Cl and NaHCO<sub>3</sub> solutions, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated to give crude as orange to brown oil.</div><div class="NLM_p"><b>Step 2</b>: The crude from step 1 was diluted in THF–water mixture (2:1, in total 6 mL), and LiOH·H<sub>2</sub>O (84 mg, 2 mmol, 2 equiv) was added. The suspension was stirred for 20–24 h at RT. The crude was diluted with anhydrous Et<sub>2</sub>O (10 mL) and washed with 1 M HCl (4 mL) followed by brine. The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to give orange oil.</div><div class="NLM_p"><b>Step 3</b>: The crude from step 2 was diluted in anhydrous DCM (8 mL) under Ar. HCl (4 M in dioxane, 5 mL, 20 equiv) was added dropwise to the solution. The mixture was stirred at RT for 2–4 h and monitored by TLC. After completion, the solvent was removed under reduced pressure and slowly taken up in 5% MeOH in DCM (10 mL). The solvent was removed again after stirring for 5 min, and the residue was redissolved in DCM. The organic phase was washed with 1 M NaOH (25 mL), followed by brine, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solution was concentrated to give light-orange oil. The crude product was purified by flash column chromatography on silica gel (from 1:1 EtOAc:hexane to 1.5:8.5 MeOH:EtOAc to yield light-yellow oil (50–80% isolated yield over three steps).</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Diethyl (<i>R</i>)- or (<i>S</i>)-(1-Amino-2-phenylethyl)phosphonate [(<i>R</i>)- or (<i>S</i>)-<b>13a</b>]</h4><div class="NLM_p last">Light-yellow oils (130–140 mg, ∼50% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.33–7.29 (m, 2H), 7.25–7.21 (m, 3H), 4.17 (dqd, <i>J</i> = 8.0, 7.0, 4.3 Hz, 4H), 3.31–3.18 (m, 2H), 2.66 (ddd, <i>J</i> = 13.9, 10.8, 9.1 Hz, 1H), 1.34 (t × 2, <i>J</i> = 7.1 Hz, 6H). <sup>31</sup>P{<sup>1</sup>H} NMR (203 MHz, CDCl<sub>3</sub>): δ 28.01. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 138.1 (d, <i>J</i> = 16.0 Hz), 129.4, 128.7, 126.97, 62.4 (t, <i>J</i> = 7.5 Hz), 50.5 (d, <i>J</i> = 154.2 Hz), 38.0, 16.7 (d, <i>J</i> = 5.6 Hz). LRMS (ESI) <i>m</i>/<i>z</i>: 258.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Diethyl (<i>R</i>)- or (<i>S</i>)-(1-Amino-2-(3-fluorophenyl)ethyl)phosphonate [(<i>R</i>)- or (<i>S</i>)-<b>13b</b>]</h4><div class="NLM_p last">Light-yellow oils (∼130 mg, ∼50% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 7.29 (dd, <i>J</i> = 7.9, 6.1 Hz, 1H), 7.02 (d, <i>J</i> = 7.7 Hz, 1H), 6.95 (ddd, <i>J</i> = 10.7, 9.0, 2.3 Hz, 2H), 4.18 (qd, <i>J</i> = 7.0, 3.0 Hz, 4H), 3.26 (dd, <i>J</i> = 10.7, 3.3 Hz, 1H), 3.20 (dd, <i>J</i> = 13.9, 3.5 Hz, 1H), 2.68 (dd, <i>J</i> = 13.9, 10.9 Hz, 1H), 1.35 (t × 2, <i>J</i> = 7.1 Hz, 6H). <sup>19</sup>F{<sup>1</sup>H}NMR (471 MHz, CDCl<sub>3</sub>): δ −113.21. <sup>31</sup>P{<sup>1</sup>H}NMR (203 MHz, CDCl<sub>3</sub>): δ 27.56. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 163.1 (d, <i>J</i> = 245.8 Hz), 140.7 (d, <i>J</i> = 7.3 Hz), 130.1 (d, <i>J</i> = 8.4 Hz), 125.1 (d, <i>J</i> = 2.8 Hz), 116.3 (d, <i>J</i> = 21.1 Hz), 113.8 (d, <i>J</i> = 21.1 Hz), 62.6 (d, <i>J</i> = 7.0 Hz), 62.5 (d, <i>J</i> = 7.0 Hz), 50.3 (d, <i>J</i> = 153.6 Hz), 37.8, 16.7 (d, <i>J</i> = 5.6 Hz). LRMS (ESI) <i>m</i>/<i>z</i>: 276.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Diethyl (<i>R</i>)- or (<i>S</i>)-(1-Amino-2-cyclohexylethyl)phosphonate [(<i>R</i>)- or (<i>S</i>)-<b>13c</b>]</h4><div class="NLM_p last">Light-yellow oils (∼30 mg, ∼80% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.27–4.05 (m, 4H), 3.07 (td, <i>J</i> = 11.0, 3.2 Hz, 1H), 1.83–1.60 (m, 7H), 1.48–1.37 (m, 1H), 1.34 (t x 2, <i>J</i> = 7.1 Hz, 6H), 1.31–1.08 (m, 3H), 1.05–0.93 (m, 1H), 0.91–0.77 (m, 1H). <sup>31</sup>P{<sup>1</sup>H}NMR (162 MHz, CDCl<sub>3</sub>): δ 29.98. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 62.2 (dd, <i>J</i> = 10.5, 7.3 Hz), 46.6, 45.5, 38.6, 34.4, 33.6 (d, <i>J</i> = 13.1 Hz), 32.0, 26.7, 26.5, 26.2, 16.7 (d, <i>J</i> = 5.5 Hz). LRMS (ESI) <i>m</i>/<i>z</i>: 264.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-Fluoro-6-(<i>p</i>-tolyl)thieno[2,3-<i>d</i>]pyrimidine (<b>14a</b>) and 6-(3-Chloro-4-methylphenyl)-4-fluorothieno[2,3-<i>d</i>]pyrimidine (<b>14b</b>)</h4><div class="NLM_p last">The preparation and characterization of <b>14a</b> and <b>14b</b> were previously reported.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Procedure for the Synthesis of Aminophosphonate Esters <b>15d</b>–<b>h</b></h3><div class="NLM_p">The S<sub>N</sub>Ar reaction between α-aminophosphonates <b>13</b> and scaffolds <b>14</b> was previously reported.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Diethyl (<i>R</i>)- or (<i>S</i>)-(2-Phenyl-1-((6-(<i>p</i>-tolyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)phosphonate [(<i>R</i>)- or (<i>S</i>)- <b>15d</b>]</h4><div class="NLM_p last">Both enantiomers were isolated as off-white solids: (<i>R</i>)-<b>15d</b> in 47% yield (9 mg) and 90% ee and (<i>S</i>)-<b>15d</b> in 67% yield (21 mg) and 71% ee. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.37 (s, 1H), 7.53 (dd, <i>J</i> = 5.6, 2.7 Hz, 3H), 7.34–7.27 (m, 2H), 7.24–7.16 (m, 4H), 7.16–7.10 (m, 1H), 6.50 (s, 1H), 5.55–5.43 (m, 1H), 4.26–3.93 (m, 4H), 3.38 (ddd, <i>J</i> = 13.9, 8.6, 5.0 Hz, 1H), 3.29–3.14 (m, 1H), 2.38 (s, 3H), 1.31 (t, <i>J</i> = 7.0 Hz, 3H), 1.11 (t, <i>J</i> = 7.0 Hz, 3H). <sup>31</sup>P{<sup>1</sup>H}NMR (162 MHz, CDCl<sub>3</sub>): δ 24.18. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 166.1, 156.2 (d, <i>J</i> = 5.0 Hz), 153.4, 141.2, 138.8, 136.9 (d, <i>J</i> = 12.7 Hz), 131.0, 129.8 (d, <i>J</i> = 2.2 Hz), 129.32 (d, <i>J</i> = 3.5 Hz), 128.5, 126.9, 126.4, 126.3, 118.2, 112.5, 63.5 (d, <i>J</i> = 6.9 Hz), 62.5 (d, <i>J</i> = 7.3 Hz), 47.3 (d, <i>J</i> = 156.2 Hz), 36.2 (d, <i>J</i> = 4.1 Hz), 21.4, 16.5 (d × 2, <i>J</i> = 5.8 Hz). LRMS (ESI) <i>m</i>/<i>z</i>: 482.4 [M + H]<sup>+</sup>. Chiral HPLC (UV abs 254 nm) condition: Chiralcel OD (250 mm × 4.6 mm), 90:10 hexane:iPrOH, 1 mL/min; (<i>R</i>)-enantiomer <i>t</i><sub>R</sub> = 7.0 min (minor), 15.0 min (major), (<i>S</i>)-enantiomer <i>t</i><sub>R</sub> = 6.9 min (major), 15.2 min (minor).</div></div><div id="sec4_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Diethyl (<i>R</i>)- or (<i>S</i>)-(2-(3-Fluorophenyl)-1-((6-(<i>p</i>-tolyl)thieno[2, 3-<i>d</i>]pyrimidin-4-yl)amino)ethyl)phosphonate [(<i>R</i>)- or (<i>S</i>)-<b>15e</b>]</h4><div class="NLM_p last">Both enantiomers were isolated as off-white solids: (<i>R</i>)-<b>15e</b> in 72% yield (21 mg) and 80% ee; (<i>S</i>)-<b>15e</b> in 50% yield (15 mg) and 86% ee. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.41 (s, 1H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 7.31 (s, 1H), 7.24 (d, <i>J</i> = 8.0 Hz, 2H), 7.16 (td, <i>J</i> = 8.1, 6.1 Hz, 1H), 7.08–7.01 (m, 2H), 6.85 (ddd, <i>J</i> = 10.6, 8.1, 2.6 Hz, 1H), 5.58 (d, <i>J</i> = 9.9 Hz, 1H), 5.44 (dtd, <i>J</i> = 16.4, 9.7, 5.0 Hz, 1H), 4.23–3.95 (m, 4H), 3.37 (ddd, <i>J</i> = 14.7, 9.9, 5.0 Hz, 1H), 3.13 (dt, <i>J</i> = 14.6, 10.3 Hz, 1H), 2.40 (s, 3H), 1.30 (t, <i>J</i> = 7.1 Hz, 3H), 1.17 (t, <i>J</i> = 7.1 Hz, 3H). <sup>19</sup>F{<sup>1</sup>H}NMR (377 MHz, CDCl<sub>3</sub>): δ −113.33. <sup>31</sup>P{<sup>1</sup>H}NMR (162 MHz, CDCl<sub>3</sub>): δ 23.87. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 166.1, 162.7 (d, <i>J</i> = 245.7 Hz), 156.1 (d, <i>J</i> = 5.0 Hz), 153.2, 141.1, 139.5 (dd, <i>J</i> = 13.5, 7.4 Hz), 138.7, 130.9, 129.8 (d, <i>J</i> = 8.5 Hz), 129.7, 126.2, 124.8 (d, <i>J</i> = 2.8 Hz), 118.1, 116.3 (d, <i>J</i> = 21.5 Hz), 113.7 (d, <i>J</i> = 21.0 Hz), 112.6, 63.0 (dd, <i>J</i> = 143.4, 7.1 Hz), 47.0 (d, <i>J</i> = 156.6 Hz), 35.7 (d, <i>J</i> = 4.4 Hz), 21.3, 16.3 (d × 2, <i>J</i> = 5.9 Hz). LRMS (ESI) <i>m</i>/<i>z</i>: 500.4 [M + H]<sup>+</sup>. Chiral HPLC (UV abs. 254 nm) condition: Chiralcel OD (250 mm × 4.6 mm), 90:10 hexane:iPrOH, 1 mL/min: (<i>R</i>)-enantiomer <i>t</i><sub>R</sub> = 5.8 min (minor), 21.4 min (major), (<i>S</i>)-enantiomer t<sub>R</sub> = 7.0 min (major), 24.3 min (minor).</div></div><div id="sec4_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Diethyl (<i>R</i>)- or (<i>S</i>)-(1-((6-(3-Chloro-4-methylphenyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)amino)-2-phenylethyl) phosphonate [(<i>R</i>)- or (<i>S</i>)-<b>15f</b>]</h4><div class="NLM_p last">Both enantiomers were isolated as off-white solids: (<i>R</i>)-<b>15f</b> in 76% yield (26 mg) and 92% ee; (<i>S</i>)-<b>15f</b> in 44% yield (11 mg) and 71% ee. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.37 (s, 1H), 7.63 (d, <i>J</i> = 2.0 Hz, 1H), 7.61 (s, 1H), 7.41 (dd, <i>J</i> = 7.9, 2.0 Hz, 1H), 7.31 (d, <i>J</i> = 7.0 Hz, 2H), 7.24 (d, <i>J</i> = 7.8 Hz, 1H), 7.19 (t, <i>J</i> = 7.5 Hz, 2H), 7.13 (m, 1H), 5.50 (dtd, <i>J</i> = 14.9, 9.9, 4.8 Hz, 1H), 4.27–3.91 (m, 2H), 3.39 (ddd, <i>J</i> = 13.5, 8.3, 4.8 Hz, 1H), 3.25 (dt, <i>J</i> = 14.4, 10.6 Hz, 1H), 2.40 (s, 3H), 1.33 (t, <i>J</i> = 7.1 Hz, 3H), 1.10 (t, <i>J</i> = 7.0 Hz, 3H). <sup>31</sup>P{<sup>1</sup>H}NMR (203 MHz, CDCl<sub>3</sub>): δ 24.16. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 166.1, 156.2 (d, <i>J</i> = 4.9 Hz), 153.4, 141.2, 138.8, 136.9 (d, <i>J</i> = 12.7 Hz), 131.0, 129.8 (d, <i>J</i> = 2.2 Hz), 129.3 (d, <i>J</i> = 3.5 Hz), 128.5, 126.9, 126.4, 126.3, 118.2, 112.5, 63.5 (d, <i>J</i> = 6.9 Hz), 62.5 (d, <i>J</i> = 7.3 Hz), 47.3 (d, <i>J</i> = 156.2 Hz), 36.2 (d, <i>J</i> = 4.1 Hz), 21.4, 16.5 (d × 2, <i>J</i> = 5.8 Hz). LRMS (ESI) <i>m</i>/<i>z</i>: 517.3 [M + H]<sup>+</sup>. Chiral HPLC (UV abs 254 nm), Chiralcel OD (250 mm × 4.6 mm), 90:10 hexane:<i>i</i>PrOH, 1 mL/min: (<i>R</i>)-enantiomer <i>t</i><sub>R</sub> = 5.5 min (minor), 12.3 min (major); (<i>S</i>)-enantiomer <i>t</i><sub>R</sub> = 5.5 min (major), 12.2 min (minor).</div></div><div id="sec4_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Diethyl(<i>R</i>)- or (<i>S</i>)-(1-((6-(3-Chloro-4-methylphenyl)thieno[2,3-<i>d</i>]pyrimidin-4-yl)amino)-2-(3-fluorophenyl)ethyl)phosphonate [(<i>R</i>)- or (<i>S</i>)-<b>15g</b>]</h4><div class="NLM_p last">Both enantiomers were isolated as off-white solids: (<i>R</i>)-<b>15g</b> in 44% yield (25 mg) and 78% ee; (<i>S</i>)-<b>15g</b> in 26% yield (14 mg) and 87% ee. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.41 (s, 1H), 7.65 (d, <i>J</i> = 1.8 Hz, 1H), 7.43 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.35 (s, 1H), 7.28 (d, <i>J</i> = 8.3 Hz, 1H), 7.21–7.13 (m, 1H), 7.04 (t, <i>J</i> = 9.3 Hz, 2H), 6.85 (td, <i>J</i> = 8.6, 1.9 Hz, 1H), 5.64 (d, 1H), 5.44 (dtd, <i>J</i> = 19.6, 9.7, 4.9 Hz, 1H), 4.28–3.98 (m, 4H), 3.38 (ddd, <i>J</i> = 14.3, 9.6, 4.6 Hz, 1H), 3.13 (dt, <i>J</i> = 14.3, 10.3 Hz, 1H), 2.41 (s, 3H), 1.31 (t, <i>J</i> = 7.1 Hz, 3H), 1.17 (t, <i>J</i> = 7.0 Hz, 3H). <sup>19</sup>F{<sup>1</sup>H}NMR (471 MHz, CDCl<sub>3</sub>): δ −113.29. <sup>31</sup>P{<sup>1</sup>H}NMR (162 MHz, CDCl<sub>3</sub>): δ 23.79. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 166.4, 162.8 (d, <i>J</i> = 245.8 Hz), 156.4 (d, <i>J</i> = 4.7 Hz), 153.7, 139.6 (dd, <i>J</i> = 13.7, 7.4 Hz), 139.3, 136.5, 135.1, 133.2, 131.6, 129.9 (d, <i>J</i> = 8.2 Hz), 126.6, 124.9 (d, <i>J</i> = 2.8 Hz), 124.8, 118.1, 116.4 (d, <i>J</i> = 21.4 Hz), 113.8, 113.8 (d, <i>J</i> = 21.0 Hz), 63.8 (d, <i>J</i> = 6.9 Hz), 62.6 (d, <i>J</i> = 7.3 Hz), 47.1 (d, <i>J</i> = 156.6 Hz), 35.8, 20.0, 16.6 (d, <i>J</i> = 6.0 Hz), 16.3 (d, <i>J</i> = 6.0 Hz). LRMS (ESI) <i>m</i>/<i>z</i>: 534.4 [M + H]<sup>+</sup>. Chiral HPLC (UV abs. 254 nm): Chiralcel OD (250 mm × 4.6 mm), 90:10 hexane:<i>i</i>PrOH, 1 mL/min: (<i>R</i>)-enantiomer <i>t</i><sub>R</sub> = 5.4 min (minor), 20.8 min (major); (<i>S</i>)-enantiomer <i>t</i><sub>R</sub> = 5.4 min (major), 21.5 min (minor).</div></div><div id="sec4_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Diethyl(<i>R</i>)- or (<i>S</i>)-(1-((6-(3-Chloro-4-methylphenyl)thieno [2,3-<i>d</i>]pyrimidin-4-yl)amino)-2-cyclohexylethyl)phosphonate [(<i>R</i>)- or (<i>S</i>)-<b>15h</b>]</h4><div class="NLM_p last">Both enantiomers were isolated as off-white solids: (<i>R</i>)-<b>15h</b> in 60% yield (15 mg) and 99% ee; (<i>S</i>)-<b>15h</b> in 52% yield (13 mg) and 91% ee. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ 8.45 (s, 1H), 7.69 (d, <i>J</i> = 4.3 Hz, 1H), 7.64 (d, <i>J</i> = 1.9 Hz, 1H), 7.42 (dd, <i>J</i> = 7.8, 1.9 Hz, 1H), 7.24 (d, <i>J</i> = 7.9 Hz, 1H), 6.58 (s, 1H), 5.34–5.22 (m, 1H), 4.28–4.07 (m, 3H), 2.39 (s, 4H), 1.91 (tt, <i>J</i> = 16.4, 7.6 Hz, 4H), 1.82–1.71 (m, 1H), 1.63–1.57 (m, 1H), 1.41 (s, 1H), 1.37–1.22 (m, 4H), 1.16–0.95 (m, 7H), 0.95–0.83 (m, 1H). <sup>31</sup>P{<sup>1</sup>H}NMR (203 MHz, CDCl<sub>3</sub>): δ 25.55. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 166.4, 156.6 (d, <i>J</i> = 3.8 Hz), 154.0, 139.2, 136.5, 135.2, 133.1, 131.6, 126.6, 124.7, 118.0, 113.9, 63.3 (d, <i>J</i> = 7.0 Hz), 62.5 (d, <i>J</i> = 7.2 Hz), 43.8 (d, <i>J</i> = 155.7 Hz), 37.5, 34.2, 33.9 (d, <i>J</i> = 13.1 Hz), 32.2, 26.6, 26.3, 26.0, 20.0, 16.5 (d × 2, <i>J</i> = 5.9 Hz). Chiral HPLC (UV abs 254 nm), Chiralcel OD (250 mm × 4.6 mm), 90:10 hexane:<i>i</i>PrOH, 1 mL/min: (<i>R</i>)-enantiomer <i>t</i><sub>R</sub> = 5.3 min (minor), 7.2 min (major); (<i>S</i>)-enantiomer <i>t</i><sub>R</sub> = 4.9 min (major), 6.5 min (minor).</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Methyl (<i>R</i>)-2-Acetamido-3-(3-fluorophenyl)propanoate [(<i>R</i>)-<b>16</b>].<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></h3><div class="NLM_p last">Methyl-2-acetamidoacrylate (1 mmol, 146 mg), potassium 3-fluorophenyl trifluoroborate <b>9d</b> (364 mg, 1.8 mmol, 1.8 equiv), bis(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate (12.2 mg, 3 mol %), and (<i>S</i>)-BINAP (37 mg, 6 mol %) were mixed in degassed, anhydrous toluene (3 mL) under Ar. Freshly distilled guaiacol (74 μL, 0.66 mmol, 1.2 equiv) was added, and the mixture was stirred at 110 °C for 16 h (monitored by TLC). After cooling to RT, the mixture was diluted with anhydrous Et<sub>2</sub>O (10 mL) and directly dry-loaded into a silica gel column. The crude was purified using 10%–75% EtOAc in hexane to obtain white solid (118 mg, 50% yield, 85% ee). <sup>1</sup>H/<sup>19</sup>F/<sup>13</sup>C NMR and LC-MS data were identical to those of the (<i>S</i>)-isomer. Chiral HPLC (UV abs 220 nm), Chiralcel OD (250 mm × 4.6 mm), 90:10 hexane:<i>i</i>PrOH, 1 mL/min: (<i>S</i>)-enantiomer <i>t</i><sub>R</sub> = 10.3 min (minor), (<i>R</i>)-enantiomer <i>t</i><sub>R</sub> = 13.4 min (major).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Methyl (<i>S</i>)-2-Acetamido-3-(3-fluorophenyl)propanoate [(<i>S</i>)-<b>16</b>]</h3><div class="NLM_p last">Synthesis of (<i>S</i>)-<b>16</b> was achieved using the procedure described for preparing (<i>R</i>)-<b>10b</b>. The crude product was purified by flash column chromatography on silica gel using a solvent gradient from 10 to 70% EtOAc in hexane to obtain the desired product as an off-white solid (125 mg, 67% yield, 81% ee). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.29–7.21 (m, 1H), 6.94 (tdd, <i>J</i> = 8.5, 2.7, 1.0 Hz, 1H), 6.87 (dt, <i>J</i> = 7.6, 1.3 Hz, 1H), 6.80 (ddd, <i>J</i> = 9.7, 2.5, 1.6 Hz, 1H), 5.96 (d, <i>J</i> = 7.7 Hz, 1H), 4.88 (dt, <i>J</i> = 7.7, 5.7 Hz, 1H), 3.74 (s, 3H), 3.12 (qd, <i>J</i> = 13.9, 5.7 Hz, 2H), 2.00 (s, 3H). <sup>19</sup>F{<sup>1</sup>H}NMR (377 MHz, CDCl<sub>3</sub>): δ −112.99. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, CDCl<sub>3</sub>): δ 172.0, 169.7, 162.9 (d, <i>J</i> = 246.3 Hz), 138.5 (d, <i>J</i> = 7.3 Hz), 130.2 (d, <i>J</i> = 8.4 Hz), 125.1 (d, <i>J</i> = 2.9 Hz), 116.3 (d, <i>J</i> = 21.1 Hz), 114.2 (d, <i>J</i> = 20.9 Hz), 53.1, 52.6, 37.7 (d, <i>J</i> = 1.8 Hz), 23.29. LRMS (ESI) <i>m</i>/<i>z</i>: 240.2 [M + H]<sup>+</sup>. Chiral HPLC (UV abs 220 nm): (<i>R</i>)-enantiomer <i>t</i><sub>R</sub> = 11.4 min (major), (<i>S</i>)-enantiomer <i>t</i><sub>R</sub> = 14.8 min (minor).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>R</i>)- or (<i>S</i>)-2-Amino-3-(3-fluorophenyl)propanoic Acid [(<i>R</i>)- or (<i>S</i>)-<b>17</b>]</h3><div class="NLM_p last">The synthesis of <b>17</b> was achieved using the same procedure as for <b>13</b>, however, in step 2, during LiOH hydrolysis, both the <i>N</i>-deacetylation and the ester hydrolysis take place to give the desired amino acid HCl salts as white solids; (<i>R</i>)-<b>17</b> in 70% yield (41 mg) and (<i>S</i>)-<b>17</b> in 74% yield (86 mg). The enantiomeric purity of amino acids <b>17</b> was not determined at this stage but assumed to be very similar to the final inhibitors (<i>R</i>)- and (<i>S</i>)-<b>7b</b>, which were analyzed by chiral HPLC and found to have 80% ee and 83% ee for (<i>R</i>) and (<i>S</i>), respectively. <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O): δ 7.43 (td, <i>J</i> = 7.9, 6.1 Hz, 1H), 7.22–7.06 (m, 3H), 4.30 (dd, <i>J</i> = 7.5, 5.8 Hz, 1H), 3.37 (dd, <i>J</i> = 14.7, 5.6 Hz, 1H), 3.23 (dd, <i>J</i> = 14.6, 7.7 Hz, 1H). <sup>19</sup>F{<sup>1</sup>H}NMR (377 MHz, D<sub>2</sub>O): δ −113.13. <sup>13</sup>C{<sup>1</sup>H}NMR (126 MHz, D<sub>2</sub>O): δ 171.7, 162.8 (d, <i>J</i> = 244.1 Hz), 136.7 (d, <i>J</i> = 7.5 Hz), 130.9 (d, <i>J</i> = 8.5 Hz), 125.2 (d, <i>J</i> = 2.8 Hz), 116.1 (d, <i>J</i> = 21.9 Hz), 114.7 (d, <i>J</i> = 21.1 Hz), 54.3, 35.4 (d, <i>J</i> = 1.8 Hz). LRMS (ESI) <i>m</i>/<i>z</i>: 184.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Expression and Purification of hFPPS</h3><div class="NLM_p last">A plasmid (vector p11, SGC Oxford) encoding hFPPS with an N-terminal His-tag was transformed into <i>Escherichia coli</i> BL21 (DE3) cells. The cells were grown in LB at 37 °C until the OD<sub>600</sub> of 0.6 was reached. Expression of the recombinant protein was induced overnight at 18 °C in the presence of 1 mM IPTG. The cells were lysed in a buffer solution composed of 50 mM HEPES, 500 mM NaCl, 5 mM β-mercaptoethanol, 5 mM imidazole, and 5% (v/v) glycerol (pH 7.5). The lysate was cleared of cell debris by centrifugation and applied to a metal ion affinity column (Ni-NTA Superflow Cartridge, Qiagen). Bound proteins were eluted with an increasing imidazole gradient, and the fractions containing hFPPS were pooled and applied to a size-exclusion column (HiLoad 26/60 Superdex 200, GE Healthcare). Imidazole was removed from the sample during the size-exclusion step, in which the running buffer consisted of 20 mM HEPES, 500 mM NaCl, 5 mM β-mercaptoethanol, and 5% (v/v) glycerol (pH 7.5). The purified sample was concentrated in a centrifugal concentrator (MWCO of 50000 Da) to the final concentration of 20 mg/mL and stored at 4 °C for later use.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> In Vitro Inhibition Assay</h3><div class="NLM_p last">Reactions were carried out with 2 μM GPP, 1.8 μM IPP (containing <sup>14</sup>C-IPP, 55 μCi/μmol), and 40 ng/mL of the purified enzyme in the final volume of 200 μL. The reaction mixture also contained 50 mM Tris (pH 7.7), 1 mM MgCl<sub>2</sub>, 0.5 mM TCEP, 20 μg/mL BSA, and 0.01% Triton X-100. Catalysis proceeded for 5 min at 37 °C after a preincubation period; the enzyme and inhibitor (if added) were incubated in the reaction mixture for 10 min before the substrates were added to initiate the reaction. The reactions were terminated by adding 400 μL of HCl/methanol (1:4) quenching solution, followed by an additional incubation of 10 min at 37 °C. The reaction product was extracted with 700 μL of ligroin, and 350 μL of the ligroin phase were added to 8 mL of scintillation cocktail (EcoLite, MP Biomedicals). Radioactivity was measured with a Beckman Coulter LS6500 liquid scintillation counter. All reactions were carried out in triplicate, and the IC<sub>50</sub> values were determined with the program <i>GraFit</i> (Erithacus Software).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Crystallization of Inhibitors Bound to hFPPS</h3><div class="NLM_p last">Each compound was added to the purified protein sample to give final concentrations of 1.0 and 0.25 mM, respectively. Crystals were produced at 22 °C by vapor diffusion in hanging drops composed of 1 μL of inhibitor/protein mixture and 1 μL of crystallization solution. The composition of the crystallization solutions was as follows: 1.6 M (NH<sub>4</sub>)<sub>2</sub>HPO<sub>4</sub>, 20% glycerol, and 0.08 M Tris (pH 8.5) for the crystals containing (<i>R</i>)- and (<i>S</i>)-<b>6d</b> and (<i>R</i>)-<b>6g</b>: 0.6 M KH<sub>2</sub>PO<sub>4</sub>, 0.6 M NaH<sub>2</sub>PO<sub>4</sub>, 25% glycerol, and 0.075 M HEPES (pH 7.5) for (<i>R</i>)- and (<i>S</i>)-<b>6f</b>, and 0.04 M KH<sub>2</sub>PO<sub>4</sub>, 16% PEG 8K, and 20% glycerol for (<i>S</i>)-<b>6g</b>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> X-ray Diffraction and Structure Refinement</h3><div class="NLM_p last">Diffraction data were collected from single crystals under cryogenic conditions with either synchrotron radiation (Canadian Light Source, Saskatoon, SK) or a home source generator (MetalJet D2, Bruker). The synchrotron data sets were indexed and scaled with the <i>xia</i>2 program package,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and the home source set with the <i>Proteum3</i> software suite (Bruker). The initial structure models were built by difference Fourier methods with the PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XQR">4XQR</a> or <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H5C">4H5C</a> as the starting template. The models were improved through iterative rounds of manual and automated refinement with COOT<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and REFMAC5.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The final models were deposited to the PDB. The discovery maps for the bound inhibitors are presented in Supporting Information, <a class="ref internalNav" href="#notes-1" aria-label="Figure S1">Figure S1</a>. Data collection and structure refinement statistics and the PDB IDs for the final structure models are summarized in Supporting Information, <a class="ref internalNav" href="#notes-1" aria-label="Table S1">Table S1</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01104" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01104" class="ext-link">10.1021/acs.jmedchem.9b01104</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H, <sup>13</sup>C, <sup>31</sup>P NMR spectra, and chiral HPLC chromatograms. X-ray data collection and structure refinement for cocrystal structures of both (<i>R</i>)- and (<i>S</i>)-enantiomers of inhibitors <b>6d</b>, <b>6f</b>, and <b>6g</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01104/suppl_file/jm9b01104_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01104/suppl_file/jm9b01104_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01104/suppl_file/jm9b01104_si_001.pdf">jm9b01104_si_001.pdf (12.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01104/suppl_file/jm9b01104_si_002.csv">jm9b01104_si_002.csv (2.7 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB accession code for the X-ray cocrystal structures of hFPPS with inhibitors bound (<i>S</i>)-<b>6d</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Z">6N7Z</a>), (<i>R</i>)-<b>6d</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Y">6N7Y</a>), (<i>S</i>)-<b>6f</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAG">6OAG</a>), (<i>R</i>)-<b>6f</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAH">6OAH</a>), (<i>S</i>)-<b>6g</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N82">6N82</a>), (<i>R</i>)-<b>6g</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N83">6N83</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b01104" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66018" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66018" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albert M. Berghuis</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, McGill University, 3649 Promenade Sir William Osler, Montreal, Quebeck H3G 0B1, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1958757b7c6b6d377b7c6b7e716c706a59747a7e707575377a78"><span class="__cf_email__" data-cfemail="450429272037316b272037222d302c36052826222c29296b2624">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Youla S. Tsantrizos</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Biochemistry, McGill University, 3649 Promenade Sir William Osler, Montreal, Quebeck H3G 0B1, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6231-7498" title="Orcid link">http://orcid.org/0000-0002-6231-7498</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#51083e243d307f2522303f2523382b3e22113c3236383d3d7f3230"><span class="__cf_email__" data-cfemail="90c9ffe5fcf1bee4e3f1fee4e2f9eaffe3d0fdf3f7f9fcfcbef3f1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuting Feng</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jaeok Park</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Biochemistry, McGill University, 3649 Promenade Sir William Osler, Montreal, Quebeck H3G 0B1, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8180-3950" title="Orcid link">http://orcid.org/0000-0002-8180-3950</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shi-Guang Li</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca Boutin</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Viereck</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, McGill University, 801 Sherbrooke Street West, Montreal, Quebec H3A 0B8, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew A. Schilling</span> - <span class="hlFld-Affiliation affiliation">Department of Biochemistry, McGill University, 3649 Promenade Sir William Osler, Montreal, Quebeck H3G 0B1, Canada</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y. F. and J. P. contributed equally; P.V. was an undergraduate research participant; conceptualization of project (Y.S.T.); synthesis of inhibitors (Y.F., S.-G. L., and P.V.); in vitro evaluation of inhibitors (J.P. and R.B.); X-ray crystallography (J.P and A.M.B.); Y.S.T. wrote the manuscript with contributions from all group members.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5142-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are very grateful for financial support from the Natural Sciences and Engineering Research Council of Canada (NSERC, grant no. RGPIN-2015-05529 to Y.S.T. and RGPIN-2019–05067 to A.M.B.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">hFPPS</td><td class="NLM_def"><p class="first last">human farnesyl pyrophosphate synthase</p></td></tr><tr><td class="NLM_term">FPP</td><td class="NLM_def"><p class="first last">farnesyl pyrophosphate</p></td></tr><tr><td class="NLM_term">IPP</td><td class="NLM_def"><p class="first last">isopentenyl pyrophosphate</p></td></tr><tr><td class="NLM_term">DMAPP</td><td class="NLM_def"><p class="first last">dimethyl allyl pyrophosphate</p></td></tr><tr><td class="NLM_term">GGPP</td><td class="NLM_def"><p class="first last">geranylgeranyl pyrophosphate</p></td></tr><tr><td class="NLM_term"><i>N</i>-BPs</td><td class="NLM_def"><p class="first last">nitrogen-containing bisphosphonates</p></td></tr><tr><td class="NLM_term">C<sup>6</sup>–ThP-MP</td><td class="NLM_def"><p class="first last">C6-substituted thienopyrimidine-based monophosphonate</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dunford, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coxon, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckman, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulter, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebetino, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, M. J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>296</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=11160603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD3MXoslaluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2001&pages=235-242&author=J.+E.+Dunfordauthor=K.+Thompsonauthor=F.+P.+Coxonauthor=S.+P.+Luckmanauthor=F.+M.+Hahnauthor=C.+D.+Poulterauthor=F.+H.+Ebetinoauthor=M.+J.+Rogers&title=Structure-activity+relationship+for+inhibition+of+farnesyl+diphosphate+synthase+in+vitro+and+inhibition+of+bone+resorption+in+vivo+by+nitrogen-containing+bisphosphonates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates</span></div><div class="casAuthors">Dunford, James E.; Thompson, Keith; Coxon, Fraser P.; Luckman, Steven P.; Hahn, Frederick M.; Poulter, C. Dale; Ebetino, Frank H.; Rogers, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">It has long been known that small changes to the structure of the side chain of nitrogen-contg. bisphosphonates can dramatically affect their potency for inhibiting bone resorption in vitro and in vivo, although the reason for these differences in antiresorptive potency have not been explained at the level of a pharmacol. target.  Recently, several nitrogen-contg. bisphosphonates were found to inhibit osteoclast-mediated bone resorption in vitro by inhibiting farnesyl diphosphate synthase, thereby preventing protein prenylation in osteoclasts.  In this study, we examd. the potency of a wider range of nitrogen-contg. bisphosphonates, including the highly potent, heterocycle-contg. zoledronic acid and minodronate (YM-529).  We found a clear correlation between the ability to inhibit farnesyl diphosphate synthase in vitro, to inhibit protein prenylation in cell-free exts. and in purified osteoclasts in vitro, and to inhibit bone resorption in vivo.  The activity of recombinant human farnesyl diphosphate synthase was inhibited at concns. ≥1 nM zoledronic acid or minodronate, the order of potency (zoledronic acid ≈ minodronate > risedronate > ibandronate > incadronate > alendronate > pamidronate) closely matching the order of antiresorptive potency.  Furthermore, minor changes to the structure of the side chain of heterocycle-contg. bisphosphonates, giving rise to less potent inhibitors of bone resorption in vivo, also caused a redn. in potency up to ∼300-fold for inhibition of farnesyl diphosphate synthase in vitro.  These data indicate that farnesyl diphosphate synthase is the major pharmacol. target of these drugs in vivo, and that small changes to the structure of the side chain alter antiresorptive potency by affecting the ability to inhibit farnesyl diphosphate synthase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg9S7IrVEnC7Vg90H21EOLACvtfcHk0lh-HdTDalzFYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXoslaluw%253D%253D&md5=25f1fe58cfbda08f1e1aa1d0779b0686</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DLuckman%26aufirst%3DS.%2BP.%26aulast%3DHahn%26aufirst%3DF.%2BM.%26aulast%3DPoulter%26aufirst%3DC.%2BD.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26atitle%3DStructure-activity%2520relationship%2520for%2520inhibition%2520of%2520farnesyl%2520diphosphate%2520synthase%2520in%2520vitro%2520and%2520inhibition%2520of%2520bone%2520resorption%2520in%2520vivo%2520by%2520nitrogen-containing%2520bisphosphonates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D296%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Coxon, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, M. J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in understanding the mechanism of action of bisphosphonates</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2006.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.coph.2006.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=16650801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFyms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=307-312&author=F.+P.+Coxonauthor=K.+Thompsonauthor=M.+J.+Rogers&title=Recent+advances+in+understanding+the+mechanism+of+action+of+bisphosphonates&doi=10.1016%2Fj.coph.2006.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in understanding the mechanism of action of bisphosphonates</span></div><div class="casAuthors">Coxon, Fraser P.; Thompson, Keith; Rogers, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-312</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Bisphosphonates (BPs) are widely used in the treatment of diseases assocd. with excessive osteoclast-mediated bone resorption, such as osteoporosis.  Although several years ago the mol. target of the potent nitrogen-contg. BPs (N-BPs) was identified as farnesyl diphosphate synthase, an enzyme in the mevalonate pathway, recent data have shed new light on the precise mechanism of inhibition and demonstrated that the acute-phase reaction, an adverse effect of N-BPs, is also caused by inhibition of this enzyme.  In addn., the identification of BP analogs that inhibit different enzymes in the mevalonate pathway could lead to the development of novel inhibitors of bone resorption with potential applications in the treatment of bone disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTh3WImCUpFrVg90H21EOLACvtfcHk0lh-HdTDalzFYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFyms7w%253D&md5=17b2b704256c23fd1cd09e5a9e6b1f70</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26atitle%3DRecent%2520advances%2520in%2520understanding%2520the%2520mechanism%2520of%2520action%2520of%2520bisphosphonates%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D307%26epage%3D312%26doi%3D10.1016%2Fj.coph.2006.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eastell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siris, E.</span></span> <span> </span><span class="NLM_article-title">Bisphosphonates for postmenopausal osteoporosis</span>. <i>Bone</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.bone.2011.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.bone.2011.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21349354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=82-88&author=R.+Eastellauthor=J.+S.+Walshauthor=N.+B.+Wattsauthor=E.+Siris&title=Bisphosphonates+for+postmenopausal+osteoporosis&doi=10.1016%2Fj.bone.2011.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Bisphosphonates for postmenopausal osteoporosis</span></div><div class="casAuthors">Eastell, Richard; Walsh, Jennifer S.; Watts, Nelson B.; Siris, Ethel</div><div class="citationInfo"><span class="NLM_cas:title">Bone (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-88</span>CODEN:
                <span class="NLM_cas:coden">BONEDL</span>;
        ISSN:<span class="NLM_cas:issn">8756-3282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Bisphosphonates are effective in reducing bone turnover, increasing BMD and reducing fracture risk in postmenopausal women with osteoporosis.  The licensed bisphosphonates exhibit some differences in potency and speed of onset and offset of action.  These differences mean that different agents may be more advantageous in different situations.  Uncertainties still exist around the optimum duration of treatment and treatment holidays, how best to use bisphosphonates with anabolic treatments, and the benefits of treatment in patients who do not have a BMD T-score below - 2.5.  This article is part of a Special Issue entitled Bisphosphonates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn52bAtFdyyrVg90H21EOLACvtfcHk0liHyA3lZfiUqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSgsbc%253D&md5=c2bae5bed147331d3ec7dc6d689185e3</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DEastell%26aufirst%3DR.%26aulast%3DWalsh%26aufirst%3DJ.%2BS.%26aulast%3DWatts%26aufirst%3DN.%2BB.%26aulast%3DSiris%26aufirst%3DE.%26atitle%3DBisphosphonates%2520for%2520postmenopausal%2520osteoporosis%26jtitle%3DBone%26date%3D2011%26volume%3D49%26spage%3D82%26epage%3D88%26doi%3D10.1016%2Fj.bone.2011.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ebetino, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoumpra, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triffitt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwaasi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunford, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnett, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppermann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundy, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashemirov, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R. G.</span></span> <span> </span><span class="NLM_article-title">The relationship between the chemistry and biological activity of the bisphosphonates</span>. <i>Bone</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.bone.2011.03.774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.bone.2011.03.774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21497677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=20-33&author=F.+H.+Ebetinoauthor=A.-M.+Hoganauthor=S.+Sunauthor=M.+K.+Tsoumpraauthor=X.+Duanauthor=J.+T.+Triffittauthor=A.+A.+Kwaasiauthor=J.+E.+Dunfordauthor=B.+L.+Barnettauthor=U.+Oppermannauthor=M.+W.+Lundyauthor=A.+Boydeauthor=B.+A.+Kashemirovauthor=C.+E.+McKennaauthor=R.+G.+Russell&title=The+relationship+between+the+chemistry+and+biological+activity+of+the+bisphosphonates&doi=10.1016%2Fj.bone.2011.03.774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship between the chemistry and biological activity of the bisphosphonates</span></div><div class="casAuthors">Ebetino, Frank H.; Hogan, Anne-Marie L.; Sun, Shuting; Tsoumpra, Maria K.; Duan, Xuchen; Triffitt, James T.; Kwaasi, Aaron A.; Dunford, James E.; Barnett, Bobby L.; Oppermann, Udo; Lundy, Mark W.; Boyde, Alan; Kashemirov, Boris A.; McKenna, Charles E.; Russell, R. Graham G.</div><div class="citationInfo"><span class="NLM_cas:title">Bone (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-33</span>CODEN:
                <span class="NLM_cas:coden">BONEDL</span>;
        ISSN:<span class="NLM_cas:issn">8756-3282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ability of bisphosphonates ((HO)2P(O)CR1R2P(O)(OH)2) to inhibit bone resorption has been known since the 1960s, but it is only recently that a detailed mol. understanding of the relationship between chem. structures and biol. activity has begun to emerge.  The early development of chem. in this area was largely empirical and based on modifying R2 groups in a variety of ways.  Apart from the general ability of bisphosphonates to chelate Ca2+ and thus target the calcium phosphate mineral component of bone, attempts to refine clear structure-activity relationships had led to ambiguous or seemingly contradictory results.  However, there was increasing evidence for cellular effects, and eventually the earliest bisphosphonate drugs, such as clodronate (R1 = R2 = Cl) and etidronate (R1 = OH, R2 = CH3), were shown to exert intracellular actions via the formation in vivo of drug derivs. of ATP.  The observation that pamidronate, a bisphosphonate with R1 = OH and R2 = CH2CH2NH2, exhibited higher potency than previously known bisphosphonate drugs represented the first step towards the later recognition of the crit. importance of having nitrogen in the R2 side chain.  The synthesis and biol. evaluation of a large no. of nitrogen-contg. bisphosphonates took place particularly in the 1980s, but still with an incomplete understanding of their structure-activity relationships.  A major advance was the discovery that the anti-resorptive effects of the nitrogen-contg. bisphosphonates (including alendronate, risedronate, ibandronate, and zoledronate) on osteoclasts appear to result from their potency as inhibitors of the enzyme farnesyl pyrophosphate synthase (FPPS), a key branch-point enzyme in the mevalonate pathway.  FPPS generates isoprenoid lipids utilized in sterol synthesis and for the post-translational modification of small GTP-binding proteins essential for osteoclast function.  Effects on other cellular targets, such as osteocytes, may also be important.  Over the years many hundreds of bisphosphonates have been synthesized and studied.  Interest in expanding the structural scope of the bisphosphonate class has also motivated new approaches to the chem. synthesis of these compds.  Recent chem. innovations include the synthesis of fluorescently labeled bisphosphonates, which has enabled studies of the biodistribution of these drugs.  As a class, bisphosphonates share common properties.  However, as with other classes of drugs, there are chem., biochem., and pharmacol. differences among the individual compds.  Differences in mineral binding affinities among bisphosphonates influence their differential distribution within bone, their biol. potency, and their duration of action.  The overall pharmacol. effects of bisphosphonates on bone, therefore, appear to depend upon these two key properties of affinity for bone mineral and inhibitory effects on osteoclasts.  The relative contributions of these properties differ among individual bisphosphonates and help det. their clin. behavior and effectiveness.  This article is part of a Special Issue entitled Bisphosphonates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkW3DAKvbJe7Vg90H21EOLACvtfcHk0liHyA3lZfiUqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSgsLk%253D&md5=0bba79f40512f2df89bd0ee36459e264</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.03.774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.03.774%26sid%3Dliteratum%253Aachs%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DHogan%26aufirst%3DA.-M.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DTsoumpra%26aufirst%3DM.%2BK.%26aulast%3DDuan%26aufirst%3DX.%26aulast%3DTriffitt%26aufirst%3DJ.%2BT.%26aulast%3DKwaasi%26aufirst%3DA.%2BA.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DBarnett%26aufirst%3DB.%2BL.%26aulast%3DOppermann%26aufirst%3DU.%26aulast%3DLundy%26aufirst%3DM.%2BW.%26aulast%3DBoyde%26aufirst%3DA.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26aulast%3DRussell%26aufirst%3DR.%2BG.%26atitle%3DThe%2520relationship%2520between%2520the%2520chemistry%2520and%2520biological%2520activity%2520of%2520the%2520bisphosphonates%26jtitle%3DBone%26date%3D2011%26volume%3D49%26spage%3D20%26epage%3D33%26doi%3D10.1016%2Fj.bone.2011.03.774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, S. M.</span></span> <span> </span><span class="NLM_article-title">Targeting protein prenylation for cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1038/nrc3151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1038%2Fnrc3151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=22020205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=775-791&author=N.+Berndtauthor=A.+D.+Hamiltonauthor=S.+M.+Sebti&title=Targeting+protein+prenylation+for+cancer+therapy&doi=10.1038%2Fnrc3151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein prenylation for cancer therapy</span></div><div class="casAuthors">Berndt, Norbert; Hamilton, Andrew D.; Sebti, Said M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">775-791</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein farnesylation and geranylgeranylation, together referred to as prenylation, are lipid post-translational modifications that are required for the transforming activity of many oncogenic proteins, including some RAS family members.  This observation prompted the development of inhibitors of farnesyltransferase (FT) and geranylgeranyltransferase 1 (GGT1) as potential anticancer drugs.  In this Review, we discuss the mechanisms by which FT and GGT1 inhibitors (FTIs and GGTIs, resp.) affect signal transduction pathways, cell cycle progression, proliferation and cell survival.  In contrast to their preclin. efficacy, only a small subset of patients responds to FTIs.  Identifying tumors that depend on farnesylation for survival remains a challenge, and strategies to overcome this are discussed.  One GGTI has recently entered the clinic, and the safety and efficacy of GGTIs await results from clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmj2vv2fG4gLVg90H21EOLACvtfcHk0li8x3QYcR2v7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7jF&md5=c98505df79a037234fb260801c9b97aa</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrc3151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3151%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DN.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DTargeting%2520protein%2520prenylation%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D775%26epage%3D791%26doi%3D10.1038%2Fnrc3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mullen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penn, L. Z.</span></span> <span> </span><span class="NLM_article-title">The interplay between cell signalling and the mevalonate pathway in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1038/nrc.2016.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1038%2Fnrc.2016.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=27562463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVSrur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=718-731&author=P.+J.+Mullenauthor=R.+Yuauthor=J.+Longoauthor=M.+C.+Archerauthor=L.+Z.+Penn&title=The+interplay+between+cell+signalling+and+the+mevalonate+pathway+in+cancer&doi=10.1038%2Fnrc.2016.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">The interplay between cell signalling and the mevalonate pathway in cancer</span></div><div class="casAuthors">Mullen, Peter J.; Yu, Rosemary; Longo, Joseph; Archer, Michael C.; Penn, Linda Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">718-731</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mevalonate (MVA) pathway is an essential metabolic pathway that uses acetyl-CoA to produce sterols and isoprenoids that are integral to tumor growth and progression.  In recent years, many oncogenic signalling pathways have been shown to increase the activity and/or the expression of MVA pathway enzymes.  This Review summarizes recent advances and discusses unique opportunities for immediately targeting this metabolic vulnerability in cancer with agents that have been approved for other therapeutic uses, such as the statin family of drugs, to improve outcomes for cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprCFV9_aKCv7Vg90H21EOLACvtfcHk0li8x3QYcR2v7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVSrur%252FN&md5=4a692b82d8eb6fc1547db5c45a36cae4</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2016.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2016.76%26sid%3Dliteratum%253Aachs%26aulast%3DMullen%26aufirst%3DP.%2BJ.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DLongo%26aufirst%3DJ.%26aulast%3DArcher%26aufirst%3DM.%2BC.%26aulast%3DPenn%26aufirst%3DL.%2BZ.%26atitle%3DThe%2520interplay%2520between%2520cell%2520signalling%2520and%2520the%2520mevalonate%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2016%26volume%3D16%26spage%3D718%26epage%3D731%26doi%3D10.1038%2Fnrc.2016.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunford, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebetino, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppermann, U.</span></span> <span> </span><span class="NLM_article-title">The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">7829</span>– <span class="NLM_lpage">7834</span>, <span class="refDoi"> DOI: 10.1073/pnas.0601643103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1073%2Fpnas.0601643103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=16684881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVGksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=7829-7834&author=K.+L.+Kavanaghauthor=K.+Guoauthor=J.+E.+Dunfordauthor=X.+Wuauthor=S.+Knappauthor=F.+H.+Ebetinoauthor=M.+J.+Rogersauthor=R.+G.+Russellauthor=U.+Oppermann&title=The+molecular+mechanism+of+nitrogen-containing+bisphosphonates+as+antiosteoporosis+drugs&doi=10.1073%2Fpnas.0601643103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs</span></div><div class="casAuthors">Kavanagh, Kathryn L.; Guo, Kunde; Dunford, James E.; Wu, Xiaoqiu; Knapp, Stefan; Ebetino, Frank H.; Rogers, Michael J.; Russell, R. Graham G.; Oppermann, Udo</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7829-7834</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Osteoporosis and low bone mass are currently estd. to be a major public health risk affecting > 50% of the female population over the age of 50.  Because of their bone-selective pharmacokinetics, nitrogen-contg. bisphosphonates (N-BPs), currently used as clin. inhibitors of bone-resorption diseases, target osteoclast farnesyl pyrophosphate synthase (FPPS) and inhibit protein prenylation.  FPPS, a key branchpoint of the mevalonate pathway, catalyzes the successive condensation of isopentenyl pyrophosphate with dimethylallyl pyrophosphate and geranyl pyrophosphate.  To understand the mol. events involved in inhibition of FPPS by N-BPs, we used protein crystallog., enzyme kinetics, and isothermal titrn. calorimetry.  We report here high-resoln. x-ray structures of the human enzyme in complexes with risedronate and zoledronate, two of the leading N-BPs in clin. use.  These agents bind to the dimethylallyl/geranyl pyrophosphate ligand pocket and induce a conformational change.  The interactions of the N-BP cyclic nitrogen with Thr-201 and Lys-200 suggest that these inhibitors achieve potency by positioning their nitrogen in the proposed carbocation-binding site.  Kinetic analyses reveal that inhibition is competitive with geranyl pyrophosphate and is of a slow, tight binding character, indicating that isomerization of an initial enzyme-inhibitor complex occurs with inhibitor binding.  Isothermal titrn. calorimetry indicates that binding of N-BPs to the apoenzyme is entropy-driven, presumably through desolvation entropy effects.  These expts. reveal the mol. binding characteristics of an important pharmacol. target and provide a route for further optimization of these important drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1EVLSV5J3IrVg90H21EOLACvtfcHk0lj7CKOPXY_ozA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVGksL0%253D&md5=d422e7cb8cfd588daa4c4a76756dc45b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601643103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601643103%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DK.%2BL.%26aulast%3DGuo%26aufirst%3DK.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DRussell%26aufirst%3DR.%2BG.%26aulast%3DOppermann%26aufirst%3DU.%26atitle%3DThe%2520molecular%2520mechanism%2520of%2520nitrogen-containing%2520bisphosphonates%2520as%2520antiosteoporosis%2520drugs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D7829%26epage%3D7834%26doi%3D10.1073%2Fpnas.0601643103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocks, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szubert, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro-Coy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drayson, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feyler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashcroft, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roddie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Child, J. A.</span></span> <span> </span><span class="NLM_article-title">First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomized controlled trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>376</i></span>,  <span class="NLM_fpage">1989</span>– <span class="NLM_lpage">1999</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(10)62051-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2FS0140-6736%2810%2962051-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21131037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCqsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=1989-1999&author=G.+J.+Morganauthor=F.+E.+Daviesauthor=W.+M.+Gregoryauthor=K.+Cocksauthor=S.+E.+Bellauthor=A.+J.+Szubertauthor=N.+Navarro-Coyauthor=M.+T.+Draysonauthor=R.+G.+Owenauthor=S.+Feylerauthor=A.+J.+Ashcroftauthor=F.+Rossauthor=J.+Byrneauthor=H.+Roddieauthor=C.+Rudinauthor=G.+Cookauthor=G.+H.+Jacksonauthor=J.+A.+Child&title=First-line+treatment+with+zoledronic+acid+as+compared+with+clodronic+acid+in+multiple+myeloma+%28MRC+Myeloma+IX%29%3A+a+randomized+controlled+trial&doi=10.1016%2FS0140-6736%2810%2962051-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial</span></div><div class="casAuthors">Morgan, Gareth J.; Davies, Faith E.; Gregory, Walter M.; Cocks, Kim; Bell, Sue E.; Szubert, Alex J.; Navarro-Coy, Nuria; Drayson, Mark T.; Owen, Roger G.; Feyler, Sylvia; Ashcroft, A. John; Ross, Fiona; Byrne, Jennifer; Roddie, Huw; Rudin, Claudius; Cook, Gordon; Jackson, Graham H.; Child, J. Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">9757</span>),
    <span class="NLM_cas:pages">1989-1999</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bisphosphonates reduce the risk of skeletal events in patients with malignant bone disease, and zoledronic acid has shown potential anticancer effects in preclin. and clin. studies.  We aimed to establish whether bisphosphonates can affect clin. outcomes in patients with multiple myeloma.  Patients of age 18 years or older with newly diagnosed multiple myeloma were enrolled from 120 centers in the UK.  Computer-generated randomisation sequence was used to allocate patients equally, via an automated telephone service, to receive 4 mg zoledronic acid as an infusion every 3-4 wk or 1600 mg oral clodronic acid daily.  Patients also received intensive or non-intensive induction chemotherapy.  No investigators, staff, or patients were masked to treatment allocation, and bisphosphonate and maintenance therapy continued at least until disease progression.  The primary endpoints were overall survival, progression-free survival, and overall response rate.  We assessed between-group differences with Cox proportional hazards models for progression-free survival and overall survival, and with logistic regression models for overall response rate.  Anal. was by intention to treat.  This trial is registered, no. ISRCTN68454111.  1970 patients were enrolled between May, 2003, and Nov., 2007, of whom 1960 were eligible for intention-to-treat anal.: 981 in the zoledronic acid group (555 on intensive chemotherapy, 426 on non-intensive chemotherapy); and 979 on clodronic acid (556 on intensive chemotherapy, 423 on non-intensive chemotherapy).  The treatment cutoff was Oct 5, 2009, with patients receiving bisphosphonates for a median of 350 days (IQR 137-632) before disease progression, with a median of 3.7 years' follow-up (IQR 2.9-4.7).  Zoledronic acid reduced mortality by 16% (95% CI 4-26) vs. clodronic acid (hazard ratio [HR] 0.84, 95% CI 0.74-0.96; p=0.0118), and extended median overall survival by 5.5 mo (50.0 mo, IQR 21.0 to not reached vs 44.5 mo, IQR 16.5 to not reached; p=0.04).  Zoledronic acid also significantly improved progression-free survival by 12% (95% CI 2-20) vs. clodronic acid (HR 0.88, 95% CI 0.80-0.98; p=0.0179), and increased median progression-free survival by 2.0 mo (19.5 mo, IQR 9.0-38.0 vs 17.5 mo, IQR 8.5-34.0; p=0.07).  Rates of complete, very good partial, or partial response did not differ significantly between the zoledronic acid and clodronic acid groups for patients receiving intensive induction chemotherapy (432 patients [78%] vs 422 [76%]; p=0.43) or non-intensive induction chemotherapy (215 [50%] vs 195 [46%]; p=0.18).  Both bisphosphonates were generally well tolerated, with similar occurrence of acute renal failure and treatment-emergent serious adverse events, but zoledronic acid was assocd. with higher rates of confirmed osteonecrosis of the jaw (35 [4%]) than was clodronic acid (3 [<1%]).  Consistent with the potential anticancer activity of zoledronic acid, overall survival improved independently of prevention of skeletal-related events, showing that zoledronic acid has treatment benefits beyond bone health.  These findings support immediate treatment with zoledronic acid in patients with newly diagnosed multiple myeloma, not only for prevention of skeletal-related events, but also for potential antimyeloma benefits.  Funding: Medical Research Council (London, UK), with unrestricted educational grants from Novartis, Schering Health Care, Chugai, Pharmion, Celgene, and Ortho Biotech.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXS5ilaeyX3rVg90H21EOLACvtfcHk0lj7CKOPXY_ozA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCqsLnL&md5=53e25efc3a82b57d286c73f7fba6a611</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2962051-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252962051-X%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DG.%2BJ.%26aulast%3DDavies%26aufirst%3DF.%2BE.%26aulast%3DGregory%26aufirst%3DW.%2BM.%26aulast%3DCocks%26aufirst%3DK.%26aulast%3DBell%26aufirst%3DS.%2BE.%26aulast%3DSzubert%26aufirst%3DA.%2BJ.%26aulast%3DNavarro-Coy%26aufirst%3DN.%26aulast%3DDrayson%26aufirst%3DM.%2BT.%26aulast%3DOwen%26aufirst%3DR.%2BG.%26aulast%3DFeyler%26aufirst%3DS.%26aulast%3DAshcroft%26aufirst%3DA.%2BJ.%26aulast%3DRoss%26aufirst%3DF.%26aulast%3DByrne%26aufirst%3DJ.%26aulast%3DRoddie%26aufirst%3DH.%26aulast%3DRudin%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DG.%2BH.%26aulast%3DChild%26aufirst%3DJ.%2BA.%26atitle%3DFirst-line%2520treatment%2520with%2520zoledronic%2520acid%2520as%2520compared%2520with%2520clodronic%2520acid%2520in%2520multiple%2520myeloma%2520%2528MRC%2520Myeloma%2520IX%2529%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D1989%26epage%3D1999%26doi%3D10.1016%2FS0140-6736%2810%2962051-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szubert, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drayson, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashcroft, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Child, J. A.</span></span> <span> </span><span class="NLM_article-title">Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">5374</span>– <span class="NLM_lpage">5383</span>, <span class="refDoi"> DOI: 10.1182/blood-2011-11-392522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1182%2Fblood-2011-11-392522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=22498739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFantLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=5374-5383&author=G.+J.+Morganauthor=F.+E.+Daviesauthor=W.+M.+Gregoryauthor=A.+J.+Szubertauthor=S.+E.+Bellauthor=M.+T.+Draysonauthor=R.+G.+Owenauthor=A.+J.+Ashcroftauthor=G.+H.+Jacksonauthor=J.+A.+Child&title=Effects+of+induction+and+maintenance+plus+long-term+bisphosphonates+on+bone+disease+in+patients+with+multiple+myeloma%3A+the+Medical+Research+Council+Myeloma+IX+Trial&doi=10.1182%2Fblood-2011-11-392522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial</span></div><div class="casAuthors">Morgan, Gareth J.; Davies, Faith E.; Gregory, Walter M.; Szubert, Alex J.; Bell, Sue E.; Drayson, Mark T.; Owen, Roger G.; Ashcroft, A. John; Jackson, Graham H.; Child, J. Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5374-5383</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The Medical Research Council Myeloma IX Trial (ISRCTNG8454111) examd. traditional and thalidomide-based induction and maintenance regimens and IV zoledronic acid (ZOL) and oral clodronate (CLO) in 1960 patients with newly diagnosed multiple myeloma.  Overall survival (OS) and skeletal-related event (SRE) data have been reported for the overall trial population.  The present anal. investigated optimal therapy regimens for different patient populations in Myeloma IX.  Patients were assigned to intensive or nonintensive treatment pathways and randomized to induction cyclophosphamide, vincristine, doxorubicin, and dexamethasone (CVAD) vs. cyclophosphamide, thalidomide, and dexamethasone (CTD; intensive) or melphalan and prednisolone vs. attenuated oral CTD (CTDa; nonintensive).  Patients were also randomized to ZOL or CLO.  In the nonintensive pathway, CTDa produced better responses and lower SRE rates than melphalan and prednisolone.  ZOL improved OS compared with CLO independently of sex, stage, or myeloma subtype, most profoundly in patients with baseline bone disease or other SREs.  In patients treated for ≥ 2 years, ZOL improved OS compared with CLO from randomization (median not reached for either; P = .02) and also from first on-study disease progression (median, 34 mo for ZOL vs 27 mo for CLO; P = .03).  Thalidomide-contg. regimens had better efficacy than traditional regimens, and ZOL demonstrated greater benefits than CLO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn6bsYwhGflrVg90H21EOLACvtfcHk0lgAcexurxU3og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFantLg%253D&md5=b908fa4236bbad0d7585647e43a02fbf</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-11-392522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-11-392522%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DG.%2BJ.%26aulast%3DDavies%26aufirst%3DF.%2BE.%26aulast%3DGregory%26aufirst%3DW.%2BM.%26aulast%3DSzubert%26aufirst%3DA.%2BJ.%26aulast%3DBell%26aufirst%3DS.%2BE.%26aulast%3DDrayson%26aufirst%3DM.%2BT.%26aulast%3DOwen%26aufirst%3DR.%2BG.%26aulast%3DAshcroft%26aufirst%3DA.%2BJ.%26aulast%3DJackson%26aufirst%3DG.%2BH.%26aulast%3DChild%26aufirst%3DJ.%2BA.%26atitle%3DEffects%2520of%2520induction%2520and%2520maintenance%2520plus%2520long-term%2520bisphosphonates%2520on%2520bone%2520disease%2520in%2520patients%2520with%2520multiple%2520myeloma%253A%2520the%2520Medical%2520Research%2520Council%2520Myeloma%2520IX%2520Trial%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D5374%26epage%3D5383%26doi%3D10.1182%2Fblood-2011-11-392522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodwell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkinshaw, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grieve, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett-Lee, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaunt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rea, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiley, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R.</span></span> <span> </span><span class="NLM_article-title">Breast-cancer adjuvant therapy with zoledronic acid</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">1396</span>– <span class="NLM_lpage">1405</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1105195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1056%2FNEJMoa1105195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21995387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlals7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=1396-1405&author=R.+E.+Colemanauthor=H.+Marshallauthor=D.+Cameronauthor=D.+Dodwellauthor=R.+Burkinshawauthor=M.+Keaneauthor=M.+Gilauthor=S.+J.+Houstonauthor=R.+J.+Grieveauthor=P.+J.+Barrett-Leeauthor=D.+Ritchieauthor=J.+Pughauthor=C.+Gauntauthor=U.+Reaauthor=J.+Petersonauthor=C.+Daviesauthor=V.+Hileyauthor=W.+Gregoryauthor=R.+Bell&title=Breast-cancer+adjuvant+therapy+with+zoledronic+acid&doi=10.1056%2FNEJMoa1105195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Breast-cancer adjuvant therapy with zoledronic acid</span></div><div class="casAuthors">Coleman, Robert E.; Marshall, Helen; Cameron, David; Dodwell, David; Burkinshaw, Roger; Keane, Maccon; Gil, Miguel; Houston, Stephen.; Grieve, Robert J.; Barrett-Lee, Peter J.; Ritchie, Diana; Pugh, Julia; Gaunt, Claire; Rea, Una; Peterson, Jennifer; Davies, Claire; Hiley, Victoria; Gregory, Walter; Bell, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1396-1405</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Data suggest that the adjuvant use of bisphosphonates reduces rates of recurrence and death in patients with early-stage breast cancer.  We conducted a study to det. whether treatment with zoledronic acid, in addn. to std. adjuvant therapy, would improve disease outcomes in such patients.  METHODS: In this open-label phase 3 study, we randomly assigned 3360 patients to receive std. adjuvant systemic therapy either with or without zoledronic acid.  The zoledronic acid was administered every 3 to 4 wk for 6 doses and then every 3 to 6 mo to complete 5 years of treatment.  The primary end point of the study was disease-free survival.  A second interim anal. revealed that a prespecified boundary for lack of benefit had been crossed.  RESULTS: At a median follow-up of 59 mo, there was no significant between-group difference in the primary end point, with a rate of disease-free survival of 77% in each group (adjusted hazard ratio in the zoledronic acid group, 0.98; 95% confidence interval [CI], 0.85 to 1.13; P = 0.79). Disease recurrence or death occurred in 377 patients in the zoledronic acid group and 375 of those in the control group.  The nos. of deaths - 243 in the zoledronic acid group and 276 in the control group - were also similar, resulting in rates of overall survival of 85.4% in the zoledronic acid group and 83.1% in the control group (adjusted hazard ratio, 0.85; 95% CI, 0.72 to 1.01; P = 0.07).  In the zoledronic acid group, there were 17 confirmed cases of osteonecrosis of the jaw (cumulative incidence, 1.1%; 95% CI, 0.6 to 1.7; P < 0.001) and 9 suspected cases; there were no cases in the control group.  Rates of other adverse effects were similar in the two study groups.  CONCLUSIONS: These findings do not support the routine use of zoledronic acid in the adjuvant management of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpISmlJLPnAebVg90H21EOLACvtfcHk0lgAcexurxU3og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlals7jP&md5=3c61150ab39db154b5370ea59896c73f</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1105195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1105195%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DR.%2BE.%26aulast%3DMarshall%26aufirst%3DH.%26aulast%3DCameron%26aufirst%3DD.%26aulast%3DDodwell%26aufirst%3DD.%26aulast%3DBurkinshaw%26aufirst%3DR.%26aulast%3DKeane%26aufirst%3DM.%26aulast%3DGil%26aufirst%3DM.%26aulast%3DHouston%26aufirst%3DS.%2BJ.%26aulast%3DGrieve%26aufirst%3DR.%2BJ.%26aulast%3DBarrett-Lee%26aufirst%3DP.%2BJ.%26aulast%3DRitchie%26aufirst%3DD.%26aulast%3DPugh%26aufirst%3DJ.%26aulast%3DGaunt%26aufirst%3DC.%26aulast%3DRea%26aufirst%3DU.%26aulast%3DPeterson%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DC.%26aulast%3DHiley%26aufirst%3DV.%26aulast%3DGregory%26aufirst%3DW.%26aulast%3DBell%26aufirst%3DR.%26atitle%3DBreast-cancer%2520adjuvant%2520therapy%2520with%2520zoledronic%2520acid%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D1396%26epage%3D1405%26doi%3D10.1056%2FNEJMoa1105195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gnant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlineritsch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luschin-Ebengreuth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakesz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pristauz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauernhofer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidtmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwasny, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochreiner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsthuber, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greil, R.</span></span> <span> </span><span class="NLM_article-title">Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(11)70122-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2FS1470-2045%2811%2970122-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21641868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1ejtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=631-641&author=M.+Gnantauthor=B.+Mlineritschauthor=H.+Stoegerauthor=G.+Luschin-Ebengreuthauthor=D.+Heckauthor=C.+Menzelauthor=R.+Jakeszauthor=M.+Seifertauthor=M.+Hubalekauthor=G.+Pristauzauthor=T.+Bauernhoferauthor=H.+Eidtmannauthor=W.+Eiermannauthor=G.+Stegerauthor=W.+Kwasnyauthor=P.+Dubskyauthor=G.+Hochreinerauthor=E.+P.+Forsthuberauthor=C.+Feslauthor=R.+Greil&title=Adjuvant+endocrine+therapy+plus+zoledronic+acid+in+premenopausal+women+with+early-stage+breast+cancer%3A+62-month+follow-up+from+the+ABCSG-12+randomised+trial&doi=10.1016%2FS1470-2045%2811%2970122-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial</span></div><div class="casAuthors">Gnant, Michael; Mlineritsch, Brigitte; Stoeger, Herbert; Luschin-Ebengreuth, Gero; Heck, Dietmar; Menzel, Christian; Jakesz, Raimund; Seifert, Michael; Hubalek, Michael; Pristauz, Gunda; Bauernhofer, Thomas; Eidtmann, Holger; Eiermann, Wolfgang; Steger, Guenther; Kwasny, Werner; Dubsky, Peter; Hochreiner, Gerhard; Forsthuber, Ernst-Pius; Fesl, Christian; Greil, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">631-641</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Anal. of the Austrian Breast and Colorectal Cancer Study Group trial-12 (ABCSG-12) at 48 mo' follow-up showed that addn. of zoledronic acid to adjuvant endocrine therapy significantly improved disease-free survival.  We have now assessed long-term clin. efficacy including disease-free survival and disease outcomes in patients receiving anastrozole or tamoxifen with or without zoledronic acid.  ABSCG-12 is a randomised, controlled, open-label, two-by-two factorial, multicentre trial in 1803 premenopausal women with endocrine-receptor-pos. early-stage (stage I-II) breast cancer receiving goserelin (3.6 mg every 28 days), comparing the efficacy and safety of anastrozole (1 mg per day) or tamoxifen (20 mg per day) with or without zoledronic acid (4 mg every 6 mo) for 3 years.  Randomisation (1:1:1:1 ratio) was computerized and based on the Pocock and Simon minimisation method to balance the four treatment arms across eight prognostic variables (age, neoadjuvant chemotherapy, pathol. tumor stage; lymph-node involvement, type of surgery or locoregional therapy, complete axillary dissection, intraoperative radiation therapy, and geog. region).  Treatment allocation was not masked.  The primary endpoint was disease-free survival (defined as disease recurrence or death) and anal. was by intention to treat.  This trial is registered with ClinicalTrials.gov, no. NCT00295646; follow-up is ongoing.  At a median follow-up of 62 mo (range 0-114.4 mo), more than 2 years after treatment completion, 186 disease-free survival events had been reported (53 events in 450 patients on tamoxifen alone, 57 in 453 patients on anastrozole alone, 36 in 450 patients on tamoxifen plus zoledronic acid, and 40 in 450 patients on anastrozole plus zoledronic acid).  Zoledronic acid reduced risk of disease-free survival events overall (HR 0.68, 95% CI 0.51-0.91; p=0.009), although the difference was not significant in the tamoxifen (HR 0.67, 95% CI 0.44-1.03; p=0.067) and anastrozole arms (HR 0.68, 95% CI 0.45-1.02; p=0.061) assessed sep.  Zoledronic acid did not significantly affect risk of death (30 deaths with zoledronic acid vs 43 deaths without; HR 0.67, 95% CI 0.41-1.07; p=0.09).  There was no difference in disease-free survival between patients on tamoxifen alone vs. anastrozole alone (HR 1.08, 95% CI 0.81-1.44; p=0.591), but overall survival was worse with anastrozole than with tamoxifen (46 vs 27 deaths; HR 1.75, 95% CI 1.08-2.83; p=0.02).  Treatments were generally well tolerated, with no reports of renal failure or osteonecrosis of the jaw.  Bone pain was reported in 601 patients (33%; 349 patients on zoledronic acid vs 252 not on the drug), fatigue in 361 (20%; 192 vs 169), headache in 280 (16%; 147 vs 133), and arthralgia in 266 (15%; 145 vs 121).  Addn. of zoledronic acid improved disease-free survival in the patients taking anastrozole or tamoxifen.  There was no difference in disease-free survival between patients receiving anastrozole and tamoxifen overall, but those on anastrozole alone had inferior overall survival.  These data show persistent benefits with zoledronic acid and support its addn. to adjuvant endocrine therapy in premenopausal patients with early-stage breast cancer.  Funding: AstraZeneca; Novartis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgMLLmua064rVg90H21EOLACvtfcHk0lh_Wrk-aanGxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1ejtLc%253D&md5=4755e1a85528b14accc4cc95bfa3d6b3</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2811%2970122-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252811%252970122-X%26sid%3Dliteratum%253Aachs%26aulast%3DGnant%26aufirst%3DM.%26aulast%3DMlineritsch%26aufirst%3DB.%26aulast%3DStoeger%26aufirst%3DH.%26aulast%3DLuschin-Ebengreuth%26aufirst%3DG.%26aulast%3DHeck%26aufirst%3DD.%26aulast%3DMenzel%26aufirst%3DC.%26aulast%3DJakesz%26aufirst%3DR.%26aulast%3DSeifert%26aufirst%3DM.%26aulast%3DHubalek%26aufirst%3DM.%26aulast%3DPristauz%26aufirst%3DG.%26aulast%3DBauernhofer%26aufirst%3DT.%26aulast%3DEidtmann%26aufirst%3DH.%26aulast%3DEiermann%26aufirst%3DW.%26aulast%3DSteger%26aufirst%3DG.%26aulast%3DKwasny%26aufirst%3DW.%26aulast%3DDubsky%26aufirst%3DP.%26aulast%3DHochreiner%26aufirst%3DG.%26aulast%3DForsthuber%26aufirst%3DE.%2BP.%26aulast%3DFesl%26aufirst%3DC.%26aulast%3DGreil%26aufirst%3DR.%26atitle%3DAdjuvant%2520endocrine%2520therapy%2520plus%2520zoledronic%2520acid%2520in%2520premenopausal%2520women%2520with%2520early-stage%2520breast%2520cancer%253A%252062-month%2520follow-up%2520from%2520the%2520ABCSG-12%2520randomised%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2011%26volume%3D12%26spage%3D631%26epage%3D641%26doi%3D10.1016%2FS1470-2045%2811%2970122-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gnant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlineritsch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schippinger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luschin-Ebengreuth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pöstlberger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakesz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjelic-Radisic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samonigg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tausch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidtmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwasny, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzal, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stierer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rücklinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greil, R.</span></span> <span> </span><span class="NLM_article-title">Endocrine therapy plus zoledronic acid in premenopaisal breast cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0806285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1056%2FNEJMoa0806285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=19213681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVyisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=679-691&author=M.+Gnantauthor=B.+Mlineritschauthor=W.+Schippingerauthor=G.+Luschin-Ebengreuthauthor=S.+P%C3%B6stlbergerauthor=C.+Menzelauthor=R.+Jakeszauthor=M.+Seifertauthor=M.+Hubalekauthor=V.+Bjelic-Radisicauthor=H.+Samoniggauthor=C.+Tauschauthor=H.+Eidtmannauthor=G.+Stegerauthor=W.+Kwasnyauthor=P.+Dubskyauthor=M.+Fridrikauthor=F.+Fitzalauthor=M.+Stiererauthor=E.+R%C3%BCcklingerauthor=R.+Greil&title=Endocrine+therapy+plus+zoledronic+acid+in+premenopaisal+breast+cancer&doi=10.1056%2FNEJMoa0806285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Endocrine therapy plus zoledronic acid in premenopausal breast cancer</span></div><div class="casAuthors">Gnant, Michael; Mlineritsch, Brigitte; Schippinger, Walter; Luschin-Ebengreuth, Gero; Postlberger, Sabine; Menzel, Christian; Jakesz, Raimund; Seifert, Michael; Hubalek, Michael; Bjelic-Radisic, Vesna; Samonigg, Hellmut; Tausch, Christoph; Eidtmann, Holger; Steger, Gunther; Kwasny, Werner; Dubsky, Peter; Fridrik, Michael; Fitzal, Florian; Stierer, Michael; Rucklinger, Ernst; Greil, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">679-691</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Ovarian suppression plus tamoxifen is a std. adjuvant treatment in premenopausal women with endocrine-responsive breast cancer.  Aromatase inhibitors are superior to tamoxifen in postmenopausal patients, and preclin. data suggest that zoledronic acid has antitumor properties.  We examd. the effect of adding zoledronic acid to a combination of either goserelin and tamoxifen or goserelin and anastrozole in premenopausal women with endocrine-responsive early breast cancer.  We randomly assigned 1803 patients to receive goserelin (3.6 mg given s.c. every 28 days) plus tamoxifen (20 mg per day given orally) or anastrozole (1 mg per day given orally) with or without zoledronic acid (4 mg given i.v. every 6 mo) for 3 years.  The primary end point was disease-free survival; recurrence-free survival and overall survival were secondary end points.  After a median follow-up of 47.8 mo, 137 events had occurred, with disease-free survival rates of 92.8% in the tamoxifen group, 92.0% in the anastrozole group, 90.8% in the group that received endocrine therapy alone, and 94.0% in the group that received endocrine therapy with zoledronic acid.  There was no significant difference in disease-free survival between the anastrozole and tamoxifen groups (hazard ratio for disease progression in the anastrozole group, 1.10; 95% confidence interval [CI], 0.78 to 1.53; P = 0.59).  The addn. of zoledronic acid to endocrine therapy, as compared with endocrine therapy without zoledronic acid, resulted in an abs. redn. of 3.2 percentage points and a relative redn. of 36% in the risk of disease progression (hazard ratio, 0.64; 95% CI, 0.46 to 0.91; P = 0.01); the addn. of zoledronic acid did not significantly reduce the risk of death (hazard ratio, 0.60; 95% CI, 0.32 to 1.11; P = 0.11).  Adverse events were consistent with known drug-safety profiles.  The addn. of zoledronic acid to adjuvant endocrine therapy improves disease-free survival in premenopausal patients with estrogen-responsive early breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqWZL1vqoy7LVg90H21EOLACvtfcHk0lh_Wrk-aanGxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVyisbk%253D&md5=f2c9103a7cfd4b4d14bf30f8a2e679d7</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0806285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0806285%26sid%3Dliteratum%253Aachs%26aulast%3DGnant%26aufirst%3DM.%26aulast%3DMlineritsch%26aufirst%3DB.%26aulast%3DSchippinger%26aufirst%3DW.%26aulast%3DLuschin-Ebengreuth%26aufirst%3DG.%26aulast%3DP%25C3%25B6stlberger%26aufirst%3DS.%26aulast%3DMenzel%26aufirst%3DC.%26aulast%3DJakesz%26aufirst%3DR.%26aulast%3DSeifert%26aufirst%3DM.%26aulast%3DHubalek%26aufirst%3DM.%26aulast%3DBjelic-Radisic%26aufirst%3DV.%26aulast%3DSamonigg%26aufirst%3DH.%26aulast%3DTausch%26aufirst%3DC.%26aulast%3DEidtmann%26aufirst%3DH.%26aulast%3DSteger%26aufirst%3DG.%26aulast%3DKwasny%26aufirst%3DW.%26aulast%3DDubsky%26aufirst%3DP.%26aulast%3DFridrik%26aufirst%3DM.%26aulast%3DFitzal%26aufirst%3DF.%26aulast%3DStierer%26aufirst%3DM.%26aulast%3DR%25C3%25BCcklinger%26aufirst%3DE.%26aulast%3DGreil%26aufirst%3DR.%26atitle%3DEndocrine%2520therapy%2520plus%2520zoledronic%2520acid%2520in%2520premenopaisal%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D679%26epage%3D691%26doi%3D10.1056%2FNEJMoa0806285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidtmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llombart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neven, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Minckwitz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleeboom, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrios, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frassoldati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paija, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundred, N.</span></span> <span> </span><span class="NLM_article-title">Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): 60-months results</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1093/annonc/mds277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1093%2Fannonc%2Fmds277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=23047045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FjsFGjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=398-405&author=R.+Colemanauthor=R.+de+Boerauthor=H.+Eidtmannauthor=A.+Llombartauthor=N.+Davidsonauthor=P.+Nevenauthor=G.+von+Minckwitzauthor=H.+P.+Sleeboomauthor=J.+Forbesauthor=C.+Barriosauthor=A.+Frassoldatiauthor=I.+Campbellauthor=O.+Paijaauthor=N.+Martinauthor=A.+Modiauthor=N.+Bundred&title=Zoledronic+acid+%28zoledronate%29+for+postmenopausal+women+with+early+breast+cancer+receiving+adjuvant+letrozole+%28ZO-FAST+study%29%3A+60-months+results&doi=10.1093%2Fannonc%2Fmds277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results</span></div><div class="casAuthors">Coleman R; de Boer R; Eidtmann H; Llombart A; Davidson N; Neven P; von Minckwitz G; Sleeboom H P; Forbes J; Barrios C; Frassoldati A; Campbell I; Paija O; Martin N; Modi A; Bundred N</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">398-405</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Aromatase inhibitors are the preferred adjuvant endocrine therapy for the majority of postmenopausal women with hormone-responsive early breast cancer.  Although generally more effective than tamoxifen, aromatase inhibitor therapy is associated with increased bone loss and fracture risk.  PATIENTS AND METHODS:  Postmenopausal women receiving adjuvant letrozole (2.5 mg/day for 5 years; N = 1065) were randomly assigned to immediate zoledronic acid (zoledronate) 4 mg every 6 months for 5 years, or delayed zoledronate (initiated for fracture or on-study bone mineral density [BMD] decrease).  The primary end point was the change in lumbar spine BMD at 12 months.  Lumbar spine and total hip BMD at subsequent follow-up, disease-free survival (DFS), and overall survival were assessed as secondary end points.  RESULTS:  At 60 months (final analysis), the mean change in lumbar spine BMD was +4.3% with immediate zoledronate and -5.4% with delayed intervention (P < 0.0001).  Immediate zoledronate reduced the risk of DFS events by 34% (hazard ratio [HR] = 0.66; P = 0.0375) with fewer local (0.9% versus 2.3%) and distant (5.5% versus 7.7%) recurrences versus delayed zoledronate.  In the delayed group, delayed initiation of zoledronate substantially improved DFS versus no zoledronate (HR = 0.46; P = 0.0334).  CONCLUSIONS:  Immediate zoledronate in postmenopausal women receiving letrozole preserved BMD and is associated with improved DFS compared with letrozole alone.  Clinical Trials Registration No NCT00171340.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSrF__4n9ssxlHFYivNCdPRfW6udTcc2eY9ALIUcaiztLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FjsFGjsg%253D%253D&md5=8c3ee5dd7ea24a157be353eca918044e</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmds277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmds277%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DR.%26aulast%3Dde%2BBoer%26aufirst%3DR.%26aulast%3DEidtmann%26aufirst%3DH.%26aulast%3DLlombart%26aufirst%3DA.%26aulast%3DDavidson%26aufirst%3DN.%26aulast%3DNeven%26aufirst%3DP.%26aulast%3Dvon%2BMinckwitz%26aufirst%3DG.%26aulast%3DSleeboom%26aufirst%3DH.%2BP.%26aulast%3DForbes%26aufirst%3DJ.%26aulast%3DBarrios%26aufirst%3DC.%26aulast%3DFrassoldati%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DI.%26aulast%3DPaija%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DModi%26aufirst%3DA.%26aulast%3DBundred%26aufirst%3DN.%26atitle%3DZoledronic%2520acid%2520%2528zoledronate%2529%2520for%2520postmenopausal%2520women%2520with%2520early%2520breast%2520cancer%2520receiving%2520adjuvant%2520letrozole%2520%2528ZO-FAST%2520study%2529%253A%252060-months%2520results%26jtitle%3DAnn.%2520Oncol.%26date%3D2013%26volume%3D24%26spage%3D398%26epage%3D405%26doi%3D10.1093%2Fannonc%2Fmds277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotesta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzinzik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellé, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitsch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roddy, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J. R.</span></span> <span> </span><span class="NLM_article-title">Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.1038/nchembio.421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1038%2Fnchembio.421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=20711197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVaisLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=660-666&author=W.+Jahnkeauthor=J.-M.+Rondeauauthor=S.+Cotestaauthor=A.+Marzinzikauthor=X.+Pell%C3%A9author=M.+Geiserauthor=A.+Straussauthor=M.+G%C3%B6tteauthor=F.+Bitschauthor=R.+Hemmigauthor=C.+Henryauthor=S.+Lehmannauthor=J.+F.+Glickmanauthor=T.+P.+Roddyauthor=S.+J.+Stoutauthor=J.+R.+Green&title=Allosteric+non-bisphosphonate+FPPS+inhibitors+identified+by+fragment-based+discovery&doi=10.1038%2Fnchembio.421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery</span></div><div class="casAuthors">Jahnke, Wolfgang; Rondeau, Jean-Michel; Cotesta, Simona; Marzinzik, Andreas; Pelle, Xavier; Geiser, Martin; Strauss, Andre; Goette, Marjo; Bitsch, Francis; Hemmig, Rene; Henry, Chrystele; Lehmann, Sylvie; Glickman, J. Fraser; Roddy, Thomas P.; Stout, Steven J.; Green, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">660-666</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bisphosphonates are potent inhibitors of farnesyl pyrophosphate synthase (FPPS) and are highly efficacious in the treatment of bone diseases such as osteoporosis, Paget's disease and tumor-induced osteolysis.  In addn., the potential for direct antitumor effects has been postulated on the basis of in vitro and in vivo studies and has recently been demonstrated clin. in early breast cancer patients treated with the potent bisphosphonate zoledronic acid.  However, the high affinity of bisphosphonates for bone mineral seems suboptimal for the direct treatment of soft-tissue tumors.  Here we report the discovery of the first potent non-bisphosphonate FPPS inhibitors.  These new inhibitors bind to a previously unknown allosteric site on FPPS, which was identified by fragment-based approaches using NMR and X-ray crystallog.  This allosteric and druggable pocket allows the development of a new generation of FPPS inhibitors that are optimized for direct antitumor effects in soft tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZFyA6x-XeY7Vg90H21EOLACvtfcHk0lirgjeTAoOWEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVaisLzO&md5=72e1bc45a05733c2748a2138d0e0824f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.421%26sid%3Dliteratum%253Aachs%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DRondeau%26aufirst%3DJ.-M.%26aulast%3DCotesta%26aufirst%3DS.%26aulast%3DMarzinzik%26aufirst%3DA.%26aulast%3DPell%25C3%25A9%26aufirst%3DX.%26aulast%3DGeiser%26aufirst%3DM.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26aulast%3DBitsch%26aufirst%3DF.%26aulast%3DHemmig%26aufirst%3DR.%26aulast%3DHenry%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DS.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DRoddy%26aufirst%3DT.%2BP.%26aulast%3DStout%26aufirst%3DS.%2BJ.%26aulast%3DGreen%26aufirst%3DJ.%2BR.%26atitle%3DAllosteric%2520non-bisphosphonate%2520FPPS%2520inhibitors%2520identified%2520by%2520fragment-based%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D660%26epage%3D666%26doi%3D10.1038%2Fnchembio.421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielinski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghuis, A. M.</span></span> <span> </span><span class="NLM_article-title">Human farnesyl pyrophosphate synthase is allosterically inhibited by its own preoducts</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">14132</span>, <span class="refDoi"> DOI: 10.1038/ncomms14132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1038%2Fncomms14132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=28098152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14132&author=J.+Parkauthor=M.+Zielinskiauthor=A.+Magderauthor=Y.+S.+Tsantrizosauthor=A.+M.+Berghuis&title=Human+farnesyl+pyrophosphate+synthase+is+allosterically+inhibited+by+its+own+preoducts&doi=10.1038%2Fncomms14132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Human farnesyl pyrophosphate synthase is allosterically inhibited by its own product</span></div><div class="casAuthors">Park, Jaeok; Zielinski, Michal; Magder, Alexandr; Tsantrizos, Youla S.; Berghuis, Albert M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14132</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Farnesyl pyrophosphate synthase (FPPS) is an enzyme of the mevalonate pathway and a well-established therapeutic target.  Recent research has focused around a newly identified druggable pocket near the enzyme's active site.  Pharmacol. exploitation of this pocket is deemed promising; however, its natural biol. function, if any, is yet unknown.  Here we report that the product of FPPS, farnesyl pyrophosphate (FPP), can bind to this pocket and lock the enzyme in an inactive state.  The Kd for this binding is 5-6 μM, within a catalytically relevant range.  These results indicate that FPPS activity is sensitive to the product concn.  Kinetic anal. shows that the enzyme is inhibited through FPP accumulation.  Having a specific physiol. effector, FPPS is a bona fide allosteric enzyme.  This allostery offers an exquisite mechanism for controlling prenyl pyrophosphate levels in vivo and thus contributes an addnl. layer of regulation to the mevalonate pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpnTdH3Q0qYrVg90H21EOLACvtfcHk0ljAV9Mu7YKF7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrg%253D&md5=a3042ec22d74c2c53aa806a52d37c4b3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fncomms14132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14132%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DZielinski%26aufirst%3DM.%26aulast%3DMagder%26aufirst%3DA.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBerghuis%26aufirst%3DA.%2BM.%26atitle%3DHuman%2520farnesyl%2520pyrophosphate%2520synthase%2520is%2520allosterically%2520inhibited%2520by%2520its%2520own%2520preoducts%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14132%26doi%3D10.1038%2Fncomms14132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">De Schutter, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghuis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span> <span> </span><span class="NLM_article-title">Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5764</span>– <span class="NLM_lpage">5776</span>, <span class="refDoi"> DOI: 10.1021/jm500629e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500629e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVegtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5764-5776&author=J.+W.+De+Schutterauthor=J.+Parkauthor=C.+Y.+Leungauthor=P.+Gormleyauthor=Y.-S.+Linauthor=Z.+Huauthor=A.+M.+Berghuisauthor=J.+Poirierauthor=Y.+S.+Tsantrizos&title=Multistage+screening+reveals+chameleon+ligands+of+the+human+farnesyl+pyrophosphate+synthase%3A+implications+to+drug+discovery+for+neurodegenerative+diseases&doi=10.1021%2Fjm500629e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Multistage Screening Reveals Chameleon Ligands of the Human Farnesyl Pyrophosphate Synthase: Implications to Drug Discovery for Neurodegenerative Diseases</span></div><div class="casAuthors">De Schutter, Joris W.; Park, Jaeok; Leung, Chun Yuen; Gormley, Patrick; Lin, Yih-Shyan; Hu, Zheping; Berghuis, Albert M.; Poirier, Judes; Tsantrizos, Youla S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5764-5776</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human farnesyl pyrophosphate synthase (hFPPS) is the gate-keeper of mammalian isoprenoids and the key target of bisphosphonate drugs.  Bisphosphonates suffer from poor "drug-like" properties and are mainly effective in treating skeletal diseases.  Recent investigations have implicated hFPPS in various nonskeletal diseases, including Alzheimer's disease (AD).  Anal. of single nucleotide polymorphisms in the hFPPS gene and mRNA levels in autopsy-confirmed AD subjects was undertaken, and a genetic link between hFPPS and phosphorylated tau (P-Tau) levels in the human brain was identified.  Elevated P-Tau levels are strongly implicated in AD progression.  The development of nonbisphosphonate inhibitors can provide mol. tools for validating hFPPS as a therapeutic target for tauopathy-assocd. neurodegeneration.  A multistage screening protocol led to the identification of a new monophosphonate chemotype that bind in an allosteric pocket of hFPPS.  Optimization of these compds. could lead to human therapeutics that block tau metab. and arrest the progression of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrenHVATZq2I7Vg90H21EOLACvtfcHk0ljAV9Mu7YKF7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVegtLo%253D&md5=b54b5f0f17e867c4c8707e3d58f26eab</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm500629e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500629e%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSchutter%26aufirst%3DJ.%2BW.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DC.%2BY.%26aulast%3DGormley%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DY.-S.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DBerghuis%26aufirst%3DA.%2BM.%26aulast%3DPoirier%26aufirst%3DJ.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DMultistage%2520screening%2520reveals%2520chameleon%2520ligands%2520of%2520the%2520human%2520farnesyl%2520pyrophosphate%2520synthase%253A%2520implications%2520to%2520drug%2520discovery%2520for%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5764%26epage%3D5776%26doi%3D10.1021%2Fjm500629e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gritzalis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Schutter, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacbay, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielinski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghuis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span> <span> </span><span class="NLM_article-title">Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1117</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.bmcl.2014.12.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=25630225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFCjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1117-1123&author=D.+Gritzalisauthor=J.+Parkauthor=W.+Chiuauthor=H.+Choauthor=Y.-S.+Linauthor=J.+W.+De+Schutterauthor=C.+M.+Lacbayauthor=M.+Zielinskiauthor=A.+M.+Berghuisauthor=Y.+S.+Tsantrizos&title=Probing+the+molecular+and+structural+elements+of+ligands+binding+to+the+active+site+versus+an+allosteric+pocket+of+the+human+farnesyl+pyrophosphate+synthase&doi=10.1016%2Fj.bmcl.2014.12.089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase</span></div><div class="casAuthors">Gritzalis, Dimitrios; Park, Jaeok; Chiu, Wei; Cho, Hyungjun; Lin, Yih-Shyan; De Schutter, Joris W.; Lacbay, Cyrus M.; Zielinski, Michal; Berghuis, Albert M.; Tsantrizos, Youla S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1117-1123</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to explore the interactions of bisphosphonate ligands with the active site and an allosteric pocket of the human farnesyl pyrophosphate synthase (hFPPS), substituted indole and azabenzimidazole bisphosphonates were designed as chameleon ligands.  NMR and crystallog. studies revealed that these compds. can occupy both sub-pockets of the active site cavity, as well as the allosteric pocket of hFPPS in the presence of the enzyme's Mg2+ ion cofactor.  These results are consistent with the previously proposed hypothesis that the allosteric pocket of hFPPS, located near the active site, plays a feed-back regulatory role for this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEpiQoQXwNGrVg90H21EOLACvtfcHk0lhBLUQqkUro8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFCjtA%253D%253D&md5=403d943906ea071b3b50dc2e97314ecd</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.089%26sid%3Dliteratum%253Aachs%26aulast%3DGritzalis%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DChiu%26aufirst%3DW.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DY.-S.%26aulast%3DDe%2BSchutter%26aufirst%3DJ.%2BW.%26aulast%3DLacbay%26aufirst%3DC.%2BM.%26aulast%3DZielinski%26aufirst%3DM.%26aulast%3DBerghuis%26aufirst%3DA.%2BM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DProbing%2520the%2520molecular%2520and%2520structural%2520elements%2520of%2520ligands%2520binding%2520to%2520the%2520active%2520site%2520versus%2520an%2520allosteric%2520pocket%2520of%2520the%2520human%2520farnesyl%2520pyrophosphate%2520synthase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1117%26epage%3D1123%26doi%3D10.1016%2Fj.bmcl.2014.12.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marzinzik, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amstutz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bold, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotesta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwieg, J. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellé, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roddy, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel allosteric non-bisphosphonate inhibitors of farnesyl pyrophosphate synthase by integrated lead finding</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1884</span>– <span class="NLM_lpage">1891</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fcmdc.201500338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=26381451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWlsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1884-1891&author=A.+L.+Marzinzikauthor=R.+Amstutzauthor=G.+Boldauthor=E.+Bourgierauthor=S.+Cotestaauthor=J.+F.+Glickmanauthor=M.+G%C3%B6tteauthor=C.+Henryauthor=S.+Lehmannauthor=J.+C.+D.+Hartwiegauthor=S.+Ofnerauthor=X.+Pell%C3%A9author=T.+P.+Roddyauthor=J.-M.+Rondeauauthor=F.+Staufferauthor=S.+J.+Stoutauthor=A.+Widmerauthor=J.+Zimmermannauthor=T.+Zollerauthor=W.+Jahnke&title=Discovery+of+novel+allosteric+non-bisphosphonate+inhibitors+of+farnesyl+pyrophosphate+synthase+by+integrated+lead+finding&doi=10.1002%2Fcmdc.201500338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead Finding</span></div><div class="casAuthors">Marzinzik, Andreas L.; Amstutz, Rene; Bold, Guido; Bourgier, Emmanuelle; Cotesta, Simona; Glickman, J. Fraser; Goette, Marjo; Henry, Christelle; Lehmann, Sylvie; Hartwieg, J. Constanze D.; Ofner, Silvio; Pelle, Xavier; Roddy, Thomas P.; Rondeau, Jean-Michel; Stauffer, Frederic; Stout, Steven J.; Widmer, Armin; Zimmermann, Johann; Zoller, Thomas; Jahnke, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1884-1891</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Farnesyl pyrophosphate synthase (FPPS) is an established target for the treatment of bone diseases, but also shows promise as an anticancer and anti-infective drug target.  Currently available anti-FPPS drugs are active-site-directed bisphosphonate inhibitors, the peculiar pharmacol. profile of which is inadequate for therapeutic indications beyond bone diseases.  The recent discovery of an allosteric binding site has paved the way toward the development of novel non-bisphosphonate FPPS inhibitors with broader therapeutic potential, notably as immunomodulators in oncol.  Herein we report the discovery, by an integrated lead finding approach, of two new chem. classes of allosteric FPPS inhibitors that belong to the salicylic acid and quinoline chemotypes.  We present their synthesis, biochem. and cellular activities, structure-activity relationships, and provide X-ray structures of several representative FPPS complexes.  These novel allosteric FPPS inhibitors are devoid of any affinity for bone mineral and could serve as leads to evaluate their potential in none-bone diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAr9SoyVzuV7Vg90H21EOLACvtfcHk0lhBLUQqkUro8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWlsLnP&md5=a32eb3354fc3a50e6e0cfedc25a31d15</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500338%26sid%3Dliteratum%253Aachs%26aulast%3DMarzinzik%26aufirst%3DA.%2BL.%26aulast%3DAmstutz%26aufirst%3DR.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DBourgier%26aufirst%3DE.%26aulast%3DCotesta%26aufirst%3DS.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26aulast%3DHenry%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DS.%26aulast%3DHartwieg%26aufirst%3DJ.%2BC.%2BD.%26aulast%3DOfner%26aufirst%3DS.%26aulast%3DPell%25C3%25A9%26aufirst%3DX.%26aulast%3DRoddy%26aufirst%3DT.%2BP.%26aulast%3DRondeau%26aufirst%3DJ.-M.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DStout%26aufirst%3DS.%2BJ.%26aulast%3DWidmer%26aufirst%3DA.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DJahnke%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520novel%2520allosteric%2520non-bisphosphonate%2520inhibitors%2520of%2520farnesyl%2520pyrophosphate%2520synthase%2520by%2520integrated%2520lead%2520finding%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1884%26epage%3D1891%26doi%3D10.1002%2Fcmdc.201500338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, E.</span></span> <span> </span><span class="NLM_article-title">Farnesyl diphosphate synthase inhibitors with unique ligand-binding geometries</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1021/ml500528x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500528x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=349-354&author=Y.-L.+Liuauthor=R.+Caoauthor=Y.+Wangauthor=E.+Oldfield&title=Farnesyl+diphosphate+synthase+inhibitors+with+unique+ligand-binding+geometries&doi=10.1021%2Fml500528x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Farnesyl Diphosphate Synthase Inhibitors With Unique Ligand-Binding Geometries</span></div><div class="casAuthors">Liu, Yi-Liang; Cao, Rong; Wang, Yang; Oldfield, Eric</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-354</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Farnesyl diphosphate synthase (FPPS) is an important drug target for bone resorption, cancer, and some infectious diseases.  Here, we report five new structures including two having unique bound ligand geometries.  The diamidine inhibitor 7 binds to human FPPS close to the homoallylic (S2) and allosteric (S3) sites and extends into a new site, here called S4.  With the bisphosphonate inhibitor 8, two mols. bind to Trypanosoma brucei FPPS, one mol. in the allylic site (S1) and the other close to S2, the first observation of two bisphosphonate mols. bound to FPPS.  We also report the structures of apo-FPPS from T. brucei, together with two more bisphosphonate-bound structures (2,9), for purposes of comparison.  The diamidine structure is of particular interest because 7 could represent a new lead for lipophilic FPPS inhibitors, while 8 has low micromolar activity against T. brucei, the causative agent of human African trypanosomiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLFB2f4Alhi7Vg90H21EOLACvtfcHk0lhCFD0N_Srb2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeisb8%253D&md5=d531c00b4e036e8b7f39dafa6476ba46</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1021%2Fml500528x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500528x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.-L.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DOldfield%26aufirst%3DE.%26atitle%3DFarnesyl%2520diphosphate%2520synthase%2520inhibitors%2520with%2520unique%2520ligand-binding%2520geometries%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D349%26epage%3D354%26doi%3D10.1021%2Fml500528x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matralis, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacbay, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsakos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández De Troconiz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghuis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacophore mapping of thienopyrimidine-based monophosphonate (ThP-MP) inhibitors of the human farnesyl pyrophosphate synthase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2119</span>– <span class="NLM_lpage">2134</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01888</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01888" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFSru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2119-2134&author=J.+Parkauthor=C.+Y.+Leungauthor=A.+N.+Matralisauthor=C.+M.+Lacbayauthor=M.+Tsakosauthor=G.+Fern%C3%A1ndez+De+Troconizauthor=A.+M.+Berghuisauthor=Y.+S.+Tsantrizos&title=Pharmacophore+mapping+of+thienopyrimidine-based+monophosphonate+%28ThP-MP%29+inhibitors+of+the+human+farnesyl+pyrophosphate+synthase&doi=10.1021%2Facs.jmedchem.6b01888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase</span></div><div class="casAuthors">Park, Jaeok; Leung, Chun Yuen; Matralis, Alexios N.; Lacbay, Cyrus M.; Tsakos, Michail; Fernandez De Troconiz, Guillermo; Berghuis, Albert M.; Tsantrizos, Youla S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2119-2134</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The human farnesyl pyrophosphate synthase (hFPPS), a key regulatory enzyme in the mevalonate pathway, catalyzes the biosynthesis of the C-15 isoprenoid farnesyl pyrophosphate (FPP).  FPP plays a crucial role in the post-translational prenylation of small GTPases that perform a plethora of cellular functions.  Although hFPPS is a well-established therapeutic target for lytic bone diseases, the currently available bisphosphonate drugs exhibit poor cellular uptake and distribution into non-skeletal tissues.  Recent drug discovery efforts have focused primarily on allosteric inhibition of hFPPS and the discovery of non-bisphosphonate drugs for potentially treating non-skeletal diseases.  Hit-to-lead optimization of a new series of thienopyrimidine-based monosphosphonates (ThP-MPs) led to the identification of analogs with nanomolar potency in inhibiting hFPPS.  Their interactions with the allosteric pocket of the enzyme were characterized by crystallog. and the results provide further insight into the pharmacophore requirements for allosteric inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyhrW7fwd66bVg90H21EOLACvtfcHk0lhCFD0N_Srb2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFSru74%253D&md5=ac44083a7b20a199cd1cfb59bec71be1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01888%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DC.%2BY.%26aulast%3DMatralis%26aufirst%3DA.%2BN.%26aulast%3DLacbay%26aufirst%3DC.%2BM.%26aulast%3DTsakos%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez%2BDe%2BTroconiz%26aufirst%3DG.%26aulast%3DBerghuis%26aufirst%3DA.%2BM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DPharmacophore%2520mapping%2520of%2520thienopyrimidine-based%2520monophosphonate%2520%2528ThP-MP%2529%2520inhibitors%2520of%2520the%2520human%2520farnesyl%2520pyrophosphate%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2119%26epage%3D2134%26doi%3D10.1021%2Facs.jmedchem.6b01888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span> For a recent review see:<span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berlicki, Ł.</span></span> <span> </span><span class="NLM_article-title">Remarkable potential of the α-aminophosphonate/phosphinate structural motif in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5955</span>– <span class="NLM_lpage">5980</span>, <span class="refDoi"> DOI: 10.1021/jm200587f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200587f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVWlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5955-5980&author=A.+Muchaauthor=P.+Kafarskiauthor=%C5%81.+Berlicki&title=Remarkable+potential+of+the+%CE%B1-aminophosphonate%2Fphosphinate+structural+motif+in+medicinal+chemistry&doi=10.1021%2Fjm200587f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry</span></div><div class="casAuthors">Mucha, Artur; Kafarski, Pawel; Berlicki, Lukasz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5955-5980</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Potential of the α-aminophosphonate/phosphinate structural motif in medicinal chem. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPPeUBOTalirVg90H21EOLACvtfcHk0lhCFD0N_Srb2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVWlsrs%253D&md5=0683f7f9ff6269b7d93ee27e623c21c5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm200587f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200587f%26sid%3Dliteratum%253Aachs%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DBerlicki%26aufirst%3D%25C5%2581.%26atitle%3DRemarkable%2520potential%2520of%2520the%2520%25CE%25B1-aminophosphonate%252Fphosphinate%2520structural%2520motif%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5955%26epage%3D5980%26doi%3D10.1021%2Fjm200587f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pompei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Francesco, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span> <span> </span><span class="NLM_article-title">Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2574</span>– <span class="NLM_lpage">2578</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.bmcl.2009.03.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=19328685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslyiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2574-2578&author=M.+Pompeiauthor=M.+E.+Di+Francescoauthor=U.+Kochauthor=N.+J.+Livertonauthor=V.+Summa&title=Phosphorous+acid+analogs+of+novel+P2-P4+macrocycles+as+inhibitors+of+HCV-NS3+protease&doi=10.1016%2Fj.bmcl.2009.03.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease</span></div><div class="casAuthors">Pompei, Marco; Di Francesco, Maria Emilia; Koch, Uwe; Liverton, Nigel J.; Summa, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2574-2578</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HCV-NS3 protease is essential for viral replication and NS3 protease inhibitors have shown proof of concept in clin. trials.  Novel P2-P4 macrocycle inhibitors of NS3/4A comprising a P1 C-terminal carboxylic acid have recently been disclosed.  A series of analogs, in which the carboxylic residue is replaced by phosphorous acid functionalities were synthesized and inhibitors of the NS3 protease.  Among them the methylphosphinate analog showed nanomolar level of enzyme inhibition and sub-micromolar potency in the replication assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF5paPaPlwc7Vg90H21EOLACvtfcHk0lhpcTZ3-CDuQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslyiu70%253D&md5=beab4e3f05a3497e4e5ae7ee78df2ed5</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.038%26sid%3Dliteratum%253Aachs%26aulast%3DPompei%26aufirst%3DM.%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DPhosphorous%2520acid%2520analogs%2520of%2520novel%2520P2-P4%2520macrocycles%2520as%2520inhibitors%2520of%2520HCV-NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2574%26epage%3D2578%26doi%3D10.1016%2Fj.bmcl.2009.03.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pyun, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis and resolution of diethyl(1<i>S</i>,2<i>S</i>)-1-amino-2-vinylcyclopropane-1-phosphonate for HCV NS3 protease inhibitors</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3833</span>– <span class="NLM_lpage">3835</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2009.04.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.tetlet.2009.04.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlKmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=3833-3835&author=H.-J.+Pyunauthor=K.+Chaudharyauthor=J.+R.+Somozaauthor=X.+C.+Shengauthor=C.+U.+Kim&title=Synthesis+and+resolution+of+diethyl%281S%2C2S%29-1-amino-2-vinylcyclopropane-1-phosphonate+for+HCV+NS3+protease+inhibitors&doi=10.1016%2Fj.tetlet.2009.04.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and resolution of diethyl (1S,2S)-1-amino-2-vinylcyclopropane-1-phosphonate for HCV NS3 protease inhibitors</span></div><div class="casAuthors">Pyun, Hyung-Jung; Chaudhary, Kleem; Somoza, John R.; Sheng, X. Christopher; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3833-3835</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The authors herein describe an efficient synthesis of optically active di-Et 1-amino-2-vinylcyclopropane-1-phosphonate (analogous to 1-amino-2-vinylcyclopropane-1-carboxylate).  The racemic phosphonate di-Et ester was obtained from an imine derived from aminomethylphosphonate diester and trans-1,4-dibromo-2-butene.  Crystns. of the dibenzoyl-L-tartaric acid salt allowed for the sepn. of enantiomers.  The enantiomerically pure material was used to synthesize an extremely potent tripeptide phosphonate inhibitor of HCV NS3 protease.  X-ray crystal structure of the inhibitor bound to the HCV NS3 protease confirmed the abs. stereochem. of the title compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppj_DLTixJfLVg90H21EOLACvtfcHk0liD2PTygV9UWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlKmsb4%253D&md5=f03f2de96dbdae562db5f85c68011eb8</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.04.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.04.044%26sid%3Dliteratum%253Aachs%26aulast%3DPyun%26aufirst%3DH.-J.%26aulast%3DChaudhary%26aufirst%3DK.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSheng%26aufirst%3DX.%2BC.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DSynthesis%2520and%2520resolution%2520of%2520diethyl%25281S%252C2S%2529-1-amino-2-vinylcyclopropane-1-phosphonate%2520for%2520HCV%2520NS3%2520protease%2520inhibitors%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D3833%26epage%3D3835%26doi%3D10.1016%2Fj.tetlet.2009.04.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyun, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleury, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurtrie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaney, W. E.,  IV</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3453</span>– <span class="NLM_lpage">3457</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.bmcl.2009.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=19477126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFGju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3453-3457&author=X.+C.+Shengauthor=H.-J.+Pyunauthor=K.+Chaudharyauthor=J.+Wangauthor=E.+Doerfflerauthor=M.+Fleuryauthor=D.+McMurtrieauthor=X.+Chenauthor=W.+E.+Delaneyauthor=C.+U.+Kim&title=Discovery+of+novel+phosphonate+derivatives+as+hepatitis+C+virus+NS3+protease+inhibitors&doi=10.1016%2Fj.bmcl.2009.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors</span></div><div class="casAuthors">Sheng, X. Christopher; Pyun, Hyung-Jung; Chaudhary, Kleem; Wang, Jianying; Doerffler, Edward; Fleury, Melissa; McMurtrie, Darren; Chen, Xiaowu; Delaney, William E.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3453-3457</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel class of phosphonate derivs. contg. amino acid and thiazolylquinoline units was designed to mimic the interaction of product-like carboxylate based inhibitors of HCV NS3 protease.  A phosphonic acid I was demonstrated to be a potent HCV NS3 protease inhibitor, and a potential candidate for treating HCV infection.  The syntheses and preliminary biol. evaluation of this phosphonate class of inhibitor are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJLUzzADl8_rVg90H21EOLACvtfcHk0liD2PTygV9UWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFGju7Y%253D&md5=19903f9636361fe7603f51792bd5af2b</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DX.%2BC.%26aulast%3DPyun%26aufirst%3DH.-J.%26aulast%3DChaudhary%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DFleury%26aufirst%3DM.%26aulast%3DMcMurtrie%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDelaney%26aufirst%3DW.%2BE.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DDiscovery%2520of%2520novel%2520phosphonate%2520derivatives%2520as%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3453%26epage%3D3457%26doi%3D10.1016%2Fj.bmcl.2009.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Burk, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammers, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straub, J. A.</span></span> <span> </span><span class="NLM_article-title">Enantioselective synthesis of α-hydroxy and α-amino phosphonates via catalytic asymmetric hydrogenation</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1021/ol9906099</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9906099" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADyaK1MXkt1SjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=387-390&author=M.+J.+Burkauthor=T.+A.+Stammersauthor=J.+A.+Straub&title=Enantioselective+synthesis+of+%CE%B1-hydroxy+and+%CE%B1-amino+phosphonates+via+catalytic+asymmetric+hydrogenation&doi=10.1021%2Fol9906099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective Synthesis of α-Hydroxy and α-Amino Phosphonates via Catalytic Asymmetric Hydrogenation</span></div><div class="casAuthors">Burk, Mark J.; Stammers, Timothy A.; Straub, Judith A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">387-390</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cationic Rh catalysts of the C2 sym. DuPHOS (o-bis(2,5-R2-1-phospholidinyl)benzene; R = Me, Et, Pr, iPr) and BPE (1,2-bis(2,5-R2-1-phospholidinyl)ethane; R = Me, iPr) ligands demonstrated the ability to asym. hydrogenate enol phosphonates, e.g. (MeO)2P(O)C(OBz):CH2, in good to excellent enantiomeric excess under mild conditions.  Initial studies toward the catalytic asym. hydrogenation of enamido phosphonates, e.g. (MeO)2P(O)C(NHAc):CH2, using the DuPHOS-Rh+ catalysts are also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkGWm4Sk13vrVg90H21EOLACvtfcHk0liD2PTygV9UWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkt1SjtLY%253D&md5=92cba8ba4963fcfd58a56b9fb5d5af40</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fol9906099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9906099%26sid%3Dliteratum%253Aachs%26aulast%3DBurk%26aufirst%3DM.%2BJ.%26aulast%3DStammers%26aufirst%3DT.%2BA.%26aulast%3DStraub%26aufirst%3DJ.%2BA.%26atitle%3DEnantioselective%2520synthesis%2520of%2520%25CE%25B1-hydroxy%2520and%2520%25CE%25B1-amino%2520phosphonates%2520via%2520catalytic%2520asymmetric%2520hydrogenation%26jtitle%3DOrg.%2520Lett.%26date%3D1999%26volume%3D1%26spage%3D387%26epage%3D390%26doi%3D10.1021%2Fol9906099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Z.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span> <span> </span><span class="NLM_article-title">Modular phosphine-aminophosphine ligands based on chiral 1,2,3,4-tetrahydro-1-naphthyamine backbone: a new class of practical ligands for enantioselective hydrogenations</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2689</span>, <span class="refDoi"> DOI: 10.1002/adsc.200800418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fadsc.200800418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSntrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2008&pages=2683-2689&author=M.+Qiuauthor=X.-P.+Huauthor=J.-D.+Huangauthor=D.-Y.+Wangauthor=J.+Dengauthor=S.-B.+Yuauthor=Z.-C.+Duanauthor=Z.+Zheng&title=Modular+phosphine-aminophosphine+ligands+based+on+chiral+1%2C2%2C3%2C4-tetrahydro-1-naphthyamine+backbone%3A+a+new+class+of+practical+ligands+for+enantioselective+hydrogenations&doi=10.1002%2Fadsc.200800418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Modular phosphine-aminophosphine ligands based on chiral 1,2,3,4-tetrahydro-1-naphthylamine backbone: a new class of practical ligands for enantioselective hydrogenations</span></div><div class="casAuthors">Qiu, Min; Hu, Xiang-Ping; Huang, Jia-Di; Wang, Dao-Yong; Deng, Jun; Yu, Sai-Bo; Duan, Zheng-Chao; Zheng, Zhuo</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2683-2689</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">New chiral phosphine-aminophosphine ligands [(R)-HW-Phos] were prepd. from (R)-1,2,3,4-tetrahydro-1-naphthylamine through a two-step procedure, and successfully applied in the Rh-catalyzed asym. hydrogenation of various functionalized olefins such as α-enol ester phosphonates, α-enamido phosphonates, (Z)-β-(acylamino)acrylates and so on.  Excellent enantioselectivities were achieved in the hydrogenation of most substrates tested, demonstrating the high potential of these newly developed phosphine-aminophosphine ligands in asym. catalysis.  The present research also discloses that these newly developed phosphine-aminophosphine ligands are more efficient than that derived from (S)-1-phenylethylamine, suggesting that the increased rigidity conferred by a cyclohexyl fragment in these phosphine-aminophosphine ligands has a pos. effect in the asym. induction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNtuTAJkoWErVg90H21EOLACvtfcHk0lgaHijvn3RG1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSntrvN&md5=78d6eaa462c2f66240fb4b8b3590e930</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1002%2Fadsc.200800418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.200800418%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DX.-P.%26aulast%3DHuang%26aufirst%3DJ.-D.%26aulast%3DWang%26aufirst%3DD.-Y.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.-B.%26aulast%3DDuan%26aufirst%3DZ.-C.%26aulast%3DZheng%26aufirst%3DZ.%26atitle%3DModular%2520phosphine-aminophosphine%2520ligands%2520based%2520on%2520chiral%25201%252C2%252C3%252C4-tetrahydro-1-naphthyamine%2520backbone%253A%2520a%2520new%2520class%2520of%2520practical%2520ligands%2520for%2520enantioselective%2520hydrogenations%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2008%26volume%3D350%26spage%3D2683%26epage%3D2689%26doi%3D10.1002%2Fadsc.200800418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span> <span> </span><span class="NLM_article-title">Asymmetric hydrogenation of α- and β-enamido phosphonates: rhodium(I)/monodentate phosphoramidite catalyst</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">11743</span>– <span class="NLM_lpage">11747</span>, <span class="refDoi"> DOI: 10.1002/anie.201104912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fanie.201104912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12qtrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=11743-11747&author=J.+Zhangauthor=Y.+Liauthor=Z.+Wangauthor=K.+Ding&title=Asymmetric+hydrogenation+of+%CE%B1-+and+%CE%B2-enamido+phosphonates%3A+rhodium%28I%29%2Fmonodentate+phosphoramidite+catalyst&doi=10.1002%2Fanie.201104912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric hydrogenation of α- and β-enamido phosphonates: rhodium(I)/monodentate phosphoramidite catalyst</span></div><div class="casAuthors">Zhang, Jinzhu; Li, Yang; Wang, Zheng; Ding, Kuiling</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">11743-11747, S11743/1-S11743/92</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Chiral α- and β-aminophosphonates RCH2CH(NHR1)PO(O)(OR)2 (2a-e, R1 = PhCO, R = 4-halophenyl; 4a-o, R1 = Cbz, R = substituted Ph, piperonyl, 2-naphthyl, 2-thienyl, cyclohexyl, alkyl) and RCH(NHPG)CH2P(O)(OEt)2 (PG = PhCO, MeCO; R = halophenyl, 2-naphthyl, 3-thienyl, cyclohexyl, 2-pyridyl, tolyl) were prepd. by asym. hydrogenation of the corresponding unsatd. phosphonates RCH:C(NHR1)PO(O)(OR)2 and RC(NHPG):CHP(O)(OEt)2 at ambient conditions catalyzed by rhodium cyclic phosphoramidite systems, Rh/Ln (Ln shown as I, R1-R3 = PhCH2, Me, H, iPr).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH41BwCIEGo7Vg90H21EOLACvtfcHk0lgaHijvn3RG1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12qtrrM&md5=a7925931de3c085d2570a105c73a3722</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1002%2Fanie.201104912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201104912%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DAsymmetric%2520hydrogenation%2520of%2520%25CE%25B1-%2520and%2520%25CE%25B2-enamido%2520phosphonates%253A%2520rhodium%2528I%2529%252Fmonodentate%2520phosphoramidite%2520catalyst%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D11743%26epage%3D11747%26doi%3D10.1002%2Fanie.201104912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-G.</span></span> <span> </span><span class="NLM_article-title">Enantioselective synthesis of α-amino phosphonates via Pd-catalyzed asymmetric hydrogenation</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.5b03664</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.5b03664" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=692-695&author=Z.+Yanauthor=B.+Wuauthor=X.+Gaoauthor=M.-W.+Chenauthor=Y.-G.+Zhou&title=Enantioselective+synthesis+of+%CE%B1-amino+phosphonates+via+Pd-catalyzed+asymmetric+hydrogenation&doi=10.1021%2Facs.orglett.5b03664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective Synthesis of α-Amino Phosphonates via Pd-Catalyzed Asymmetric Hydrogenation</span></div><div class="casAuthors">Yan, Zhong; Wu, Bo; Gao, Xiang; Chen, Mu-Wang; Zhou, Yong-Gui</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">692-695</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A highly enantioselective palladium-catalyzed hydrogenation of a series of linear and cyclic α-iminophosphonates has been achieved, providing efficient access to optically active α-aminophosphonates with up to 99% ee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Uh0L4-v01rVg90H21EOLACvtfcHk0lgaHijvn3RG1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVynsL4%253D&md5=7102c58194f26a5baa63d7b7f9343238</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.5b03664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.5b03664%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DM.-W.%26aulast%3DZhou%26aufirst%3DY.-G.%26atitle%3DEnantioselective%2520synthesis%2520of%2520%25CE%25B1-amino%2520phosphonates%2520via%2520Pd-catalyzed%2520asymmetric%2520hydrogenation%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D692%26epage%3D695%26doi%3D10.1021%2Facs.orglett.5b03664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goulioukina, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shergold, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybakov, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I. P.</span></span> <span> </span><span class="NLM_article-title">One-pot two-step synthesis of optically active α-aminophosphonates by palladium-catalyzed hydrogenation/hydrogenolysis of α-hydrazono phosphonates</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1002/adsc.201600945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fadsc.201600945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGht7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2017&pages=153-162&author=N.+S.+Goulioukinaauthor=I.+A.+Shergoldauthor=V.+B.+Rybakovauthor=I.+P.+Beletskaya&title=One-pot+two-step+synthesis+of+optically+active+%CE%B1-aminophosphonates+by+palladium-catalyzed+hydrogenation%2Fhydrogenolysis+of+%CE%B1-hydrazono+phosphonates&doi=10.1002%2Fadsc.201600945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">One-Pot Two-Step Synthesis of Optically Active α-Amino Phosphonates by Palladium-Catalyzed Hydrogenation/Hydrogenolysis of α-Hydrazono Phosphonates</span></div><div class="casAuthors">Goulioukina, Nataliya S.; Shergold, Ilya A.; Rybakov, Victor B.; Beletskaya, Irina P.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-162</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">An efficient and convenient 1-pot procedure for the stereoselective catalytic synthesis of ring-substituted [amino(phenyl)methyl]phosphonates was developed.  The enantioselective hydrogenation of easily available diisopropyl (Z)-[aryl(phenylhydrazono)methyl]phosphonates using Pd(II) acetate as a precatalyst, (R)-2,2'-bis(diphenylphosphino)-5,5'-dichloro-6,6'-dimethoxy-1,1'-biphenyl [(R)-Cl-MeO-BIPHEP] as a ligand, and (1S)-(+)-10-camphorsulfonic acid as an activator in a mixt. of 2,2,2-trifluoroethanol and CH2Cl2 at ambient temp. gave corresponding [aryl(2-phenylhydrazino)methyl]phosphonates.  The subsequent cleavage of the N-N bond was accomplished with H2 after the addn. of Pd on C and MeOH into crude reaction mixt. to afford the optically active [amino(aryl)methyl]phosphonates.  The method is operationally simple and provides an appreciable enantioselectivity up to 98% ee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPkGWO1E-oxrVg90H21EOLACvtfcHk0lhQ-jMjlOzy9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGht7nI&md5=aceb980169d5a33daa4ee37a7019d590</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fadsc.201600945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.201600945%26sid%3Dliteratum%253Aachs%26aulast%3DGoulioukina%26aufirst%3DN.%2BS.%26aulast%3DShergold%26aufirst%3DI.%2BA.%26aulast%3DRybakov%26aufirst%3DV.%2BB.%26aulast%3DBeletskaya%26aufirst%3DI.%2BP.%26atitle%3DOne-pot%2520two-step%2520synthesis%2520of%2520optically%2520active%2520%25CE%25B1-aminophosphonates%2520by%2520palladium-catalyzed%2520hydrogenation%252Fhydrogenolysis%2520of%2520%25CE%25B1-hydrazono%2520phosphonates%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2017%26volume%3D359%26spage%3D153%26epage%3D162%26doi%3D10.1002%2Fadsc.201600945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Joly, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, E. N.</span></span> <span> </span><span class="NLM_article-title">Thiourea-catalyzed enantioselective hydrophosphonylation of imines: practical access to enantiomerically enriched α-amino phosphonic acids</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">4102</span>– <span class="NLM_lpage">4103</span>, <span class="refDoi"> DOI: 10.1021/ja0494398</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0494398" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVals7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=4102-4103&author=G.+D.+Jolyauthor=E.+N.+Jacobsen&title=Thiourea-catalyzed+enantioselective+hydrophosphonylation+of+imines%3A+practical+access+to+enantiomerically+enriched+%CE%B1-amino+phosphonic+acids&doi=10.1021%2Fja0494398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Thiourea-Catalyzed Enantioselective Hydrophosphonylation of Imines: Practical Access to Enantiomerically Enriched α-Amino Phosphonic Acids</span></div><div class="casAuthors">Joly, Guy D.; Jacobsen, Eric N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4102-4103</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chiral thiourea (I) catalyzes the highly enantioselective hydrophosphonylation of a wide range of N-benzyl imines.  For example, (o-NO2C6H4CH2O)2P(O)H reacted with PhCH:NCH2Ph in the presence of I giving (o-NO2C6H4CH2O)2P(O)CH(Ph)NHCH2Ph (87% yield, 98% ee).  The hydrophosphonylation products are readily deprotected by hydrogenolysis, providing access to free α-amino phosphonic acids in highly enantioenriched form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqlGWeNIVz9LVg90H21EOLACvtfcHk0lhQ-jMjlOzy9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVals7o%253D&md5=c0c2502329be7c6020077a8191e412e6</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fja0494398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0494398%26sid%3Dliteratum%253Aachs%26aulast%3DJoly%26aufirst%3DG.%2BD.%26aulast%3DJacobsen%26aufirst%3DE.%2BN.%26atitle%3DThiourea-catalyzed%2520enantioselective%2520hydrophosphonylation%2520of%2520imines%253A%2520practical%2520access%2520to%2520enantiomerically%2520enriched%2520%25CE%25B1-amino%2520phosphonic%2520acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D4102%26epage%3D4103%26doi%3D10.1021%2Fja0494398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuki, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of an optically active Al(salalen) complex and its application to catalytic hydrophosphonylation of aldehydes and aldimines</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1978</span>– <span class="NLM_lpage">1986</span>, <span class="refDoi"> DOI: 10.1021/ja0651005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0651005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlemsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1978-1986&author=B.+Saitoauthor=H.+Egamiauthor=T.+Katsuki&title=Synthesis+of+an+optically+active+Al%28salalen%29+complex+and+its+application+to+catalytic+hydrophosphonylation+of+aldehydes+and+aldimines&doi=10.1021%2Fja0651005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of an Optically Active Al(salalen) Complex and Its Application to Catalytic Hydrophosphonylation of Aldehydes and Aldimines</span></div><div class="casAuthors">Saito, Bunnai; Egami, Hiromichi; Katsuki, Tsutomu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1978-1986</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optically active aluminum(salalen) complex I was newly synthesized in a modular synthetic manner, and it was found to serve as an efficient catalyst for hydrophosphonylation of aldehydes and aldimines, giving the corresponding α-hydroxy and α-amino phosphonates with high enantioselectivity, resp.  Thus, I-catalyzed hydrophosphonylation of PhCHO in THF at -15° gave 87% (S)-PhCHOHP(O)(OMe)2 in 48h and 90% enantiomeric excess.  The scope of the hydrophosphonylation was wide, and both aliph. and arom. aldehydes and aldimines were successfully used as substrates for the reaction.  The potent catalysis of the complex is attributed to its unique structure: it adopts a distorted trigonal bipyramidal configuration which allows the salalen ligand to take a cis-β-like structure wherein the chiral amino group is located close to the metal center.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI6IdQ0gvDJLVg90H21EOLACvtfcHk0lhQ-jMjlOzy9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlemsb4%253D&md5=f1f5a02bfb9454f1828ebb3c4d553a2d</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fja0651005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0651005%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DB.%26aulast%3DEgami%26aufirst%3DH.%26aulast%3DKatsuki%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520an%2520optically%2520active%2520Al%2528salalen%2529%2520complex%2520and%2520its%2520application%2520to%2520catalytic%2520hydrophosphonylation%2520of%2520aldehydes%2520and%2520aldimines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D1978%26epage%3D1986%26doi%3D10.1021%2Fja0651005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, B.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis and bioselective activities of α-aminophosphonates based on the dufulin motif</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">4207</span>– <span class="NLM_lpage">4213</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.6b01256</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.6b01256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsF2qtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2016&pages=4207-4213&author=G.+Zhangauthor=G.+Haoauthor=J.+Panauthor=J.+Zhangauthor=D.+Huauthor=B.+Song&title=Asymmetric+synthesis+and+bioselective+activities+of+%CE%B1-aminophosphonates+based+on+the+dufulin+motif&doi=10.1021%2Facs.jafc.6b01256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis and Bioselective Activities of α-Amino-phosphonates Based on the Dufulin Motif</span></div><div class="casAuthors">Zhang, Guoping; Hao, Gefei; Pan, Jianke; Zhang, Jian; Hu, Deyu; Song, Baoan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4207-4213</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The asym. synthesis of enantiomerically pure α-aminophosphonates with high and bioselective activities is a challenge.  Here, we report that both enantiomers of α-aminophosphonates bearing the N-benzothiazole moiety can be prepd. in high yields (up to 99%) and excellent enantioselectivities (up to 99% ee) by using chiral thiourea organocatalysts.  Evaluation of the antiviral activities of our reaction products against cucumber mosaic virus (CMV) led to promising hits with high and selective biol. activities, wherein (R)-enantiomers exhibit higher biol. activities than the corresponding (S)-enantiomers.  Esp., compd. (I) with excellent anti-CMV activity (curative activity, 72.3%; protection activity, 56.9%; and inactivation activity, 96.9%) at 500 μg/mL emerged as a potential inhibitor of the plant virus.  The difference in the selective bioactivity could be affected by the combination mode of the three-dimensional space between the enantiomers of α-aminophosphonate and cucumber mosaic virus coat protein (CMV-CP) via florescence spectroscopy and mol. docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqvkIetROq-rVg90H21EOLACvtfcHk0lhx6uI2mMM2yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsF2qtrY%253D&md5=437a6e273c845af2110d19eadb55222b</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.6b01256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.6b01256%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DHao%26aufirst%3DG.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DB.%26atitle%3DAsymmetric%2520synthesis%2520and%2520bioselective%2520activities%2520of%2520%25CE%25B1-aminophosphonates%2520based%2520on%2520the%2520dufulin%2520motif%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2016%26volume%3D64%26spage%3D4207%26epage%3D4213%26doi%3D10.1021%2Facs.jafc.6b01256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit15d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of α-amino phosphonates by using cinchona alkaloids chiral phase transfer catalyst</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">5422</span>– <span class="NLM_lpage">5426</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201801013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fejoc.201801013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOrtbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=5422-5426&author=W.+Liauthor=Y.+Wangauthor=D.+Xu&title=Asymmetric+synthesis+of+%CE%B1-amino+phosphonates+by+using+cinchona+alkaloids+chiral+phase+transfer+catalyst&doi=10.1002%2Fejoc.201801013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15dR"><div class="casContent"><span class="casTitleNuber">15d</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of α-Amino Phosphonates by Using Cinchona Alkaloid-Based Chiral Phase Transfer Catalyst</span></div><div class="casAuthors">Li, Weihua; Wang, Yifeng; Xu, Danqian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">5422-5426</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A highly enantioselective nucleophilic addn. of phosphite esters to imines catalyzed by a chiral phase-transfer catalyst has been developed.  The process affords the hydrophosphonylation of imine products with quaternary stereocenters in good to high yields (up to 95 % yield) and excellent enantioselectivities (up to 99 % ee).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofCr0e4AZYSbVg90H21EOLACvtfcHk0lhx6uI2mMM2yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOrtbvL&md5=478b2d0d1aa6c295d68c60b240b080d0</span></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201801013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201801013%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DD.%26atitle%3DAsymmetric%2520synthesis%2520of%2520%25CE%25B1-amino%2520phosphonates%2520by%2520using%2520cinchona%2520alkaloids%2520chiral%2520phase%2520transfer%2520catalyst%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2018%26volume%3D2018%26spage%3D5422%26epage%3D5426%26doi%3D10.1002%2Fejoc.201801013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">Transition-metal-free [3 + 2] cycloaddition of dehydroaminophosphonates and <i>N</i>-tosylhydrazones: access to aminocyclopropanephossphonates with ajacent quaternary tetrasubstituted carbon centers</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">12746</span>– <span class="NLM_lpage">12756</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.7b01862</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.7b01862" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVejs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=12746-12756&author=W.+Wuauthor=Z.+Linauthor=C.+Zhuauthor=P.+Chenauthor=J.+Liauthor=H.+Jiang&title=Transition-metal-free+%5B3+%2B+2%5D+cycloaddition+of+dehydroaminophosphonates+and+N-tosylhydrazones%3A+access+to+aminocyclopropanephossphonates+with+ajacent+quaternary+tetrasubstituted+carbon+centers&doi=10.1021%2Facs.joc.7b01862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Transition-Metal-Free [3+2] Cycloaddition of Dehydroaminophosphonates and N-Tosylhydrazones: Access to Aminocyclopropanephosphonates with Adjacent Quaternary-Tetrasubstituted Carbon Centers</span></div><div class="casAuthors">Wu, Wanqing; Lin, Zhiming; Zhu, Chuanle; Chen, Pengquan; Li, Jiawei; Jiang, Huanfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">12746-12756</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel 1-step strategy for the synthesis of aminocyclopropanephosphonates contg. adjacent quaternary-tetrasubstituted C centers under transition-metal-free catalysis via [3 + 2] cycloaddn. process was developed.  Aminocyclopropanephosphonates with adjacent quaternary-tetrasubstituted C centers including spirocyclopropyl adducts were obtained in moderate to excellent yields under mild reaction conditions.  This protocol would find the potential applications in biochem. and medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMC_E2-C1TgrVg90H21EOLACvtfcHk0lhx6uI2mMM2yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVejs7vP&md5=dd5a34d2928cdc0ca4e19152553eea4f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.7b01862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.7b01862%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DTransition-metal-free%2520%255B3%2520%252B%25202%255D%2520cycloaddition%2520of%2520dehydroaminophosphonates%2520and%2520N-tosylhydrazones%253A%2520access%2520to%2520aminocyclopropanephossphonates%2520with%2520ajacent%2520quaternary%2520tetrasubstituted%2520carbon%2520centers%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D12746%26epage%3D12756%26doi%3D10.1021%2Facs.joc.7b01862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">List, B.</span></span> <span> </span><span class="NLM_article-title">Direct catalytic asymmetric three-component Kabachnik-Fields reaction</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5079</span>– <span class="NLM_lpage">5081</span>, <span class="refDoi"> DOI: 10.1002/anie.200801173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fanie.200801173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslajtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5079-5081&author=X.+Chengauthor=R.+Goddardauthor=G.+Buthauthor=B.+List&title=Direct+catalytic+asymmetric+three-component+Kabachnik-Fields+reaction&doi=10.1002%2Fanie.200801173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Direct catalytic asymmetric three-component Kabachnik-Fields reaction</span></div><div class="casAuthors">Cheng, Xu; Goddard, Richard; Buth, Gernot; List, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">5079-5081</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Chiral α-amino-β-branched 2-arylethylphosphonates were prepd. by in situ hydrophosphonylation of α-branched aldimines by di-3-pentyl hydrophosphonate catalyzed by a chiral Bronsted acid, 9-anthracenylphenyl-substituted BINOL hydrogen phosphate.  Reaction of rac-ArCHR1CHO (1; R1 = cyclopentyl) with 4-MeOC6H4NH2 and HP(O)(O-3-pentyl)2 catalyzed by hydrogen phosphate I (7) gave α-aminophosphonates (R,R)-ArCHR1CH(NHC6H4OMe-4)P(O)(O-3-pentyl)2 (4a-o; Ar = Ph, MeC6H4, MeOC6H4, ClC6H4, 4-BrC6H4, 2-naphthalenyl, 2-thienyl) with 6:1 to 28:1 d.r. and 88-96% ee.  Esters 4a-o were converted into free α-aminophosphonic acids (R,R)-ArCHR1CH(NH2)P(O)(OH)2 by subsequent treatment by CAN and TMSBr.  As mimics of α-amino acids, α-amino phosphonates have great promise as antibacterial and anti-HIV agents as well as protease inhibitors.  Racemic α-branched aldehydes react, in the presence the new chiral phosphoric acid catalyst I, directly with p-anisidine and a dialkyl phosphite to furnish β-branched α-amino phosphonates highly diastereoselectively and enantioselectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9qNT_GZCxBLVg90H21EOLACvtfcHk0lgcbAH3iTJGgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslajtrc%253D&md5=a7ca09fd6d1cc299d74fbfcd178a498f</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1002%2Fanie.200801173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200801173%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DGoddard%26aufirst%3DR.%26aulast%3DButh%26aufirst%3DG.%26aulast%3DList%26aufirst%3DB.%26atitle%3DDirect%2520catalytic%2520asymmetric%2520three-component%2520Kabachnik-Fields%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D5079%26epage%3D5081%26doi%3D10.1002%2Fanie.200801173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span> <span> </span><span class="NLM_article-title">Enantioselective three-component Kabachnik-Fields reaction catalyzed by chiral scandium(III)-<i>N,N</i>′-dioxide complexes</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1401</span>– <span class="NLM_lpage">1404</span>, <span class="refDoi"> DOI: 10.1021/ol9000813</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9000813" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1eltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=1401-1404&author=X.+Zhouauthor=D.+Shangauthor=Q.+Zhangauthor=L.+Linauthor=X.+Liuauthor=X.+Feng&title=Enantioselective+three-component+Kabachnik-Fields+reaction+catalyzed+by+chiral+scandium%28III%29-N%2CN%E2%80%B2-dioxide+complexes&doi=10.1021%2Fol9000813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective Three-Component Kabachnik-Fields Reaction Catalyzed by Chiral Scandium(III)-N,N'-Dioxide Complexes</span></div><div class="casAuthors">Zhou, Xin; Shang, Deju; Zhang, Qi; Lin, Lili; Liu, Xiaohua; Feng, Xiaoming</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1401-1404</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The N,N'-dioxide-Sc(III) complex has been applied in the three-component Kabachnik-Fields reaction of aldehydes (e.g. PhCHO), 2-aminophenol, and di-Ph phosphite, giving the corresponding α-amino phosphonates (e.g. 86% 2-HOC6H4NHCHPhP(O)(OPh)2 in 84% enantiomeric excess) in good yields with high enantioselectivities (up to 87% ee).  The direct Kabachnik-Fields reaction proceeded with extremely high reactivity under mild reaction conditions and could be used for large-scale synthesis of the α-amino phosphonates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFeCms8kkVL7Vg90H21EOLACvtfcHk0lgcbAH3iTJGgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1eltr4%253D&md5=fee5edbbf32961b8a26696e398637768</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fol9000813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9000813%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DShang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DX.%26atitle%3DEnantioselective%2520three-component%2520Kabachnik-Fields%2520reaction%2520catalyzed%2520by%2520chiral%2520scandium%2528III%2529-N%252CN%25E2%2580%25B2-dioxide%2520complexes%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D1401%26epage%3D1404%26doi%3D10.1021%2Fol9000813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefevre, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brayer, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folléas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darses, S.</span></span> <span> </span><span class="NLM_article-title">Chiral α-amino phosphonates via rhodium-catalyzed asymmetric 1,4-addition reactions</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4274</span>– <span class="NLM_lpage">4276</span>, <span class="refDoi"> DOI: 10.1021/ol402059w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol402059w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2ru7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=4274-4276&author=N.+Lefevreauthor=J.-L.+Brayerauthor=B.+Foll%C3%A9asauthor=S.+Darses&title=Chiral+%CE%B1-amino+phosphonates+via+rhodium-catalyzed+asymmetric+1%2C4-addition+reactions&doi=10.1021%2Fol402059w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral α-Amino Phosphonates via Rhodium-Catalyzed Asymmetric 1,4-Addition Reactions</span></div><div class="casAuthors">Lefevre, Nicolas; Brayer, Jean-Louis; Folleas, Benoit; Darses, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4274-4276</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new approach for the prepn. of enantioenriched α-amino phosphonates and derivs. is described.  Indeed, the Rh-catalyzed asym. 1,4-addn. of K organotrifluoroborates to dehydroaminophosphonates afforded α-amino phosphonates in good yields and high enantioselectivities (up to 96%) using Difluorphos as a chiral ligand.  E.g., reaction of di-Et (1-acetamidovinyl)phosphonate with K phenyltrifluoroborate in the presence of 1.5 mol% [RhCl(CH2:CH2)2]2 and 3.3 mol% (S)-Difluorphos with NaHCO3 in iPrOH at 90° to give 91% yield of (-)-di-Et (1-acetamido-2-phenylethyl)phosphonate (94% ee).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2LLspZNjzCrVg90H21EOLACvtfcHk0lgcbAH3iTJGgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2ru7nO&md5=ef6d475e46049ffd8bb43cafd116f2b3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fol402059w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol402059w%26sid%3Dliteratum%253Aachs%26aulast%3DLefevre%26aufirst%3DN.%26aulast%3DBrayer%26aufirst%3DJ.-L.%26aulast%3DFoll%25C3%25A9as%26aufirst%3DB.%26aulast%3DDarses%26aufirst%3DS.%26atitle%3DChiral%2520%25CE%25B1-amino%2520phosphonates%2520via%2520rhodium-catalyzed%2520asymmetric%25201%252C4-addition%2520reactions%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D4274%26epage%3D4276%26doi%3D10.1021%2Fol402059w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Key, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. J.</span></span> <span> </span><span class="NLM_article-title">Site- and stereoselective chemical editing of thiostrepton by Rh-catalysed conjugate arylation: new analogues and collateral enantioselective synthesis of amino acids</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">15460</span>– <span class="NLM_lpage">15466</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b08775</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b08775" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Slur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=15460-15466&author=H.+M.+Keyauthor=S.+J.+Miller&title=Site-+and+stereoselective+chemical+editing+of+thiostrepton+by+Rh-catalysed+conjugate+arylation%3A+new+analogues+and+collateral+enantioselective+synthesis+of+amino+acids&doi=10.1021%2Fjacs.7b08775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Site- and stereoselective chemical editing of thiostrepton by Rh-catalyzed conjugate arylation: New analogues and collateral enantioselective synthesis of amino acids</span></div><div class="casAuthors">Key, Hanna M.; Miller, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15460-15466</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of complex, biol. active mols. by catalyst-controlled, selective functionalization of complex mols. is an emerging capability.  We describe the application of Rh-catalyzed conjugate arylation to the modification of thiostrepton, a complex mol. with potent antibacterial properties for which few analogs are known.  By this approach, we achieve the site- and stereoselective functionalization of one subterminal dehydroalanine residue (Dha16) present in thiostrepton.  The broad scope of this method enabled the prepn. and isolation of 24 new analogs of thiostrepton, the biol. testing of which revealed that the antimicrobial activity of thiostrepton tolerates the alteration of Dha16 to a range of amino acids.  Further anal. of this Rh-catalyzed process revealed that use of sodium or potassium salts was crucial for achieving high stereoselectivity.  The catalyst system was studied further by application to the synthesis of amino esters and amides from dehydroalanine monomers, a process which was found to occur with up to 93:7 er under conditions milder than those previously reported for analogous reactions.  Furthermore, the addn. of the same sodium and potassium salts as applied in the case of thiostrepton leads to a nearly full reversal of the enantioselectivity of the reaction.  As such, this study of site-selective catalysis in a complex mol. setting also delivered synergistic insights in the arena of enantioselective catalysis.  In addn., these studies greatly expand the no. of known thiostrepton analogs obtained by any method and reveal a high level of functional group tolerance for metal-catalyzed, site-selective modifications of highly complex natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroBlJ0cEpJarVg90H21EOLACvtfcHk0lgcbAH3iTJGgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Slur3I&md5=28a8558907ba84caf6a9413f44b797f8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b08775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b08775%26sid%3Dliteratum%253Aachs%26aulast%3DKey%26aufirst%3DH.%2BM.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26atitle%3DSite-%2520and%2520stereoselective%2520chemical%2520editing%2520of%2520thiostrepton%2520by%2520Rh-catalysed%2520conjugate%2520arylation%253A%2520new%2520analogues%2520and%2520collateral%2520enantioselective%2520synthesis%2520of%2520amino%2520acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D15460%26epage%3D15466%26doi%3D10.1021%2Fjacs.7b08775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trost, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span> <span> </span><span class="NLM_article-title">A direct catalytic enantioselective Aldol reaction via a novel catalyst design</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">12003</span>– <span class="NLM_lpage">12004</span>, <span class="refDoi"> DOI: 10.1021/ja003033n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja003033n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVyhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=12003-12004&author=B.+M.+Trostauthor=H.+Ito&title=A+direct+catalytic+enantioselective+Aldol+reaction+via+a+novel+catalyst+design&doi=10.1021%2Fja003033n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">A direct catalytic enantioselective aldol reaction via a novel catalyst design</span></div><div class="casAuthors">Trost, Barry M.; Ito, Hisanaka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">12003-12004</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An enantioselective catalyst for aldol addn. reactions was prepd. in situ from amino acid-derived pyrrolidinyldiphenylmethanol I and diethylzinc in the presence of triphenylphosphine sulfide; in the presence of I, aldehydes RCHO [R = EtCH2, Me2CHCH2, Me2CH, c-C6H11, Ph2CH, Me3CSi(Me)2OCH2CMe2] and ketones R1COMe (R1 = Ph, 2-furanyl, 2-MeOC6H4, 4-MeOC6H4, 2-naphthyl) reacted to give the 3-hydroxyketones RCH(OH)CH2COR1 in 24-79% yields and with 56-99% ee.  E.g., diethylzinc was added to a soln. of 0.20 equiv. I in THF under argon to yield a catalyst soln.; 2-methylpropanal, 5-10 equiv. acetophenone, and 15 mol% triphenylphosphine sulfide were dissolved in THF to which was added a soln. with 5 mol% catalyst; after stirring at 5° for 2 days and workup to give (S)-Me2CHCH(OH)CH2COPh in 62% yield and in 98% ee.  Calcns. of a complex of I and two equiv. of zinc diethoxide indicate that the lowest energy complex is one with each zinc atom coordinated to both the phenol oxygen and one of the pyrrolidinyldiphenylmethanol moieties rather than a structure with one zinc atom coordinated to all three alc. moieties and a second zinc atom coordinated to the two pyrrolidinyldiphenylmethanol moieties and an ethoxide ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9oOIIrPuzV7Vg90H21EOLACvtfcHk0ljaQ0CTKI8sIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVyhsLY%253D&md5=3bbdc7bfc8384ea03b630bbc22ae0efc</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fja003033n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja003033n%26sid%3Dliteratum%253Aachs%26aulast%3DTrost%26aufirst%3DB.%2BM.%26aulast%3DIto%26aufirst%3DH.%26atitle%3DA%2520direct%2520catalytic%2520enantioselective%2520Aldol%2520reaction%2520via%2520a%2520novel%2520catalyst%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D12003%26epage%3D12004%26doi%3D10.1021%2Fja003033n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trost, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silcoff, E. R.</span></span> <span> </span><span class="NLM_article-title">Asymmetric Aldol reaction via a dinuclear zinc catalyst: α-hydroxyketones as donors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">3367</span>– <span class="NLM_lpage">3368</span>, <span class="refDoi"> DOI: 10.1021/ja003871h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja003871h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslClur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=3367-3368&author=B.+M.+Trostauthor=H.+Itoauthor=E.+R.+Silcoff&title=Asymmetric+Aldol+reaction+via+a+dinuclear+zinc+catalyst%3A+%CE%B1-hydroxyketones+as+donors&doi=10.1021%2Fja003871h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric aldol reaction via a dinuclear zinc catalyst: α-Hydroxy ketones as donors</span></div><div class="casAuthors">Trost, Barry M.; Ito, Hisanaka; Silcoff, Elliad R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3367-3368</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A dinuclear zinc compd., formed in situ by reaction of the bis(pyrrolidino)cresol I with Et2Zn, catalyzed asym. aldol reactions of α-hydroxy ketones with aldehydes to give α,β-dihydroxy ketones with high diastereoselectivity and enantioselective.  Thus, the catalyst was prepd. by reaction of I with Et2Zn in THF and then added to a near stoichiometric mixt. of cyclohexanecarboxaldehyde and HOCH2COPh in THF at -35° to give, after a reaction time of 24 h, the syn-dihydroxypropiophenone II in 83% yield with a 30:1 diastereoisomer ratio and 92% enantiomeric excess.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfZ28SqVhzFLVg90H21EOLACvtfcHk0ljaQ0CTKI8sIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslClur8%253D&md5=2180b77ce617f7c1655559460dc8cbd4</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fja003871h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja003871h%26sid%3Dliteratum%253Aachs%26aulast%3DTrost%26aufirst%3DB.%2BM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSilcoff%26aufirst%3DE.%2BR.%26atitle%3DAsymmetric%2520Aldol%2520reaction%2520via%2520a%2520dinuclear%2520zinc%2520catalyst%253A%2520%25CE%25B1-hydroxyketones%2520as%2520donors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D3367%26epage%3D3368%26doi%3D10.1021%2Fja003871h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trost, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnanamani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalnmals, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C.-I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, J. S.</span></span> <span> </span><span class="NLM_article-title">Direct enantio- and diastereoselective vinylogous addition of butenolides to chromones catalyzed by Zn-ProPhenol</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">1489</span>– <span class="NLM_lpage">1493</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b13367</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b13367" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFGrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2019&pages=1489-1493&author=B.+M.+Trostauthor=E.+Gnanamaniauthor=C.+A.+Kalnmalsauthor=C.-I.+J.+Hungauthor=J.+S.+Tracy&title=Direct+enantio-+and+diastereoselective+vinylogous+addition+of+butenolides+to+chromones+catalyzed+by+Zn-ProPhenol&doi=10.1021%2Fjacs.8b13367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20cR"><div class="casContent"><span class="casTitleNuber">20c</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Enantio- and Diastereoselective Vinylogous Addition of Butenolides to Chromones Catalyzed by Zn-ProPhenol</span></div><div class="casAuthors">Trost, Barry M.; Gnanamani, Elumalai; Kalnmals, Christopher A.; Hung, Chao-I. "Joey"; Tracy, Jacob S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1489-1493</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the first enantio- and diastereoselective 1,4-addn. of butenolides to chromones.  Both α,β- and β,γ-butenolide nucleophiles are compatible with the Zn-ProPhenol catalyst, and preactivation as the siloxyfurans is not required.  The scope of electrophiles includes a variety of substituted chromones, as well as a thiochromone and a quinolone, and the resulting vinylogous addn. products, e.g. I, are generated in good yield (31 to 98%), diastereo- (3:1 to >30:1), and enantioselectivity (90:10 to 99:1 er).  These Michael adducts allow rapid access to several natural product analogs, and can be easily transformed into a variety of other interesting scaffolds as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlPd4H2qr6CLVg90H21EOLACvtfcHk0ljaQ0CTKI8sIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFGrsA%253D%253D&md5=dd02804feee30ae94506e8adc44ba44e</span></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b13367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b13367%26sid%3Dliteratum%253Aachs%26aulast%3DTrost%26aufirst%3DB.%2BM.%26aulast%3DGnanamani%26aufirst%3DE.%26aulast%3DKalnmals%26aufirst%3DC.%2BA.%26aulast%3DHung%26aufirst%3DC.-I.%2BJ.%26aulast%3DTracy%26aufirst%3DJ.%2BS.%26atitle%3DDirect%2520enantio-%2520and%2520diastereoselective%2520vinylogous%2520addition%2520of%2520butenolides%2520to%2520chromones%2520catalyzed%2520by%2520Zn-ProPhenol%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2019%26volume%3D141%26spage%3D1489%26epage%3D1493%26doi%3D10.1021%2Fjacs.8b13367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trost, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C.-I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnanamani, E.</span></span> <span> </span><span class="NLM_article-title">Tuning the reactivity of ketones through unsaturation: Construction of cyclic and acyclic quaternary stereocenters via Zn-ProPhenol catalyzed Mannich reaction</span>. <i>ACS Catal.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1549</span>– <span class="NLM_lpage">1557</span>, <span class="refDoi"> DOI: 10.1021/acscatal.8b04685</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscatal.8b04685" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFGmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1549-1557&author=B.+M.+Trostauthor=C.-I.+J.+Hungauthor=E.+Gnanamani&title=Tuning+the+reactivity+of+ketones+through+unsaturation%3A+Construction+of+cyclic+and+acyclic+quaternary+stereocenters+via+Zn-ProPhenol+catalyzed+Mannich+reaction&doi=10.1021%2Facscatal.8b04685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20dR"><div class="casContent"><span class="casTitleNuber">20d</span><div class="casTitle"><span class="NLM_cas:atitle">Tuning the Reactivity of Ketones through Unsaturation: Construction of Cyclic and Acyclic Quaternary Stereocenters via Zn-ProPhenol Catalyzed Mannich Reactions</span></div><div class="casAuthors">Trost, Barry M.; Hung, Chao-I. Joey; Gnanamani, Elumalai</div><div class="citationInfo"><span class="NLM_cas:title">ACS Catalysis</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1549-1557</span>CODEN:
                <span class="NLM_cas:coden">ACCACS</span>;
        ISSN:<span class="NLM_cas:issn">2155-5435</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Introduction of unsatn. adjacent to the carbonyl drastically improves the reactivity of the Zn-ProPhenol catalyzed Mannich reactions between N-carbamoyl imines and a-branched ketones.  Despite only a small change in the substrate acidity, the bimetallic catalyst can preferentially recognize and activate unsatd. ketones over their fully satd. counterparts, providing a chemo-, diastereo-, and enantioselective route to valuable β-aminoketones bearing both cyclic and acyclic quaternary stereocenters, which are common motifs in numerous biol. active alkaloids.  Unsatd. ketones and imines with various substitution patterns are viable substrates, and the reaction can be performed on multi-millimole scale at low catalyst loading without impacting its efficiency.  More importantly, the unsatn. introduced via the nucleophile provides a useful platform for structural diversification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFbSt4-9N8kLVg90H21EOLACvtfcHk0liJKr1BECF3nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFGmsw%253D%253D&md5=5852b3a309ed2f9d05008fd536eb5237</span></div><a href="/servlet/linkout?suffix=cit20d&amp;dbid=16384&amp;doi=10.1021%2Facscatal.8b04685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscatal.8b04685%26sid%3Dliteratum%253Aachs%26aulast%3DTrost%26aufirst%3DB.%2BM.%26aulast%3DHung%26aufirst%3DC.-I.%2BJ.%26aulast%3DGnanamani%26aufirst%3DE.%26atitle%3DTuning%2520the%2520reactivity%2520of%2520ketones%2520through%2520unsaturation%253A%2520Construction%2520of%2520cyclic%2520and%2520acyclic%2520quaternary%2520stereocenters%2520via%2520Zn-ProPhenol%2520catalyzed%2520Mannich%2520reaction%26jtitle%3DACS%2520Catal.%26date%3D2019%26volume%3D9%26spage%3D1549%26epage%3D1557%26doi%3D10.1021%2Facscatal.8b04685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Highly enantioselective conjugated addition of phosphite to α,β-unsaturated <i>N</i>-acylpyrroles and imines: a practical approach to enantiomerically enriched amino phosphate</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">10983</span>– <span class="NLM_lpage">10987</span>, <span class="refDoi"> DOI: 10.1002/chem.200901901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fchem.200901901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=19739227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ymt7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=10983-10987&author=D.+Zhaoauthor=Y.+Wangauthor=L.+Maoauthor=R.+Wang&title=Highly+enantioselective+conjugated+addition+of+phosphite+to+%CE%B1%2C%CE%B2-unsaturated+N-acylpyrroles+and+imines%3A+a+practical+approach+to+enantiomerically+enriched+amino+phosphate&doi=10.1002%2Fchem.200901901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Enantioselective Conjugate Additions of Phosphites to α,β-Unsaturated N-Acylpyrroles and Imines: A Practical Approach to Enantiomerically Enriched Amino Phosphonates</span></div><div class="casAuthors">Zhao, Depeng; Wang, Yuan; Mao, Lijuan; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10983-10987, S10983/1-S10983/193</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The first highly enantioselective phosphonylation of α,β-unsatd. N-acylpyrroles has been developed.  Excellent yields (91-99 %) and enantioselectivities (up to >99 % enantiomeric excess (ee)) were obsd. for a broad spectrum of both phosphites and N-acylpyrroles under mild conditions.  In particular, when di-Et phosphite was employed to test the scope of the N-acylpyrroles, almost optically pure products (98 to >99 % ee) were obtained for 20 examples of N-acylpyrroles.  Moreover, optically pure α-substituted β- or γ-amino phosphonates can be obtained by several simple transformations of the pyrrolyl phosphonates.  The versatility of the N-acylpyrrole moiety makes the phosphorus adducts powerful chiral building blocks that enable the synthesis of various phosphonate-contg. compds.  Finally, the present strategy can also be applied to the asym. hydrophosphonylation of N-acylimines with high enantioselectivities (93 to >99 % ee).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvoS1qKjpGkLVg90H21EOLACvtfcHk0liJKr1BECF3nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ymt7nM&md5=d1fbc5c65145cb934920545808351a85</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fchem.200901901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200901901%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DHighly%2520enantioselective%2520conjugated%2520addition%2520of%2520phosphite%2520to%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520N-acylpyrroles%2520and%2520imines%253A%2520a%2520practical%2520approach%2520to%2520enantiomerically%2520enriched%2520amino%2520phosphate%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2009%26volume%3D15%26spage%3D10983%26epage%3D10987%26doi%3D10.1002%2Fchem.200901901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonnella, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senanayake, C. H.</span></span> <span> </span><span class="NLM_article-title">Direct titanium-mediated conversion of ketones into enamides with ammonia and acetic anhydride</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1400</span>– <span class="NLM_lpage">1404</span>, <span class="refDoi"> DOI: 10.1002/anie.201107601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fanie.201107601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1400-1404&author=J.+T.+Reevesauthor=Z.+Tanauthor=Z.+S.+Hanauthor=G.+Liauthor=Y.+Zhangauthor=Y.+Xuauthor=D.+C.+Reevesauthor=N.+C.+Gonnellaauthor=S.+Maauthor=H.+Leeauthor=B.+Z.+Luauthor=C.+H.+Senanayake&title=Direct+titanium-mediated+conversion+of+ketones+into+enamides+with+ammonia+and+acetic+anhydride&doi=10.1002%2Fanie.201107601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Titanium-Mediated Conversion of Ketones to Enamides with Ammonia and Acetic Anhydride</span></div><div class="casAuthors">Reeves, Jonathan T.; Tan, Zhulin; Han, Zhengxu S.; Li, Guisheng; Zhang, Yongda; Xu, Yibo; Reeves, Diana C.; Gonnella, Nina C.; Ma, Shengli; Lee, Heewon; Lu, Bruce Z.; Senanayake, Chris H.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1400-1404, S1400/1-S1400/84</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The direct conversion of ketones to enamides with ammonia and acetic anhydride catalyzed by Ti(OCHMe2)4 is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCM8Ss1s2hHbVg90H21EOLACvtfcHk0liJKr1BECF3nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFKhsw%253D%253D&md5=52bc22182efc93703ed29c979f61c00e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fanie.201107601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201107601%26sid%3Dliteratum%253Aachs%26aulast%3DReeves%26aufirst%3DJ.%2BT.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DZ.%2BS.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DReeves%26aufirst%3DD.%2BC.%26aulast%3DGonnella%26aufirst%3DN.%2BC.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DB.%2BZ.%26aulast%3DSenanayake%26aufirst%3DC.%2BH.%26atitle%3DDirect%2520titanium-mediated%2520conversion%2520of%2520ketones%2520into%2520enamides%2520with%2520ammonia%2520and%2520acetic%2520anhydride%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D1400%26epage%3D1404%26doi%3D10.1002%2Fanie.201107601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Burk, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. G.</span></span> <span> </span><span class="NLM_article-title">A mild amide to carbamate transformation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7054</span>– <span class="NLM_lpage">7057</span>, <span class="refDoi"> DOI: 10.1021/jo970903j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo970903j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADyaK2sXmtVersrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7054-7057&author=M.+J.+Burkauthor=J.+G.+Allen&title=A+mild+amide+to+carbamate+transformation&doi=10.1021%2Fjo970903j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">A Mild Amide to Carbamate Transformation</span></div><div class="casAuthors">Burk, Mark J.; Allen, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7054-7057</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general method for the conversion of benzamides and acetamides to tert-butoxycarbamates in one pot was optimized.  Short reaction times and high yields without racemization were demonstrated for a range of amino acids.  Tolerance of the conditions by various functional groups was found allowing amide cleavage in the presence of different esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8RC3FbaG907Vg90H21EOLACvtfcHk0liJKr1BECF3nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtVersrc%253D&md5=25c190e8319287753948d673624edb93</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fjo970903j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo970903j%26sid%3Dliteratum%253Aachs%26aulast%3DBurk%26aufirst%3DM.%2BJ.%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26atitle%3DA%2520mild%2520amide%2520to%2520carbamate%2520transformation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7054%26epage%3D7057%26doi%3D10.1021%2Fjo970903j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Faucher, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duceppe, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferland, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorys, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinàs-Brunet, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2901</span>– <span class="NLM_lpage">2904</span>, <span class="refDoi"> DOI: 10.1021/ol0489907</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0489907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVSkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=2901-2904&author=A.-M.+Faucherauthor=M.+D.+Baileyauthor=P.+L.+Beaulieuauthor=C.+Brochuauthor=J.-S.+Duceppeauthor=J.-M.+Ferlandauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=S.+H.+Kawaiauthor=M.+Poirierauthor=B.+Simoneauauthor=Y.+S.+Tsantrizosauthor=M.+Llin%C3%A0s-Brunet&title=Synthesis+of+BILN+2061%2C+an+HCV+NS3+protease+inhibitor+with+proven+antiviral+effect+in+humans&doi=10.1021%2Fol0489907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans</span></div><div class="casAuthors">Faucher, Anne-Marie; Bailey, Murray D.; Beaulieu, Pierre L.; Brochu, Christian; Duceppe, Jean-Simon; Ferland, Jean-Marie; Ghiro, Elise; Gorys, Vida; Halmos, Ted; Kawai, Stephen H.; Poirier, Martin; Simoneau, Bruno; Tsantrizos, Youla S.; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2901-2904</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of BILN 2061 (I), a hepatitis C virus (HCV) NS3 protease inhibitor with proven antiviral effect in humans, was accomplished in a convergent manner from four building blocks.  The procedure described here was suitable for the prepn. of multigram quantities of BILN 2061 for preclin. pharmacol. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3e_dv4CxKirVg90H21EOLACvtfcHk0li6HcBaCIfxhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVSkur0%253D&md5=cfc1b877b24dc5df86fe3ea7f8996f9c</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fol0489907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0489907%26sid%3Dliteratum%253Aachs%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DDuceppe%26aufirst%3DJ.-S.%26aulast%3DFerland%26aufirst%3DJ.-M.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520BILN%25202061%252C%2520an%2520HCV%2520NS3%2520protease%2520inhibitor%2520with%2520proven%2520antiviral%2520effect%2520in%2520humans%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D2901%26epage%3D2904%26doi%3D10.1021%2Fol0489907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Navarre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genet, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darses, S.</span></span> <span> </span><span class="NLM_article-title">Access to enantioenriched α-amino esters via rhodium-catalyzed 1,4-addition/enantioselective protonation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">6159</span>– <span class="NLM_lpage">6169</span>, <span class="refDoi"> DOI: 10.1021/ja710691p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja710691p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksVShur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=6159-6169&author=L.+Navarreauthor=R.+Martinezauthor=J.-P.+Genetauthor=S.+Darses&title=Access+to+enantioenriched+%CE%B1-amino+esters+via+rhodium-catalyzed+1%2C4-addition%2Fenantioselective+protonation&doi=10.1021%2Fja710691p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Access to enantioenriched α-amino esters via rhodium-catalyzed 1,4-addition/enantioselective protonation</span></div><div class="casAuthors">Navarre, Laure; Martinez, Remi; Genet, Jean-Pierre; Darses, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6159-6169</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conjugate addn. of potassium trifluoro(organo)borates to dehydroalanine derivs., mediated by a chiral rhodium catalyst and in situ enantioselective protonation, afforded straightforward access to a variety of protected α-amino esters with high yields and enantiomeric excesses up to 95%.  Among the tested chiral ligands and proton sources, Binap, in combination with guaiacol (2-methoxyphenol), an inexpensive and nontoxic phenol, afforded the highest asym. inductions.  Organostannanes have also shown to participate in this reaction.  By a fine-tuning of the ester moiety, and using Difluorophos as chiral ligand, increased levels of enantioselectivity, generally close to 95%, were achieved.  Deuterium labeling expts. revealed, and DFT calcn. supported, an unusual mechanism involving a hydride transfer from the amido substituent to the α carbon explaining the high levels of enantioselectivity attained in controlling this α chiral center.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqHXV_W9YJ7Vg90H21EOLACvtfcHk0li6HcBaCIfxhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksVShur0%253D&md5=f2c743b43aaf64bc4137920c5bfb6089</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja710691p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja710691p%26sid%3Dliteratum%253Aachs%26aulast%3DNavarre%26aufirst%3DL.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DGenet%26aufirst%3DJ.-P.%26aulast%3DDarses%26aufirst%3DS.%26atitle%3DAccess%2520to%2520enantioenriched%2520%25CE%25B1-amino%2520esters%2520via%2520rhodium-catalyzed%25201%252C4-addition%252Fenantioselective%2520protonation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D6159%26epage%3D6169%26doi%3D10.1021%2Fja710691p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoń, J.</span></span> <span> </span><span class="NLM_article-title">A simple preparation of diethyl 1-acylamino-1-ethenephosphonates</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>1981</i></span>,  <span class="NLM_fpage">324</span>, <span class="refDoi"> DOI: 10.1055/s-1981-29440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1055%2Fs-1981-29440" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1981&publication_year=1981&pages=324&author=J.+Zo%C5%84&title=A+simple+preparation+of+diethyl+1-acylamino-1-ethenephosphonates&doi=10.1055%2Fs-1981-29440"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1055%2Fs-1981-29440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1981-29440%26sid%3Dliteratum%253Aachs%26aulast%3DZo%25C5%2584%26aufirst%3DJ.%26atitle%3DA%2520simple%2520preparation%2520of%2520diethyl%25201-acylamino-1-ethenephosphonates%26jtitle%3DSynthesis%26date%3D1981%26volume%3D1981%26spage%3D324%26doi%3D10.1055%2Fs-1981-29440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vedejs, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrimpf, M. R.</span></span> <span> </span><span class="NLM_article-title">Conversion of arylboronic acids into potassium aryltrifluoroborates: convenient precursors of arylboron difluoride Lewis acids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3020</span>– <span class="NLM_lpage">3027</span>, <span class="refDoi"> DOI: 10.1021/jo00115a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00115a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADyaK2MXlsFCjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=3020-3027&author=E.+Vedejsauthor=R.+W.+Chapmanauthor=S.+C.+Fieldsauthor=S.+Linauthor=M.+R.+Schrimpf&title=Conversion+of+arylboronic+acids+into+potassium+aryltrifluoroborates%3A+convenient+precursors+of+arylboron+difluoride+Lewis+acids&doi=10.1021%2Fjo00115a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion of Arylboronic Acids into Potassium Aryltrifluoroborates: Convenient Precursors of Arylboron Difluoride Lewis Acids</span></div><div class="casAuthors">Vedejs, E.; Chapman, R. W.; Fields, S. C.; Lin, S.; Schrimpf, M. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3020-7</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reaction of ArB(OH)2 (Ar = Ph, 1-naphthyl, 4-F3CC6H4, etc.) with KHF2 affords cryst. salts KArBF3 (I).  In the presence of TMSCl in acetonitrile, I (R = Ph) reacts to give NMR signals typical of PhBF2 in acetonitrile soln.  When the reaction of I + TMSCl is performed in the presence of potential Lewis bases, the trivalent borane is intercepted, resulting in organoboron complexes.  Thus, the oxazaborolidinones, e.g. II, have been prepd. from amino acid-derived amidine carboxylates NaO2CCH(R)N:CHNMe2 (R = H or phenyl).  Complexes, e.g. III, derived from 1,3-diketones are also easily prepd.  The KHF2 fluoride exchange coupled with the TMSCl activation method allows in situ generation of ArBF2 without having to handle corrosive trivalent boron halides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIrPrKhcU6UbVg90H21EOLACvtfcHk0li6HcBaCIfxhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsFCjsL0%253D&md5=0b641b7b7b0f070925a72a60e3dbea95</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo00115a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00115a016%26sid%3Dliteratum%253Aachs%26aulast%3DVedejs%26aufirst%3DE.%26aulast%3DChapman%26aufirst%3DR.%2BW.%26aulast%3DFields%26aufirst%3DS.%2BC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26atitle%3DConversion%2520of%2520arylboronic%2520acids%2520into%2520potassium%2520aryltrifluoroborates%253A%2520convenient%2520precursors%2520of%2520arylboron%2520difluoride%2520Lewis%2520acids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D3020%26epage%3D3027%26doi%3D10.1021%2Fjo00115a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, J. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupton, D. W.</span></span> <span> </span><span class="NLM_article-title">Enantioselective <i>N</i>-heterocyclic carbene catalysis that exploits imine umpolung</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4007</span>– <span class="NLM_lpage">4011</span>, <span class="refDoi"> DOI: 10.1002/anie.201812585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fanie.201812585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFGhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=4007-4011&author=J.+E.+M.+Fernandoauthor=Y.+Nakanoauthor=C.+Zhangauthor=D.+W.+Lupton&title=Enantioselective+N-heterocyclic+carbene+catalysis+that+exploits+imine+umpolung&doi=10.1002%2Fanie.201812585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective N-Heterocyclic Carbene Catalysis that Exploits Imine Umpolung</span></div><div class="casAuthors">Fernando, Jared E. M.; Nakano, Yuji; Zhang, Changhe; Lupton, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4007-4011</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">An enantioselective aza-Stetter reaction that proceeds via imine umpolung using N-heterocyclic carbene catalysis was reported.  The reaction proceeded with high levels of enantioselectivity (all ≥96:4 er) and good generality (21 examples).  Mechanistic studies are reported and are consistent with turnover-limiting addn. of the NHC to the imine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEzPyfNZR3LVg90H21EOLACvtfcHk0liktUFU0qYcQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFGhurk%253D&md5=facd43a2a8888b2a10fce118e5028f27</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fanie.201812585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201812585%26sid%3Dliteratum%253Aachs%26aulast%3DFernando%26aufirst%3DJ.%2BE.%2BM.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLupton%26aufirst%3DD.%2BW.%26atitle%3DEnantioselective%2520N-heterocyclic%2520carbene%2520catalysis%2520that%2520exploits%2520imine%2520umpolung%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D4007%26epage%3D4011%26doi%3D10.1002%2Fanie.201812585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobley, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, S. M.</span></span> <span> </span><span class="NLM_article-title">Decision making in xia2</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1260</span>– <span class="NLM_lpage">1273</span>, <span class="refDoi"> DOI: 10.1107/S0907444913015308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1107%2FS0907444913015308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=23793152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1260-1273&author=G.+Winterauthor=C.+M.+Lobleyauthor=S.+M.+Prince&title=Decision+making+in+xia2&doi=10.1107%2FS0907444913015308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Decision making in xia2</span></div><div class="casAuthors">Winter, Graeme; Lobley, Carina M. C.; Prince, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1260-1273</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Xia2 is an expert system for the automated redn. of macromol. crystallog. (MX) data employing well trusted existing software.  The system can process a full MX data set consisting of one or more sequences of images at one or more wavelengths from images to structure-factor amplitudes with no user input.  To achieve this many decisions are made, the rationale for which is described here.  In addn., it is crit. to support the testing of hypotheses and to allow feedback of results from later stages in the anal. to earlier points where decisions were made: the flexible framework employed by xia2 to support this feedback is summarized here.  While the decision-making protocols described here were developed for xia2, they are equally applicable to interactive data redn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMCxz3Jkl1CrVg90H21EOLACvtfcHk0liktUFU0qYcQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsro%253D&md5=48d02842ee5967636a5f6042cfd90b25</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444913015308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913015308%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DLobley%26aufirst%3DC.%2BM.%26aulast%3DPrince%26aufirst%3DS.%2BM.%26atitle%3DDecision%2520making%2520in%2520xia2%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1260%26epage%3D1273%26doi%3D10.1107%2FS0907444913015308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0liktUFU0qYcQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span> <span> </span><span class="NLM_article-title">A REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+Vagin&title=A+REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lilgrd3E-KFOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%26atitle%3DA%2520REFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, G. O.</span></span> <span> </span><span class="NLM_article-title">The preparation and properties of phosphonic acids</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1021/cr50015a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr50015a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADyaG2sXptVCmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1957&pages=479-523&author=L.+D.+Freedmanauthor=G.+O.+Doak&title=The+preparation+and+properties+of+phosphonic+acids&doi=10.1021%2Fcr50015a003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The preparation and properties of phosphonic acids</span></div><div class="casAuthors">Freedman, Leon D.; Doak, G. O.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-523</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">Review, 253 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonwI1ZgKdM3LVg90H21EOLACvtfcHk0lilgrd3E-KFOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2sXptVCmug%253D%253D&md5=d46a5c11d0399b42741173fcf0baaa77</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fcr50015a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr50015a003%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DL.%2BD.%26aulast%3DDoak%26aufirst%3DG.%2BO.%26atitle%3DThe%2520preparation%2520and%2520properties%2520of%2520phosphonic%2520acids%26jtitle%3DChem.%2520Rev.%26date%3D1957%26volume%3D57%26spage%3D479%26epage%3D523%26doi%3D10.1021%2Fcr50015a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c','cit1d'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c','cit5d'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c','cit8d'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15a','cit15b','cit15c','cit15d'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b','cit20c','cit20d'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23a','cit23b'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Héctor Fernández-Pérez, Paweł Lenartowicz, Lucas Carreras, Arnald Grabulosa, Paweł Kafarski, <span class="NLM_string-name hlFld-ContribAuthor">Anton Vidal-Ferran</span>. </span><span class="cited-content_cbyCitation_article-title">Access to α-Aminophosphonic Acid Derivatives and Phosphonopeptides by [Rh(P–OP)]-Catalyzed Stereoselective Hydrogenation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (22)
                                     , 14779-14784. <a href="https://doi.org/10.1021/acs.joc.0c00914" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00914%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAccess%252Bto%252B%2525CE%2525B1-Aminophosphonic%252BAcid%252BDerivatives%252Band%252BPhosphonopeptides%252Bby%252B%25255BRh%252528P%2525E2%252580%252593OP%252529%25255D-Catalyzed%252BStereoselective%252BHydrogenation%26aulast%3DFern%25C3%25A1ndez-P%25C3%25A9rez%26aufirst%3DH%25C3%25A9ctor%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14042020%26date%3D30062020%26date%3D12062020%26volume%3D85%26issue%3D22%26spage%3D14779%26epage%3D14784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jaeok  Park</span>, <span class="hlFld-ContribAuthor ">Vishal R.  Pandya</span>, <span class="hlFld-ContribAuthor ">Sean J.  Ezekiel</span>, <span class="hlFld-ContribAuthor ">Albert M.  Berghuis</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphonate and Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthases: A Structure-Guided Perspective. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.612728" title="DOI URL">https://doi.org/10.3389/fchem.2020.612728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.612728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.612728%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DPhosphonate%252Band%252BBisphosphonate%252BInhibitors%252Bof%252BFarnesyl%252BPyrophosphate%252BSynthases%25253A%252BA%252BStructure-Guided%252BPerspective%26aulast%3DPark%26aufirst%3DJaeok%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of active site (<b>1</b>) and allosteric inhibitors (<b>2</b>–<b>7</b>) of hFPPS.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Asymmetric Synthesis of α-Aminophosphonic Acid hFPPS Allosteric Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) [Rh(C<sub>2</sub>H<sub>4</sub>)<sub>2</sub>Cl]<sub>2</sub> (1.5 mol %), (<i>S</i>)-Difluorphos (3.3 mol %), NaHCO<sub>3</sub> (2 equiv), <i>i</i>PrOH, 90°C, 18 h (70–80% yield); (b) Rh(nbd)<sub>2</sub>BF<sub>4</sub> (7.5 mol %), (<i>S</i>,<i>S</i>)-Chiraphos (8 mol %), Na<sub>2</sub>CO<sub>3</sub> (1 equiv), MeOH (8 equiv), dioxane/H<sub>2</sub>O, 70°C, 20 h (60–70% yield); (c) (i) Boc<sub>2</sub>O, DMAP (cat.), THF, 80°C, 4 h, (ii) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O (2:1), RT, 20 h, (iii) HCl (4M in dioxane), DCM, RT, 3 h (50%); (d) Et<sub>3</sub>N, DMSO, 100°C, 2 h (50–80%); (e) TMSBr/MeOH, RT, 24 h (40–80% yield); (f) HPO(OEt)<sub>2</sub>, (<i>R</i>,<i>R</i>)- or (<i>S</i>,<i>S</i>)-ProPhenol/Et<sub>2</sub>Zn (10 mol %) toluene, 0 °C, 0.5 h (30% yield); (g) [Rh(cod)<sub>2</sub>]BF<sub>4</sub> (3 mol %), (<i>S</i>)-BINAP (6 mol %), guaiacol (1 equiv), toluene, 110 °C, 16 h (50% yield).</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Previously determined cocrystal structures of C<sup>6</sup>–ThP-MP inhibitors <b>6</b> (racemic samples of inhibitors <b>6b</b> and <b>6g</b> were used):<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (a) <b>6a</b>, (b) <b>6b</b>, and (c) <b>6g</b> bound in the allosteric pocket of hFPPS. For clarity, protein residues are only labeled in (a).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cocrystal structures of inhibitor/hFPPS complexes. Inhibitors: (a) (<i>S</i>)-<b>6d</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Z">6N7Z</a>), (b) (<i>R</i>)-<b>6d</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Y">6N7Y</a>), (c) (<i>S</i>)-<b>6f</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAG">6OAG</a>), (d) (<i>R</i>)-<b>6f</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAH">6OAH</a>), (e) (<i>S</i>)-<b>6g</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N82">6N82</a>), and (f) (<i>R</i>)-<b>6g</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N83">6N83</a>). The red spheres represent water molecules.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/medium/jm9b01104_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Sideview of (<i>R</i>)-enantiomeric C<sup>6</sup>–ThP-MP inhibitor binding in space-filling representation. (a) (<i>R</i>)-<b>6d</b>, (b) (<i>R</i>)-<b>6f</b>, and (c) (<i>R</i>)-<b>6g</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-21/acs.jmedchem.9b01104/20191108/images/large/jm9b01104_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01104&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27871" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27871" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dunford, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coxon, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luckman, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulter, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebetino, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, M. J.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>296</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=11160603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD3MXoslaluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2001&pages=235-242&author=J.+E.+Dunfordauthor=K.+Thompsonauthor=F.+P.+Coxonauthor=S.+P.+Luckmanauthor=F.+M.+Hahnauthor=C.+D.+Poulterauthor=F.+H.+Ebetinoauthor=M.+J.+Rogers&title=Structure-activity+relationship+for+inhibition+of+farnesyl+diphosphate+synthase+in+vitro+and+inhibition+of+bone+resorption+in+vivo+by+nitrogen-containing+bisphosphonates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates</span></div><div class="casAuthors">Dunford, James E.; Thompson, Keith; Coxon, Fraser P.; Luckman, Steven P.; Hahn, Frederick M.; Poulter, C. Dale; Ebetino, Frank H.; Rogers, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">It has long been known that small changes to the structure of the side chain of nitrogen-contg. bisphosphonates can dramatically affect their potency for inhibiting bone resorption in vitro and in vivo, although the reason for these differences in antiresorptive potency have not been explained at the level of a pharmacol. target.  Recently, several nitrogen-contg. bisphosphonates were found to inhibit osteoclast-mediated bone resorption in vitro by inhibiting farnesyl diphosphate synthase, thereby preventing protein prenylation in osteoclasts.  In this study, we examd. the potency of a wider range of nitrogen-contg. bisphosphonates, including the highly potent, heterocycle-contg. zoledronic acid and minodronate (YM-529).  We found a clear correlation between the ability to inhibit farnesyl diphosphate synthase in vitro, to inhibit protein prenylation in cell-free exts. and in purified osteoclasts in vitro, and to inhibit bone resorption in vivo.  The activity of recombinant human farnesyl diphosphate synthase was inhibited at concns. ≥1 nM zoledronic acid or minodronate, the order of potency (zoledronic acid ≈ minodronate > risedronate > ibandronate > incadronate > alendronate > pamidronate) closely matching the order of antiresorptive potency.  Furthermore, minor changes to the structure of the side chain of heterocycle-contg. bisphosphonates, giving rise to less potent inhibitors of bone resorption in vivo, also caused a redn. in potency up to ∼300-fold for inhibition of farnesyl diphosphate synthase in vitro.  These data indicate that farnesyl diphosphate synthase is the major pharmacol. target of these drugs in vivo, and that small changes to the structure of the side chain alter antiresorptive potency by affecting the ability to inhibit farnesyl diphosphate synthase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqg9S7IrVEnC7Vg90H21EOLACvtfcHk0ljq6D5GOykCpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXoslaluw%253D%253D&md5=25f1fe58cfbda08f1e1aa1d0779b0686</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DLuckman%26aufirst%3DS.%2BP.%26aulast%3DHahn%26aufirst%3DF.%2BM.%26aulast%3DPoulter%26aufirst%3DC.%2BD.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26atitle%3DStructure-activity%2520relationship%2520for%2520inhibition%2520of%2520farnesyl%2520diphosphate%2520synthase%2520in%2520vitro%2520and%2520inhibition%2520of%2520bone%2520resorption%2520in%2520vivo%2520by%2520nitrogen-containing%2520bisphosphonates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D296%26spage%3D235%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Coxon, F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, M. J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in understanding the mechanism of action of bisphosphonates</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2006.03.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.coph.2006.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=16650801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFyms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=307-312&author=F.+P.+Coxonauthor=K.+Thompsonauthor=M.+J.+Rogers&title=Recent+advances+in+understanding+the+mechanism+of+action+of+bisphosphonates&doi=10.1016%2Fj.coph.2006.03.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in understanding the mechanism of action of bisphosphonates</span></div><div class="casAuthors">Coxon, Fraser P.; Thompson, Keith; Rogers, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-312</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Bisphosphonates (BPs) are widely used in the treatment of diseases assocd. with excessive osteoclast-mediated bone resorption, such as osteoporosis.  Although several years ago the mol. target of the potent nitrogen-contg. BPs (N-BPs) was identified as farnesyl diphosphate synthase, an enzyme in the mevalonate pathway, recent data have shed new light on the precise mechanism of inhibition and demonstrated that the acute-phase reaction, an adverse effect of N-BPs, is also caused by inhibition of this enzyme.  In addn., the identification of BP analogs that inhibit different enzymes in the mevalonate pathway could lead to the development of novel inhibitors of bone resorption with potential applications in the treatment of bone disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTh3WImCUpFrVg90H21EOLACvtfcHk0li-BRUt3DNG8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFyms7w%253D&md5=17b2b704256c23fd1cd09e5a9e6b1f70</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2006.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2006.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DCoxon%26aufirst%3DF.%2BP.%26aulast%3DThompson%26aufirst%3DK.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26atitle%3DRecent%2520advances%2520in%2520understanding%2520the%2520mechanism%2520of%2520action%2520of%2520bisphosphonates%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2006%26volume%3D6%26spage%3D307%26epage%3D312%26doi%3D10.1016%2Fj.coph.2006.03.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Eastell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watts, N. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siris, E.</span></span> <span> </span><span class="NLM_article-title">Bisphosphonates for postmenopausal osteoporosis</span>. <i>Bone</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">82</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1016/j.bone.2011.02.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.bone.2011.02.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21349354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=82-88&author=R.+Eastellauthor=J.+S.+Walshauthor=N.+B.+Wattsauthor=E.+Siris&title=Bisphosphonates+for+postmenopausal+osteoporosis&doi=10.1016%2Fj.bone.2011.02.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Bisphosphonates for postmenopausal osteoporosis</span></div><div class="casAuthors">Eastell, Richard; Walsh, Jennifer S.; Watts, Nelson B.; Siris, Ethel</div><div class="citationInfo"><span class="NLM_cas:title">Bone (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">82-88</span>CODEN:
                <span class="NLM_cas:coden">BONEDL</span>;
        ISSN:<span class="NLM_cas:issn">8756-3282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Bisphosphonates are effective in reducing bone turnover, increasing BMD and reducing fracture risk in postmenopausal women with osteoporosis.  The licensed bisphosphonates exhibit some differences in potency and speed of onset and offset of action.  These differences mean that different agents may be more advantageous in different situations.  Uncertainties still exist around the optimum duration of treatment and treatment holidays, how best to use bisphosphonates with anabolic treatments, and the benefits of treatment in patients who do not have a BMD T-score below - 2.5.  This article is part of a Special Issue entitled Bisphosphonates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn52bAtFdyyrVg90H21EOLACvtfcHk0ljIO6e9dX9k0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSgsbc%253D&md5=c2bae5bed147331d3ec7dc6d689185e3</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.02.011%26sid%3Dliteratum%253Aachs%26aulast%3DEastell%26aufirst%3DR.%26aulast%3DWalsh%26aufirst%3DJ.%2BS.%26aulast%3DWatts%26aufirst%3DN.%2BB.%26aulast%3DSiris%26aufirst%3DE.%26atitle%3DBisphosphonates%2520for%2520postmenopausal%2520osteoporosis%26jtitle%3DBone%26date%3D2011%26volume%3D49%26spage%3D82%26epage%3D88%26doi%3D10.1016%2Fj.bone.2011.02.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ebetino, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoumpra, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triffitt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwaasi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunford, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnett, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppermann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundy, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashemirov, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenna, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R. G.</span></span> <span> </span><span class="NLM_article-title">The relationship between the chemistry and biological activity of the bisphosphonates</span>. <i>Bone</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.bone.2011.03.774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.bone.2011.03.774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21497677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2011&pages=20-33&author=F.+H.+Ebetinoauthor=A.-M.+Hoganauthor=S.+Sunauthor=M.+K.+Tsoumpraauthor=X.+Duanauthor=J.+T.+Triffittauthor=A.+A.+Kwaasiauthor=J.+E.+Dunfordauthor=B.+L.+Barnettauthor=U.+Oppermannauthor=M.+W.+Lundyauthor=A.+Boydeauthor=B.+A.+Kashemirovauthor=C.+E.+McKennaauthor=R.+G.+Russell&title=The+relationship+between+the+chemistry+and+biological+activity+of+the+bisphosphonates&doi=10.1016%2Fj.bone.2011.03.774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1dR"><div class="casContent"><span class="casTitleNuber">1d</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship between the chemistry and biological activity of the bisphosphonates</span></div><div class="casAuthors">Ebetino, Frank H.; Hogan, Anne-Marie L.; Sun, Shuting; Tsoumpra, Maria K.; Duan, Xuchen; Triffitt, James T.; Kwaasi, Aaron A.; Dunford, James E.; Barnett, Bobby L.; Oppermann, Udo; Lundy, Mark W.; Boyde, Alan; Kashemirov, Boris A.; McKenna, Charles E.; Russell, R. Graham G.</div><div class="citationInfo"><span class="NLM_cas:title">Bone (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-33</span>CODEN:
                <span class="NLM_cas:coden">BONEDL</span>;
        ISSN:<span class="NLM_cas:issn">8756-3282</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The ability of bisphosphonates ((HO)2P(O)CR1R2P(O)(OH)2) to inhibit bone resorption has been known since the 1960s, but it is only recently that a detailed mol. understanding of the relationship between chem. structures and biol. activity has begun to emerge.  The early development of chem. in this area was largely empirical and based on modifying R2 groups in a variety of ways.  Apart from the general ability of bisphosphonates to chelate Ca2+ and thus target the calcium phosphate mineral component of bone, attempts to refine clear structure-activity relationships had led to ambiguous or seemingly contradictory results.  However, there was increasing evidence for cellular effects, and eventually the earliest bisphosphonate drugs, such as clodronate (R1 = R2 = Cl) and etidronate (R1 = OH, R2 = CH3), were shown to exert intracellular actions via the formation in vivo of drug derivs. of ATP.  The observation that pamidronate, a bisphosphonate with R1 = OH and R2 = CH2CH2NH2, exhibited higher potency than previously known bisphosphonate drugs represented the first step towards the later recognition of the crit. importance of having nitrogen in the R2 side chain.  The synthesis and biol. evaluation of a large no. of nitrogen-contg. bisphosphonates took place particularly in the 1980s, but still with an incomplete understanding of their structure-activity relationships.  A major advance was the discovery that the anti-resorptive effects of the nitrogen-contg. bisphosphonates (including alendronate, risedronate, ibandronate, and zoledronate) on osteoclasts appear to result from their potency as inhibitors of the enzyme farnesyl pyrophosphate synthase (FPPS), a key branch-point enzyme in the mevalonate pathway.  FPPS generates isoprenoid lipids utilized in sterol synthesis and for the post-translational modification of small GTP-binding proteins essential for osteoclast function.  Effects on other cellular targets, such as osteocytes, may also be important.  Over the years many hundreds of bisphosphonates have been synthesized and studied.  Interest in expanding the structural scope of the bisphosphonate class has also motivated new approaches to the chem. synthesis of these compds.  Recent chem. innovations include the synthesis of fluorescently labeled bisphosphonates, which has enabled studies of the biodistribution of these drugs.  As a class, bisphosphonates share common properties.  However, as with other classes of drugs, there are chem., biochem., and pharmacol. differences among the individual compds.  Differences in mineral binding affinities among bisphosphonates influence their differential distribution within bone, their biol. potency, and their duration of action.  The overall pharmacol. effects of bisphosphonates on bone, therefore, appear to depend upon these two key properties of affinity for bone mineral and inhibitory effects on osteoclasts.  The relative contributions of these properties differ among individual bisphosphonates and help det. their clin. behavior and effectiveness.  This article is part of a Special Issue entitled Bisphosphonates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkW3DAKvbJe7Vg90H21EOLACvtfcHk0ljIO6e9dX9k0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSgsLk%253D&md5=0bba79f40512f2df89bd0ee36459e264</span></div><a href="/servlet/linkout?suffix=cit1d&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2011.03.774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2011.03.774%26sid%3Dliteratum%253Aachs%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DHogan%26aufirst%3DA.-M.%26aulast%3DSun%26aufirst%3DS.%26aulast%3DTsoumpra%26aufirst%3DM.%2BK.%26aulast%3DDuan%26aufirst%3DX.%26aulast%3DTriffitt%26aufirst%3DJ.%2BT.%26aulast%3DKwaasi%26aufirst%3DA.%2BA.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DBarnett%26aufirst%3DB.%2BL.%26aulast%3DOppermann%26aufirst%3DU.%26aulast%3DLundy%26aufirst%3DM.%2BW.%26aulast%3DBoyde%26aufirst%3DA.%26aulast%3DKashemirov%26aufirst%3DB.%2BA.%26aulast%3DMcKenna%26aufirst%3DC.%2BE.%26aulast%3DRussell%26aufirst%3DR.%2BG.%26atitle%3DThe%2520relationship%2520between%2520the%2520chemistry%2520and%2520biological%2520activity%2520of%2520the%2520bisphosphonates%26jtitle%3DBone%26date%3D2011%26volume%3D49%26spage%3D20%26epage%3D33%26doi%3D10.1016%2Fj.bone.2011.03.774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Berndt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, S. M.</span></span> <span> </span><span class="NLM_article-title">Targeting protein prenylation for cancer therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1038/nrc3151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1038%2Fnrc3151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=22020205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=775-791&author=N.+Berndtauthor=A.+D.+Hamiltonauthor=S.+M.+Sebti&title=Targeting+protein+prenylation+for+cancer+therapy&doi=10.1038%2Fnrc3151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein prenylation for cancer therapy</span></div><div class="casAuthors">Berndt, Norbert; Hamilton, Andrew D.; Sebti, Said M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">775-791</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein farnesylation and geranylgeranylation, together referred to as prenylation, are lipid post-translational modifications that are required for the transforming activity of many oncogenic proteins, including some RAS family members.  This observation prompted the development of inhibitors of farnesyltransferase (FT) and geranylgeranyltransferase 1 (GGT1) as potential anticancer drugs.  In this Review, we discuss the mechanisms by which FT and GGT1 inhibitors (FTIs and GGTIs, resp.) affect signal transduction pathways, cell cycle progression, proliferation and cell survival.  In contrast to their preclin. efficacy, only a small subset of patients responds to FTIs.  Identifying tumors that depend on farnesylation for survival remains a challenge, and strategies to overcome this are discussed.  One GGTI has recently entered the clinic, and the safety and efficacy of GGTIs await results from clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmj2vv2fG4gLVg90H21EOLACvtfcHk0lj-GRyeYPpHcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGks7jF&md5=c98505df79a037234fb260801c9b97aa</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1038%2Fnrc3151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3151%26sid%3Dliteratum%253Aachs%26aulast%3DBerndt%26aufirst%3DN.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26atitle%3DTargeting%2520protein%2520prenylation%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2011%26volume%3D11%26spage%3D775%26epage%3D791%26doi%3D10.1038%2Fnrc3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mullen, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penn, L. Z.</span></span> <span> </span><span class="NLM_article-title">The interplay between cell signalling and the mevalonate pathway in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">718</span>– <span class="NLM_lpage">731</span>, <span class="refDoi"> DOI: 10.1038/nrc.2016.76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1038%2Fnrc.2016.76" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=27562463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVSrur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=718-731&author=P.+J.+Mullenauthor=R.+Yuauthor=J.+Longoauthor=M.+C.+Archerauthor=L.+Z.+Penn&title=The+interplay+between+cell+signalling+and+the+mevalonate+pathway+in+cancer&doi=10.1038%2Fnrc.2016.76"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">The interplay between cell signalling and the mevalonate pathway in cancer</span></div><div class="casAuthors">Mullen, Peter J.; Yu, Rosemary; Longo, Joseph; Archer, Michael C.; Penn, Linda Z.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">718-731</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The mevalonate (MVA) pathway is an essential metabolic pathway that uses acetyl-CoA to produce sterols and isoprenoids that are integral to tumor growth and progression.  In recent years, many oncogenic signalling pathways have been shown to increase the activity and/or the expression of MVA pathway enzymes.  This Review summarizes recent advances and discusses unique opportunities for immediately targeting this metabolic vulnerability in cancer with agents that have been approved for other therapeutic uses, such as the statin family of drugs, to improve outcomes for cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprCFV9_aKCv7Vg90H21EOLACvtfcHk0lj-GRyeYPpHcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVSrur%252FN&md5=4a692b82d8eb6fc1547db5c45a36cae4</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1038%2Fnrc.2016.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc.2016.76%26sid%3Dliteratum%253Aachs%26aulast%3DMullen%26aufirst%3DP.%2BJ.%26aulast%3DYu%26aufirst%3DR.%26aulast%3DLongo%26aufirst%3DJ.%26aulast%3DArcher%26aufirst%3DM.%2BC.%26aulast%3DPenn%26aufirst%3DL.%2BZ.%26atitle%3DThe%2520interplay%2520between%2520cell%2520signalling%2520and%2520the%2520mevalonate%2520pathway%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2016%26volume%3D16%26spage%3D718%26epage%3D731%26doi%3D10.1038%2Fnrc.2016.76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunford, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebetino, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oppermann, U.</span></span> <span> </span><span class="NLM_article-title">The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">7829</span>– <span class="NLM_lpage">7834</span>, <span class="refDoi"> DOI: 10.1073/pnas.0601643103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1073%2Fpnas.0601643103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=16684881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsVGksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=7829-7834&author=K.+L.+Kavanaghauthor=K.+Guoauthor=J.+E.+Dunfordauthor=X.+Wuauthor=S.+Knappauthor=F.+H.+Ebetinoauthor=M.+J.+Rogersauthor=R.+G.+Russellauthor=U.+Oppermann&title=The+molecular+mechanism+of+nitrogen-containing+bisphosphonates+as+antiosteoporosis+drugs&doi=10.1073%2Fpnas.0601643103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs</span></div><div class="casAuthors">Kavanagh, Kathryn L.; Guo, Kunde; Dunford, James E.; Wu, Xiaoqiu; Knapp, Stefan; Ebetino, Frank H.; Rogers, Michael J.; Russell, R. Graham G.; Oppermann, Udo</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7829-7834</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Osteoporosis and low bone mass are currently estd. to be a major public health risk affecting > 50% of the female population over the age of 50.  Because of their bone-selective pharmacokinetics, nitrogen-contg. bisphosphonates (N-BPs), currently used as clin. inhibitors of bone-resorption diseases, target osteoclast farnesyl pyrophosphate synthase (FPPS) and inhibit protein prenylation.  FPPS, a key branchpoint of the mevalonate pathway, catalyzes the successive condensation of isopentenyl pyrophosphate with dimethylallyl pyrophosphate and geranyl pyrophosphate.  To understand the mol. events involved in inhibition of FPPS by N-BPs, we used protein crystallog., enzyme kinetics, and isothermal titrn. calorimetry.  We report here high-resoln. x-ray structures of the human enzyme in complexes with risedronate and zoledronate, two of the leading N-BPs in clin. use.  These agents bind to the dimethylallyl/geranyl pyrophosphate ligand pocket and induce a conformational change.  The interactions of the N-BP cyclic nitrogen with Thr-201 and Lys-200 suggest that these inhibitors achieve potency by positioning their nitrogen in the proposed carbocation-binding site.  Kinetic analyses reveal that inhibition is competitive with geranyl pyrophosphate and is of a slow, tight binding character, indicating that isomerization of an initial enzyme-inhibitor complex occurs with inhibitor binding.  Isothermal titrn. calorimetry indicates that binding of N-BPs to the apoenzyme is entropy-driven, presumably through desolvation entropy effects.  These expts. reveal the mol. binding characteristics of an important pharmacol. target and provide a route for further optimization of these important drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1EVLSV5J3IrVg90H21EOLACvtfcHk0lgSuUlwd3YkfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsVGksL0%253D&md5=d422e7cb8cfd588daa4c4a76756dc45b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601643103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601643103%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DK.%2BL.%26aulast%3DGuo%26aufirst%3DK.%26aulast%3DDunford%26aufirst%3DJ.%2BE.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DEbetino%26aufirst%3DF.%2BH.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26aulast%3DRussell%26aufirst%3DR.%2BG.%26aulast%3DOppermann%26aufirst%3DU.%26atitle%3DThe%2520molecular%2520mechanism%2520of%2520nitrogen-containing%2520bisphosphonates%2520as%2520antiosteoporosis%2520drugs%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D7829%26epage%3D7834%26doi%3D10.1073%2Fpnas.0601643103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocks, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szubert, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro-Coy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drayson, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feyler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashcroft, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roddie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Child, J. A.</span></span> <span> </span><span class="NLM_article-title">First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomized controlled trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>376</i></span>,  <span class="NLM_fpage">1989</span>– <span class="NLM_lpage">1999</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(10)62051-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2FS0140-6736%2810%2962051-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21131037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCqsLnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=1989-1999&author=G.+J.+Morganauthor=F.+E.+Daviesauthor=W.+M.+Gregoryauthor=K.+Cocksauthor=S.+E.+Bellauthor=A.+J.+Szubertauthor=N.+Navarro-Coyauthor=M.+T.+Draysonauthor=R.+G.+Owenauthor=S.+Feylerauthor=A.+J.+Ashcroftauthor=F.+Rossauthor=J.+Byrneauthor=H.+Roddieauthor=C.+Rudinauthor=G.+Cookauthor=G.+H.+Jacksonauthor=J.+A.+Child&title=First-line+treatment+with+zoledronic+acid+as+compared+with+clodronic+acid+in+multiple+myeloma+%28MRC+Myeloma+IX%29%3A+a+randomized+controlled+trial&doi=10.1016%2FS0140-6736%2810%2962051-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial</span></div><div class="casAuthors">Morgan, Gareth J.; Davies, Faith E.; Gregory, Walter M.; Cocks, Kim; Bell, Sue E.; Szubert, Alex J.; Navarro-Coy, Nuria; Drayson, Mark T.; Owen, Roger G.; Feyler, Sylvia; Ashcroft, A. John; Ross, Fiona; Byrne, Jennifer; Roddie, Huw; Rudin, Claudius; Cook, Gordon; Jackson, Graham H.; Child, J. Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">9757</span>),
    <span class="NLM_cas:pages">1989-1999</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Bisphosphonates reduce the risk of skeletal events in patients with malignant bone disease, and zoledronic acid has shown potential anticancer effects in preclin. and clin. studies.  We aimed to establish whether bisphosphonates can affect clin. outcomes in patients with multiple myeloma.  Patients of age 18 years or older with newly diagnosed multiple myeloma were enrolled from 120 centers in the UK.  Computer-generated randomisation sequence was used to allocate patients equally, via an automated telephone service, to receive 4 mg zoledronic acid as an infusion every 3-4 wk or 1600 mg oral clodronic acid daily.  Patients also received intensive or non-intensive induction chemotherapy.  No investigators, staff, or patients were masked to treatment allocation, and bisphosphonate and maintenance therapy continued at least until disease progression.  The primary endpoints were overall survival, progression-free survival, and overall response rate.  We assessed between-group differences with Cox proportional hazards models for progression-free survival and overall survival, and with logistic regression models for overall response rate.  Anal. was by intention to treat.  This trial is registered, no. ISRCTN68454111.  1970 patients were enrolled between May, 2003, and Nov., 2007, of whom 1960 were eligible for intention-to-treat anal.: 981 in the zoledronic acid group (555 on intensive chemotherapy, 426 on non-intensive chemotherapy); and 979 on clodronic acid (556 on intensive chemotherapy, 423 on non-intensive chemotherapy).  The treatment cutoff was Oct 5, 2009, with patients receiving bisphosphonates for a median of 350 days (IQR 137-632) before disease progression, with a median of 3.7 years' follow-up (IQR 2.9-4.7).  Zoledronic acid reduced mortality by 16% (95% CI 4-26) vs. clodronic acid (hazard ratio [HR] 0.84, 95% CI 0.74-0.96; p=0.0118), and extended median overall survival by 5.5 mo (50.0 mo, IQR 21.0 to not reached vs 44.5 mo, IQR 16.5 to not reached; p=0.04).  Zoledronic acid also significantly improved progression-free survival by 12% (95% CI 2-20) vs. clodronic acid (HR 0.88, 95% CI 0.80-0.98; p=0.0179), and increased median progression-free survival by 2.0 mo (19.5 mo, IQR 9.0-38.0 vs 17.5 mo, IQR 8.5-34.0; p=0.07).  Rates of complete, very good partial, or partial response did not differ significantly between the zoledronic acid and clodronic acid groups for patients receiving intensive induction chemotherapy (432 patients [78%] vs 422 [76%]; p=0.43) or non-intensive induction chemotherapy (215 [50%] vs 195 [46%]; p=0.18).  Both bisphosphonates were generally well tolerated, with similar occurrence of acute renal failure and treatment-emergent serious adverse events, but zoledronic acid was assocd. with higher rates of confirmed osteonecrosis of the jaw (35 [4%]) than was clodronic acid (3 [<1%]).  Consistent with the potential anticancer activity of zoledronic acid, overall survival improved independently of prevention of skeletal-related events, showing that zoledronic acid has treatment benefits beyond bone health.  These findings support immediate treatment with zoledronic acid in patients with newly diagnosed multiple myeloma, not only for prevention of skeletal-related events, but also for potential antimyeloma benefits.  Funding: Medical Research Council (London, UK), with unrestricted educational grants from Novartis, Schering Health Care, Chugai, Pharmion, Celgene, and Ortho Biotech.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXS5ilaeyX3rVg90H21EOLACvtfcHk0lgSuUlwd3YkfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCqsLnL&md5=53e25efc3a82b57d286c73f7fba6a611</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2810%2962051-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252810%252962051-X%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DG.%2BJ.%26aulast%3DDavies%26aufirst%3DF.%2BE.%26aulast%3DGregory%26aufirst%3DW.%2BM.%26aulast%3DCocks%26aufirst%3DK.%26aulast%3DBell%26aufirst%3DS.%2BE.%26aulast%3DSzubert%26aufirst%3DA.%2BJ.%26aulast%3DNavarro-Coy%26aufirst%3DN.%26aulast%3DDrayson%26aufirst%3DM.%2BT.%26aulast%3DOwen%26aufirst%3DR.%2BG.%26aulast%3DFeyler%26aufirst%3DS.%26aulast%3DAshcroft%26aufirst%3DA.%2BJ.%26aulast%3DRoss%26aufirst%3DF.%26aulast%3DByrne%26aufirst%3DJ.%26aulast%3DRoddie%26aufirst%3DH.%26aulast%3DRudin%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DG.%2BH.%26aulast%3DChild%26aufirst%3DJ.%2BA.%26atitle%3DFirst-line%2520treatment%2520with%2520zoledronic%2520acid%2520as%2520compared%2520with%2520clodronic%2520acid%2520in%2520multiple%2520myeloma%2520%2528MRC%2520Myeloma%2520IX%2529%253A%2520a%2520randomized%2520controlled%2520trial%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D1989%26epage%3D1999%26doi%3D10.1016%2FS0140-6736%2810%2962051-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szubert, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drayson, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashcroft, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Child, J. A.</span></span> <span> </span><span class="NLM_article-title">Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">5374</span>– <span class="NLM_lpage">5383</span>, <span class="refDoi"> DOI: 10.1182/blood-2011-11-392522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1182%2Fblood-2011-11-392522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=22498739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFantLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2012&pages=5374-5383&author=G.+J.+Morganauthor=F.+E.+Daviesauthor=W.+M.+Gregoryauthor=A.+J.+Szubertauthor=S.+E.+Bellauthor=M.+T.+Draysonauthor=R.+G.+Owenauthor=A.+J.+Ashcroftauthor=G.+H.+Jacksonauthor=J.+A.+Child&title=Effects+of+induction+and+maintenance+plus+long-term+bisphosphonates+on+bone+disease+in+patients+with+multiple+myeloma%3A+the+Medical+Research+Council+Myeloma+IX+Trial&doi=10.1182%2Fblood-2011-11-392522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial</span></div><div class="casAuthors">Morgan, Gareth J.; Davies, Faith E.; Gregory, Walter M.; Szubert, Alex J.; Bell, Sue E.; Drayson, Mark T.; Owen, Roger G.; Ashcroft, A. John; Jackson, Graham H.; Child, J. Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5374-5383</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The Medical Research Council Myeloma IX Trial (ISRCTNG8454111) examd. traditional and thalidomide-based induction and maintenance regimens and IV zoledronic acid (ZOL) and oral clodronate (CLO) in 1960 patients with newly diagnosed multiple myeloma.  Overall survival (OS) and skeletal-related event (SRE) data have been reported for the overall trial population.  The present anal. investigated optimal therapy regimens for different patient populations in Myeloma IX.  Patients were assigned to intensive or nonintensive treatment pathways and randomized to induction cyclophosphamide, vincristine, doxorubicin, and dexamethasone (CVAD) vs. cyclophosphamide, thalidomide, and dexamethasone (CTD; intensive) or melphalan and prednisolone vs. attenuated oral CTD (CTDa; nonintensive).  Patients were also randomized to ZOL or CLO.  In the nonintensive pathway, CTDa produced better responses and lower SRE rates than melphalan and prednisolone.  ZOL improved OS compared with CLO independently of sex, stage, or myeloma subtype, most profoundly in patients with baseline bone disease or other SREs.  In patients treated for ≥ 2 years, ZOL improved OS compared with CLO from randomization (median not reached for either; P = .02) and also from first on-study disease progression (median, 34 mo for ZOL vs 27 mo for CLO; P = .03).  Thalidomide-contg. regimens had better efficacy than traditional regimens, and ZOL demonstrated greater benefits than CLO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn6bsYwhGflrVg90H21EOLACvtfcHk0lhXWBwhoqyyQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFantLg%253D&md5=b908fa4236bbad0d7585647e43a02fbf</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-11-392522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-11-392522%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DG.%2BJ.%26aulast%3DDavies%26aufirst%3DF.%2BE.%26aulast%3DGregory%26aufirst%3DW.%2BM.%26aulast%3DSzubert%26aufirst%3DA.%2BJ.%26aulast%3DBell%26aufirst%3DS.%2BE.%26aulast%3DDrayson%26aufirst%3DM.%2BT.%26aulast%3DOwen%26aufirst%3DR.%2BG.%26aulast%3DAshcroft%26aufirst%3DA.%2BJ.%26aulast%3DJackson%26aufirst%3DG.%2BH.%26aulast%3DChild%26aufirst%3DJ.%2BA.%26atitle%3DEffects%2520of%2520induction%2520and%2520maintenance%2520plus%2520long-term%2520bisphosphonates%2520on%2520bone%2520disease%2520in%2520patients%2520with%2520multiple%2520myeloma%253A%2520the%2520Medical%2520Research%2520Council%2520Myeloma%2520IX%2520Trial%26jtitle%3DBlood%26date%3D2012%26volume%3D119%26spage%3D5374%26epage%3D5383%26doi%3D10.1182%2Fblood-2011-11-392522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodwell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkinshaw, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grieve, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett-Lee, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaunt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rea, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiley, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R.</span></span> <span> </span><span class="NLM_article-title">Breast-cancer adjuvant therapy with zoledronic acid</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">1396</span>– <span class="NLM_lpage">1405</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa1105195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1056%2FNEJMoa1105195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21995387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlals7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2011&pages=1396-1405&author=R.+E.+Colemanauthor=H.+Marshallauthor=D.+Cameronauthor=D.+Dodwellauthor=R.+Burkinshawauthor=M.+Keaneauthor=M.+Gilauthor=S.+J.+Houstonauthor=R.+J.+Grieveauthor=P.+J.+Barrett-Leeauthor=D.+Ritchieauthor=J.+Pughauthor=C.+Gauntauthor=U.+Reaauthor=J.+Petersonauthor=C.+Daviesauthor=V.+Hileyauthor=W.+Gregoryauthor=R.+Bell&title=Breast-cancer+adjuvant+therapy+with+zoledronic+acid&doi=10.1056%2FNEJMoa1105195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Breast-cancer adjuvant therapy with zoledronic acid</span></div><div class="casAuthors">Coleman, Robert E.; Marshall, Helen; Cameron, David; Dodwell, David; Burkinshaw, Roger; Keane, Maccon; Gil, Miguel; Houston, Stephen.; Grieve, Robert J.; Barrett-Lee, Peter J.; Ritchie, Diana; Pugh, Julia; Gaunt, Claire; Rea, Una; Peterson, Jennifer; Davies, Claire; Hiley, Victoria; Gregory, Walter; Bell, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1396-1405</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Data suggest that the adjuvant use of bisphosphonates reduces rates of recurrence and death in patients with early-stage breast cancer.  We conducted a study to det. whether treatment with zoledronic acid, in addn. to std. adjuvant therapy, would improve disease outcomes in such patients.  METHODS: In this open-label phase 3 study, we randomly assigned 3360 patients to receive std. adjuvant systemic therapy either with or without zoledronic acid.  The zoledronic acid was administered every 3 to 4 wk for 6 doses and then every 3 to 6 mo to complete 5 years of treatment.  The primary end point of the study was disease-free survival.  A second interim anal. revealed that a prespecified boundary for lack of benefit had been crossed.  RESULTS: At a median follow-up of 59 mo, there was no significant between-group difference in the primary end point, with a rate of disease-free survival of 77% in each group (adjusted hazard ratio in the zoledronic acid group, 0.98; 95% confidence interval [CI], 0.85 to 1.13; P = 0.79). Disease recurrence or death occurred in 377 patients in the zoledronic acid group and 375 of those in the control group.  The nos. of deaths - 243 in the zoledronic acid group and 276 in the control group - were also similar, resulting in rates of overall survival of 85.4% in the zoledronic acid group and 83.1% in the control group (adjusted hazard ratio, 0.85; 95% CI, 0.72 to 1.01; P = 0.07).  In the zoledronic acid group, there were 17 confirmed cases of osteonecrosis of the jaw (cumulative incidence, 1.1%; 95% CI, 0.6 to 1.7; P < 0.001) and 9 suspected cases; there were no cases in the control group.  Rates of other adverse effects were similar in the two study groups.  CONCLUSIONS: These findings do not support the routine use of zoledronic acid in the adjuvant management of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpISmlJLPnAebVg90H21EOLACvtfcHk0lg1-eD_ETv8sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlals7jP&md5=3c61150ab39db154b5370ea59896c73f</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1105195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1105195%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DR.%2BE.%26aulast%3DMarshall%26aufirst%3DH.%26aulast%3DCameron%26aufirst%3DD.%26aulast%3DDodwell%26aufirst%3DD.%26aulast%3DBurkinshaw%26aufirst%3DR.%26aulast%3DKeane%26aufirst%3DM.%26aulast%3DGil%26aufirst%3DM.%26aulast%3DHouston%26aufirst%3DS.%2BJ.%26aulast%3DGrieve%26aufirst%3DR.%2BJ.%26aulast%3DBarrett-Lee%26aufirst%3DP.%2BJ.%26aulast%3DRitchie%26aufirst%3DD.%26aulast%3DPugh%26aufirst%3DJ.%26aulast%3DGaunt%26aufirst%3DC.%26aulast%3DRea%26aufirst%3DU.%26aulast%3DPeterson%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DC.%26aulast%3DHiley%26aufirst%3DV.%26aulast%3DGregory%26aufirst%3DW.%26aulast%3DBell%26aufirst%3DR.%26atitle%3DBreast-cancer%2520adjuvant%2520therapy%2520with%2520zoledronic%2520acid%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2011%26volume%3D365%26spage%3D1396%26epage%3D1405%26doi%3D10.1056%2FNEJMoa1105195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gnant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlineritsch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luschin-Ebengreuth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakesz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pristauz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauernhofer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidtmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiermann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwasny, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hochreiner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsthuber, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesl, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greil, R.</span></span> <span> </span><span class="NLM_article-title">Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(11)70122-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2FS1470-2045%2811%2970122-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21641868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1ejtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=631-641&author=M.+Gnantauthor=B.+Mlineritschauthor=H.+Stoegerauthor=G.+Luschin-Ebengreuthauthor=D.+Heckauthor=C.+Menzelauthor=R.+Jakeszauthor=M.+Seifertauthor=M.+Hubalekauthor=G.+Pristauzauthor=T.+Bauernhoferauthor=H.+Eidtmannauthor=W.+Eiermannauthor=G.+Stegerauthor=W.+Kwasnyauthor=P.+Dubskyauthor=G.+Hochreinerauthor=E.+P.+Forsthuberauthor=C.+Feslauthor=R.+Greil&title=Adjuvant+endocrine+therapy+plus+zoledronic+acid+in+premenopausal+women+with+early-stage+breast+cancer%3A+62-month+follow-up+from+the+ABCSG-12+randomised+trial&doi=10.1016%2FS1470-2045%2811%2970122-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial</span></div><div class="casAuthors">Gnant, Michael; Mlineritsch, Brigitte; Stoeger, Herbert; Luschin-Ebengreuth, Gero; Heck, Dietmar; Menzel, Christian; Jakesz, Raimund; Seifert, Michael; Hubalek, Michael; Pristauz, Gunda; Bauernhofer, Thomas; Eidtmann, Holger; Eiermann, Wolfgang; Steger, Guenther; Kwasny, Werner; Dubsky, Peter; Hochreiner, Gerhard; Forsthuber, Ernst-Pius; Fesl, Christian; Greil, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">631-641</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Anal. of the Austrian Breast and Colorectal Cancer Study Group trial-12 (ABCSG-12) at 48 mo' follow-up showed that addn. of zoledronic acid to adjuvant endocrine therapy significantly improved disease-free survival.  We have now assessed long-term clin. efficacy including disease-free survival and disease outcomes in patients receiving anastrozole or tamoxifen with or without zoledronic acid.  ABSCG-12 is a randomised, controlled, open-label, two-by-two factorial, multicentre trial in 1803 premenopausal women with endocrine-receptor-pos. early-stage (stage I-II) breast cancer receiving goserelin (3.6 mg every 28 days), comparing the efficacy and safety of anastrozole (1 mg per day) or tamoxifen (20 mg per day) with or without zoledronic acid (4 mg every 6 mo) for 3 years.  Randomisation (1:1:1:1 ratio) was computerized and based on the Pocock and Simon minimisation method to balance the four treatment arms across eight prognostic variables (age, neoadjuvant chemotherapy, pathol. tumor stage; lymph-node involvement, type of surgery or locoregional therapy, complete axillary dissection, intraoperative radiation therapy, and geog. region).  Treatment allocation was not masked.  The primary endpoint was disease-free survival (defined as disease recurrence or death) and anal. was by intention to treat.  This trial is registered with ClinicalTrials.gov, no. NCT00295646; follow-up is ongoing.  At a median follow-up of 62 mo (range 0-114.4 mo), more than 2 years after treatment completion, 186 disease-free survival events had been reported (53 events in 450 patients on tamoxifen alone, 57 in 453 patients on anastrozole alone, 36 in 450 patients on tamoxifen plus zoledronic acid, and 40 in 450 patients on anastrozole plus zoledronic acid).  Zoledronic acid reduced risk of disease-free survival events overall (HR 0.68, 95% CI 0.51-0.91; p=0.009), although the difference was not significant in the tamoxifen (HR 0.67, 95% CI 0.44-1.03; p=0.067) and anastrozole arms (HR 0.68, 95% CI 0.45-1.02; p=0.061) assessed sep.  Zoledronic acid did not significantly affect risk of death (30 deaths with zoledronic acid vs 43 deaths without; HR 0.67, 95% CI 0.41-1.07; p=0.09).  There was no difference in disease-free survival between patients on tamoxifen alone vs. anastrozole alone (HR 1.08, 95% CI 0.81-1.44; p=0.591), but overall survival was worse with anastrozole than with tamoxifen (46 vs 27 deaths; HR 1.75, 95% CI 1.08-2.83; p=0.02).  Treatments were generally well tolerated, with no reports of renal failure or osteonecrosis of the jaw.  Bone pain was reported in 601 patients (33%; 349 patients on zoledronic acid vs 252 not on the drug), fatigue in 361 (20%; 192 vs 169), headache in 280 (16%; 147 vs 133), and arthralgia in 266 (15%; 145 vs 121).  Addn. of zoledronic acid improved disease-free survival in the patients taking anastrozole or tamoxifen.  There was no difference in disease-free survival between patients receiving anastrozole and tamoxifen overall, but those on anastrozole alone had inferior overall survival.  These data show persistent benefits with zoledronic acid and support its addn. to adjuvant endocrine therapy in premenopausal patients with early-stage breast cancer.  Funding: AstraZeneca; Novartis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgMLLmua064rVg90H21EOLACvtfcHk0lg1-eD_ETv8sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1ejtLc%253D&md5=4755e1a85528b14accc4cc95bfa3d6b3</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2811%2970122-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252811%252970122-X%26sid%3Dliteratum%253Aachs%26aulast%3DGnant%26aufirst%3DM.%26aulast%3DMlineritsch%26aufirst%3DB.%26aulast%3DStoeger%26aufirst%3DH.%26aulast%3DLuschin-Ebengreuth%26aufirst%3DG.%26aulast%3DHeck%26aufirst%3DD.%26aulast%3DMenzel%26aufirst%3DC.%26aulast%3DJakesz%26aufirst%3DR.%26aulast%3DSeifert%26aufirst%3DM.%26aulast%3DHubalek%26aufirst%3DM.%26aulast%3DPristauz%26aufirst%3DG.%26aulast%3DBauernhofer%26aufirst%3DT.%26aulast%3DEidtmann%26aufirst%3DH.%26aulast%3DEiermann%26aufirst%3DW.%26aulast%3DSteger%26aufirst%3DG.%26aulast%3DKwasny%26aufirst%3DW.%26aulast%3DDubsky%26aufirst%3DP.%26aulast%3DHochreiner%26aufirst%3DG.%26aulast%3DForsthuber%26aufirst%3DE.%2BP.%26aulast%3DFesl%26aufirst%3DC.%26aulast%3DGreil%26aufirst%3DR.%26atitle%3DAdjuvant%2520endocrine%2520therapy%2520plus%2520zoledronic%2520acid%2520in%2520premenopausal%2520women%2520with%2520early-stage%2520breast%2520cancer%253A%252062-month%2520follow-up%2520from%2520the%2520ABCSG-12%2520randomised%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2011%26volume%3D12%26spage%3D631%26epage%3D641%26doi%3D10.1016%2FS1470-2045%2811%2970122-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gnant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlineritsch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schippinger, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luschin-Ebengreuth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pöstlberger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakesz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjelic-Radisic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samonigg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tausch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidtmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwasny, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubsky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzal, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stierer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rücklinger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greil, R.</span></span> <span> </span><span class="NLM_article-title">Endocrine therapy plus zoledronic acid in premenopaisal breast cancer</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>360</i></span>,  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0806285</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1056%2FNEJMoa0806285" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=19213681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVyisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=679-691&author=M.+Gnantauthor=B.+Mlineritschauthor=W.+Schippingerauthor=G.+Luschin-Ebengreuthauthor=S.+P%C3%B6stlbergerauthor=C.+Menzelauthor=R.+Jakeszauthor=M.+Seifertauthor=M.+Hubalekauthor=V.+Bjelic-Radisicauthor=H.+Samoniggauthor=C.+Tauschauthor=H.+Eidtmannauthor=G.+Stegerauthor=W.+Kwasnyauthor=P.+Dubskyauthor=M.+Fridrikauthor=F.+Fitzalauthor=M.+Stiererauthor=E.+R%C3%BCcklingerauthor=R.+Greil&title=Endocrine+therapy+plus+zoledronic+acid+in+premenopaisal+breast+cancer&doi=10.1056%2FNEJMoa0806285"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Endocrine therapy plus zoledronic acid in premenopausal breast cancer</span></div><div class="casAuthors">Gnant, Michael; Mlineritsch, Brigitte; Schippinger, Walter; Luschin-Ebengreuth, Gero; Postlberger, Sabine; Menzel, Christian; Jakesz, Raimund; Seifert, Michael; Hubalek, Michael; Bjelic-Radisic, Vesna; Samonigg, Hellmut; Tausch, Christoph; Eidtmann, Holger; Steger, Gunther; Kwasny, Werner; Dubsky, Peter; Fridrik, Michael; Fitzal, Florian; Stierer, Michael; Rucklinger, Ernst; Greil, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">679-691</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Ovarian suppression plus tamoxifen is a std. adjuvant treatment in premenopausal women with endocrine-responsive breast cancer.  Aromatase inhibitors are superior to tamoxifen in postmenopausal patients, and preclin. data suggest that zoledronic acid has antitumor properties.  We examd. the effect of adding zoledronic acid to a combination of either goserelin and tamoxifen or goserelin and anastrozole in premenopausal women with endocrine-responsive early breast cancer.  We randomly assigned 1803 patients to receive goserelin (3.6 mg given s.c. every 28 days) plus tamoxifen (20 mg per day given orally) or anastrozole (1 mg per day given orally) with or without zoledronic acid (4 mg given i.v. every 6 mo) for 3 years.  The primary end point was disease-free survival; recurrence-free survival and overall survival were secondary end points.  After a median follow-up of 47.8 mo, 137 events had occurred, with disease-free survival rates of 92.8% in the tamoxifen group, 92.0% in the anastrozole group, 90.8% in the group that received endocrine therapy alone, and 94.0% in the group that received endocrine therapy with zoledronic acid.  There was no significant difference in disease-free survival between the anastrozole and tamoxifen groups (hazard ratio for disease progression in the anastrozole group, 1.10; 95% confidence interval [CI], 0.78 to 1.53; P = 0.59).  The addn. of zoledronic acid to endocrine therapy, as compared with endocrine therapy without zoledronic acid, resulted in an abs. redn. of 3.2 percentage points and a relative redn. of 36% in the risk of disease progression (hazard ratio, 0.64; 95% CI, 0.46 to 0.91; P = 0.01); the addn. of zoledronic acid did not significantly reduce the risk of death (hazard ratio, 0.60; 95% CI, 0.32 to 1.11; P = 0.11).  Adverse events were consistent with known drug-safety profiles.  The addn. of zoledronic acid to adjuvant endocrine therapy improves disease-free survival in premenopausal patients with estrogen-responsive early breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqWZL1vqoy7LVg90H21EOLACvtfcHk0lhBBHldP6CCbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVyisbk%253D&md5=f2c9103a7cfd4b4d14bf30f8a2e679d7</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0806285&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0806285%26sid%3Dliteratum%253Aachs%26aulast%3DGnant%26aufirst%3DM.%26aulast%3DMlineritsch%26aufirst%3DB.%26aulast%3DSchippinger%26aufirst%3DW.%26aulast%3DLuschin-Ebengreuth%26aufirst%3DG.%26aulast%3DP%25C3%25B6stlberger%26aufirst%3DS.%26aulast%3DMenzel%26aufirst%3DC.%26aulast%3DJakesz%26aufirst%3DR.%26aulast%3DSeifert%26aufirst%3DM.%26aulast%3DHubalek%26aufirst%3DM.%26aulast%3DBjelic-Radisic%26aufirst%3DV.%26aulast%3DSamonigg%26aufirst%3DH.%26aulast%3DTausch%26aufirst%3DC.%26aulast%3DEidtmann%26aufirst%3DH.%26aulast%3DSteger%26aufirst%3DG.%26aulast%3DKwasny%26aufirst%3DW.%26aulast%3DDubsky%26aufirst%3DP.%26aulast%3DFridrik%26aufirst%3DM.%26aulast%3DFitzal%26aufirst%3DF.%26aulast%3DStierer%26aufirst%3DM.%26aulast%3DR%25C3%25BCcklinger%26aufirst%3DE.%26aulast%3DGreil%26aufirst%3DR.%26atitle%3DEndocrine%2520therapy%2520plus%2520zoledronic%2520acid%2520in%2520premenopaisal%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D679%26epage%3D691%26doi%3D10.1056%2FNEJMoa0806285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidtmann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llombart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neven, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Minckwitz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleeboom, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forbes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrios, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frassoldati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paija, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Modi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundred, N.</span></span> <span> </span><span class="NLM_article-title">Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): 60-months results</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1093/annonc/mds277</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1093%2Fannonc%2Fmds277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=23047045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FjsFGjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=398-405&author=R.+Colemanauthor=R.+de+Boerauthor=H.+Eidtmannauthor=A.+Llombartauthor=N.+Davidsonauthor=P.+Nevenauthor=G.+von+Minckwitzauthor=H.+P.+Sleeboomauthor=J.+Forbesauthor=C.+Barriosauthor=A.+Frassoldatiauthor=I.+Campbellauthor=O.+Paijaauthor=N.+Martinauthor=A.+Modiauthor=N.+Bundred&title=Zoledronic+acid+%28zoledronate%29+for+postmenopausal+women+with+early+breast+cancer+receiving+adjuvant+letrozole+%28ZO-FAST+study%29%3A+60-months+results&doi=10.1093%2Fannonc%2Fmds277"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results</span></div><div class="casAuthors">Coleman R; de Boer R; Eidtmann H; Llombart A; Davidson N; Neven P; von Minckwitz G; Sleeboom H P; Forbes J; Barrios C; Frassoldati A; Campbell I; Paija O; Martin N; Modi A; Bundred N</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">398-405</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Aromatase inhibitors are the preferred adjuvant endocrine therapy for the majority of postmenopausal women with hormone-responsive early breast cancer.  Although generally more effective than tamoxifen, aromatase inhibitor therapy is associated with increased bone loss and fracture risk.  PATIENTS AND METHODS:  Postmenopausal women receiving adjuvant letrozole (2.5 mg/day for 5 years; N = 1065) were randomly assigned to immediate zoledronic acid (zoledronate) 4 mg every 6 months for 5 years, or delayed zoledronate (initiated for fracture or on-study bone mineral density [BMD] decrease).  The primary end point was the change in lumbar spine BMD at 12 months.  Lumbar spine and total hip BMD at subsequent follow-up, disease-free survival (DFS), and overall survival were assessed as secondary end points.  RESULTS:  At 60 months (final analysis), the mean change in lumbar spine BMD was +4.3% with immediate zoledronate and -5.4% with delayed intervention (P < 0.0001).  Immediate zoledronate reduced the risk of DFS events by 34% (hazard ratio [HR] = 0.66; P = 0.0375) with fewer local (0.9% versus 2.3%) and distant (5.5% versus 7.7%) recurrences versus delayed zoledronate.  In the delayed group, delayed initiation of zoledronate substantially improved DFS versus no zoledronate (HR = 0.46; P = 0.0334).  CONCLUSIONS:  Immediate zoledronate in postmenopausal women receiving letrozole preserved BMD and is associated with improved DFS compared with letrozole alone.  Clinical Trials Registration No NCT00171340.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSrF__4n9ssxlHFYivNCdPRfW6udTcc2eYugxJv0W-bpbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FjsFGjsg%253D%253D&md5=8c3ee5dd7ea24a157be353eca918044e</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmds277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmds277%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DR.%26aulast%3Dde%2BBoer%26aufirst%3DR.%26aulast%3DEidtmann%26aufirst%3DH.%26aulast%3DLlombart%26aufirst%3DA.%26aulast%3DDavidson%26aufirst%3DN.%26aulast%3DNeven%26aufirst%3DP.%26aulast%3Dvon%2BMinckwitz%26aufirst%3DG.%26aulast%3DSleeboom%26aufirst%3DH.%2BP.%26aulast%3DForbes%26aufirst%3DJ.%26aulast%3DBarrios%26aufirst%3DC.%26aulast%3DFrassoldati%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DI.%26aulast%3DPaija%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DN.%26aulast%3DModi%26aufirst%3DA.%26aulast%3DBundred%26aufirst%3DN.%26atitle%3DZoledronic%2520acid%2520%2528zoledronate%2529%2520for%2520postmenopausal%2520women%2520with%2520early%2520breast%2520cancer%2520receiving%2520adjuvant%2520letrozole%2520%2528ZO-FAST%2520study%2529%253A%252060-months%2520results%26jtitle%3DAnn.%2520Oncol.%26date%3D2013%26volume%3D24%26spage%3D398%26epage%3D405%26doi%3D10.1093%2Fannonc%2Fmds277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotesta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzinzik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellé, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bitsch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roddy, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, J. R.</span></span> <span> </span><span class="NLM_article-title">Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">660</span>– <span class="NLM_lpage">666</span>, <span class="refDoi"> DOI: 10.1038/nchembio.421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1038%2Fnchembio.421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=20711197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVaisLzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=660-666&author=W.+Jahnkeauthor=J.-M.+Rondeauauthor=S.+Cotestaauthor=A.+Marzinzikauthor=X.+Pell%C3%A9author=M.+Geiserauthor=A.+Straussauthor=M.+G%C3%B6tteauthor=F.+Bitschauthor=R.+Hemmigauthor=C.+Henryauthor=S.+Lehmannauthor=J.+F.+Glickmanauthor=T.+P.+Roddyauthor=S.+J.+Stoutauthor=J.+R.+Green&title=Allosteric+non-bisphosphonate+FPPS+inhibitors+identified+by+fragment-based+discovery&doi=10.1038%2Fnchembio.421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery</span></div><div class="casAuthors">Jahnke, Wolfgang; Rondeau, Jean-Michel; Cotesta, Simona; Marzinzik, Andreas; Pelle, Xavier; Geiser, Martin; Strauss, Andre; Goette, Marjo; Bitsch, Francis; Hemmig, Rene; Henry, Chrystele; Lehmann, Sylvie; Glickman, J. Fraser; Roddy, Thomas P.; Stout, Steven J.; Green, Jonathan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">660-666</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bisphosphonates are potent inhibitors of farnesyl pyrophosphate synthase (FPPS) and are highly efficacious in the treatment of bone diseases such as osteoporosis, Paget's disease and tumor-induced osteolysis.  In addn., the potential for direct antitumor effects has been postulated on the basis of in vitro and in vivo studies and has recently been demonstrated clin. in early breast cancer patients treated with the potent bisphosphonate zoledronic acid.  However, the high affinity of bisphosphonates for bone mineral seems suboptimal for the direct treatment of soft-tissue tumors.  Here we report the discovery of the first potent non-bisphosphonate FPPS inhibitors.  These new inhibitors bind to a previously unknown allosteric site on FPPS, which was identified by fragment-based approaches using NMR and X-ray crystallog.  This allosteric and druggable pocket allows the development of a new generation of FPPS inhibitors that are optimized for direct antitumor effects in soft tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZFyA6x-XeY7Vg90H21EOLACvtfcHk0lim6-IUbjXJTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVaisLzO&md5=72e1bc45a05733c2748a2138d0e0824f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.421%26sid%3Dliteratum%253Aachs%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DRondeau%26aufirst%3DJ.-M.%26aulast%3DCotesta%26aufirst%3DS.%26aulast%3DMarzinzik%26aufirst%3DA.%26aulast%3DPell%25C3%25A9%26aufirst%3DX.%26aulast%3DGeiser%26aufirst%3DM.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26aulast%3DBitsch%26aufirst%3DF.%26aulast%3DHemmig%26aufirst%3DR.%26aulast%3DHenry%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DS.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DRoddy%26aufirst%3DT.%2BP.%26aulast%3DStout%26aufirst%3DS.%2BJ.%26aulast%3DGreen%26aufirst%3DJ.%2BR.%26atitle%3DAllosteric%2520non-bisphosphonate%2520FPPS%2520inhibitors%2520identified%2520by%2520fragment-based%2520discovery%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D660%26epage%3D666%26doi%3D10.1038%2Fnchembio.421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielinski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghuis, A. M.</span></span> <span> </span><span class="NLM_article-title">Human farnesyl pyrophosphate synthase is allosterically inhibited by its own preoducts</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">14132</span>, <span class="refDoi"> DOI: 10.1038/ncomms14132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1038%2Fncomms14132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=28098152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=14132&author=J.+Parkauthor=M.+Zielinskiauthor=A.+Magderauthor=Y.+S.+Tsantrizosauthor=A.+M.+Berghuis&title=Human+farnesyl+pyrophosphate+synthase+is+allosterically+inhibited+by+its+own+preoducts&doi=10.1038%2Fncomms14132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Human farnesyl pyrophosphate synthase is allosterically inhibited by its own product</span></div><div class="casAuthors">Park, Jaeok; Zielinski, Michal; Magder, Alexandr; Tsantrizos, Youla S.; Berghuis, Albert M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14132</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Farnesyl pyrophosphate synthase (FPPS) is an enzyme of the mevalonate pathway and a well-established therapeutic target.  Recent research has focused around a newly identified druggable pocket near the enzyme's active site.  Pharmacol. exploitation of this pocket is deemed promising; however, its natural biol. function, if any, is yet unknown.  Here we report that the product of FPPS, farnesyl pyrophosphate (FPP), can bind to this pocket and lock the enzyme in an inactive state.  The Kd for this binding is 5-6 μM, within a catalytically relevant range.  These results indicate that FPPS activity is sensitive to the product concn.  Kinetic anal. shows that the enzyme is inhibited through FPP accumulation.  Having a specific physiol. effector, FPPS is a bona fide allosteric enzyme.  This allostery offers an exquisite mechanism for controlling prenyl pyrophosphate levels in vivo and thus contributes an addnl. layer of regulation to the mevalonate pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpnTdH3Q0qYrVg90H21EOLACvtfcHk0lh39K_O-fL6xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlarsrg%253D&md5=a3042ec22d74c2c53aa806a52d37c4b3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fncomms14132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms14132%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DZielinski%26aufirst%3DM.%26aulast%3DMagder%26aufirst%3DA.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBerghuis%26aufirst%3DA.%2BM.%26atitle%3DHuman%2520farnesyl%2520pyrophosphate%2520synthase%2520is%2520allosterically%2520inhibited%2520by%2520its%2520own%2520preoducts%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D14132%26doi%3D10.1038%2Fncomms14132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">De Schutter, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gormley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghuis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span> <span> </span><span class="NLM_article-title">Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5764</span>– <span class="NLM_lpage">5776</span>, <span class="refDoi"> DOI: 10.1021/jm500629e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500629e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsVegtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5764-5776&author=J.+W.+De+Schutterauthor=J.+Parkauthor=C.+Y.+Leungauthor=P.+Gormleyauthor=Y.-S.+Linauthor=Z.+Huauthor=A.+M.+Berghuisauthor=J.+Poirierauthor=Y.+S.+Tsantrizos&title=Multistage+screening+reveals+chameleon+ligands+of+the+human+farnesyl+pyrophosphate+synthase%3A+implications+to+drug+discovery+for+neurodegenerative+diseases&doi=10.1021%2Fjm500629e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Multistage Screening Reveals Chameleon Ligands of the Human Farnesyl Pyrophosphate Synthase: Implications to Drug Discovery for Neurodegenerative Diseases</span></div><div class="casAuthors">De Schutter, Joris W.; Park, Jaeok; Leung, Chun Yuen; Gormley, Patrick; Lin, Yih-Shyan; Hu, Zheping; Berghuis, Albert M.; Poirier, Judes; Tsantrizos, Youla S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5764-5776</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human farnesyl pyrophosphate synthase (hFPPS) is the gate-keeper of mammalian isoprenoids and the key target of bisphosphonate drugs.  Bisphosphonates suffer from poor "drug-like" properties and are mainly effective in treating skeletal diseases.  Recent investigations have implicated hFPPS in various nonskeletal diseases, including Alzheimer's disease (AD).  Anal. of single nucleotide polymorphisms in the hFPPS gene and mRNA levels in autopsy-confirmed AD subjects was undertaken, and a genetic link between hFPPS and phosphorylated tau (P-Tau) levels in the human brain was identified.  Elevated P-Tau levels are strongly implicated in AD progression.  The development of nonbisphosphonate inhibitors can provide mol. tools for validating hFPPS as a therapeutic target for tauopathy-assocd. neurodegeneration.  A multistage screening protocol led to the identification of a new monophosphonate chemotype that bind in an allosteric pocket of hFPPS.  Optimization of these compds. could lead to human therapeutics that block tau metab. and arrest the progression of neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrenHVATZq2I7Vg90H21EOLACvtfcHk0ljxgdlzoegZzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsVegtLo%253D&md5=b54b5f0f17e867c4c8707e3d58f26eab</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm500629e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500629e%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSchutter%26aufirst%3DJ.%2BW.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DC.%2BY.%26aulast%3DGormley%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DY.-S.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DBerghuis%26aufirst%3DA.%2BM.%26aulast%3DPoirier%26aufirst%3DJ.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DMultistage%2520screening%2520reveals%2520chameleon%2520ligands%2520of%2520the%2520human%2520farnesyl%2520pyrophosphate%2520synthase%253A%2520implications%2520to%2520drug%2520discovery%2520for%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5764%26epage%3D5776%26doi%3D10.1021%2Fjm500629e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gritzalis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Schutter, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacbay, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zielinski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghuis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span> <span> </span><span class="NLM_article-title">Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1117</span>– <span class="NLM_lpage">1123</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.12.089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.bmcl.2014.12.089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=25630225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFCjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1117-1123&author=D.+Gritzalisauthor=J.+Parkauthor=W.+Chiuauthor=H.+Choauthor=Y.-S.+Linauthor=J.+W.+De+Schutterauthor=C.+M.+Lacbayauthor=M.+Zielinskiauthor=A.+M.+Berghuisauthor=Y.+S.+Tsantrizos&title=Probing+the+molecular+and+structural+elements+of+ligands+binding+to+the+active+site+versus+an+allosteric+pocket+of+the+human+farnesyl+pyrophosphate+synthase&doi=10.1016%2Fj.bmcl.2014.12.089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase</span></div><div class="casAuthors">Gritzalis, Dimitrios; Park, Jaeok; Chiu, Wei; Cho, Hyungjun; Lin, Yih-Shyan; De Schutter, Joris W.; Lacbay, Cyrus M.; Zielinski, Michal; Berghuis, Albert M.; Tsantrizos, Youla S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1117-1123</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to explore the interactions of bisphosphonate ligands with the active site and an allosteric pocket of the human farnesyl pyrophosphate synthase (hFPPS), substituted indole and azabenzimidazole bisphosphonates were designed as chameleon ligands.  NMR and crystallog. studies revealed that these compds. can occupy both sub-pockets of the active site cavity, as well as the allosteric pocket of hFPPS in the presence of the enzyme's Mg2+ ion cofactor.  These results are consistent with the previously proposed hypothesis that the allosteric pocket of hFPPS, located near the active site, plays a feed-back regulatory role for this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEpiQoQXwNGrVg90H21EOLACvtfcHk0ljxgdlzoegZzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFCjtA%253D%253D&md5=403d943906ea071b3b50dc2e97314ecd</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.089%26sid%3Dliteratum%253Aachs%26aulast%3DGritzalis%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DChiu%26aufirst%3DW.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DY.-S.%26aulast%3DDe%2BSchutter%26aufirst%3DJ.%2BW.%26aulast%3DLacbay%26aufirst%3DC.%2BM.%26aulast%3DZielinski%26aufirst%3DM.%26aulast%3DBerghuis%26aufirst%3DA.%2BM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DProbing%2520the%2520molecular%2520and%2520structural%2520elements%2520of%2520ligands%2520binding%2520to%2520the%2520active%2520site%2520versus%2520an%2520allosteric%2520pocket%2520of%2520the%2520human%2520farnesyl%2520pyrophosphate%2520synthase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1117%26epage%3D1123%26doi%3D10.1016%2Fj.bmcl.2014.12.089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marzinzik, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amstutz, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bold, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgier, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotesta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glickman, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwieg, J. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ofner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellé, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roddy, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondeau, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stauffer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel allosteric non-bisphosphonate inhibitors of farnesyl pyrophosphate synthase by integrated lead finding</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1884</span>– <span class="NLM_lpage">1891</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fcmdc.201500338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=26381451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWlsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1884-1891&author=A.+L.+Marzinzikauthor=R.+Amstutzauthor=G.+Boldauthor=E.+Bourgierauthor=S.+Cotestaauthor=J.+F.+Glickmanauthor=M.+G%C3%B6tteauthor=C.+Henryauthor=S.+Lehmannauthor=J.+C.+D.+Hartwiegauthor=S.+Ofnerauthor=X.+Pell%C3%A9author=T.+P.+Roddyauthor=J.-M.+Rondeauauthor=F.+Staufferauthor=S.+J.+Stoutauthor=A.+Widmerauthor=J.+Zimmermannauthor=T.+Zollerauthor=W.+Jahnke&title=Discovery+of+novel+allosteric+non-bisphosphonate+inhibitors+of+farnesyl+pyrophosphate+synthase+by+integrated+lead+finding&doi=10.1002%2Fcmdc.201500338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead Finding</span></div><div class="casAuthors">Marzinzik, Andreas L.; Amstutz, Rene; Bold, Guido; Bourgier, Emmanuelle; Cotesta, Simona; Glickman, J. Fraser; Goette, Marjo; Henry, Christelle; Lehmann, Sylvie; Hartwieg, J. Constanze D.; Ofner, Silvio; Pelle, Xavier; Roddy, Thomas P.; Rondeau, Jean-Michel; Stauffer, Frederic; Stout, Steven J.; Widmer, Armin; Zimmermann, Johann; Zoller, Thomas; Jahnke, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1884-1891</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Farnesyl pyrophosphate synthase (FPPS) is an established target for the treatment of bone diseases, but also shows promise as an anticancer and anti-infective drug target.  Currently available anti-FPPS drugs are active-site-directed bisphosphonate inhibitors, the peculiar pharmacol. profile of which is inadequate for therapeutic indications beyond bone diseases.  The recent discovery of an allosteric binding site has paved the way toward the development of novel non-bisphosphonate FPPS inhibitors with broader therapeutic potential, notably as immunomodulators in oncol.  Herein we report the discovery, by an integrated lead finding approach, of two new chem. classes of allosteric FPPS inhibitors that belong to the salicylic acid and quinoline chemotypes.  We present their synthesis, biochem. and cellular activities, structure-activity relationships, and provide X-ray structures of several representative FPPS complexes.  These novel allosteric FPPS inhibitors are devoid of any affinity for bone mineral and could serve as leads to evaluate their potential in none-bone diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAr9SoyVzuV7Vg90H21EOLACvtfcHk0liB1T-U4P5rUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWlsLnP&md5=a32eb3354fc3a50e6e0cfedc25a31d15</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500338%26sid%3Dliteratum%253Aachs%26aulast%3DMarzinzik%26aufirst%3DA.%2BL.%26aulast%3DAmstutz%26aufirst%3DR.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DBourgier%26aufirst%3DE.%26aulast%3DCotesta%26aufirst%3DS.%26aulast%3DGlickman%26aufirst%3DJ.%2BF.%26aulast%3DG%25C3%25B6tte%26aufirst%3DM.%26aulast%3DHenry%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DS.%26aulast%3DHartwieg%26aufirst%3DJ.%2BC.%2BD.%26aulast%3DOfner%26aufirst%3DS.%26aulast%3DPell%25C3%25A9%26aufirst%3DX.%26aulast%3DRoddy%26aufirst%3DT.%2BP.%26aulast%3DRondeau%26aufirst%3DJ.-M.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DStout%26aufirst%3DS.%2BJ.%26aulast%3DWidmer%26aufirst%3DA.%26aulast%3DZimmermann%26aufirst%3DJ.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DJahnke%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520novel%2520allosteric%2520non-bisphosphonate%2520inhibitors%2520of%2520farnesyl%2520pyrophosphate%2520synthase%2520by%2520integrated%2520lead%2520finding%26jtitle%3DChemMedChem%26date%3D2015%26volume%3D10%26spage%3D1884%26epage%3D1891%26doi%3D10.1002%2Fcmdc.201500338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldfield, E.</span></span> <span> </span><span class="NLM_article-title">Farnesyl diphosphate synthase inhibitors with unique ligand-binding geometries</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1021/ml500528x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500528x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVeisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=349-354&author=Y.-L.+Liuauthor=R.+Caoauthor=Y.+Wangauthor=E.+Oldfield&title=Farnesyl+diphosphate+synthase+inhibitors+with+unique+ligand-binding+geometries&doi=10.1021%2Fml500528x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Farnesyl Diphosphate Synthase Inhibitors With Unique Ligand-Binding Geometries</span></div><div class="casAuthors">Liu, Yi-Liang; Cao, Rong; Wang, Yang; Oldfield, Eric</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-354</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Farnesyl diphosphate synthase (FPPS) is an important drug target for bone resorption, cancer, and some infectious diseases.  Here, we report five new structures including two having unique bound ligand geometries.  The diamidine inhibitor 7 binds to human FPPS close to the homoallylic (S2) and allosteric (S3) sites and extends into a new site, here called S4.  With the bisphosphonate inhibitor 8, two mols. bind to Trypanosoma brucei FPPS, one mol. in the allylic site (S1) and the other close to S2, the first observation of two bisphosphonate mols. bound to FPPS.  We also report the structures of apo-FPPS from T. brucei, together with two more bisphosphonate-bound structures (2,9), for purposes of comparison.  The diamidine structure is of particular interest because 7 could represent a new lead for lipophilic FPPS inhibitors, while 8 has low micromolar activity against T. brucei, the causative agent of human African trypanosomiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLFB2f4Alhi7Vg90H21EOLACvtfcHk0liB1T-U4P5rUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVeisb8%253D&md5=d531c00b4e036e8b7f39dafa6476ba46</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1021%2Fml500528x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500528x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.-L.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DOldfield%26aufirst%3DE.%26atitle%3DFarnesyl%2520diphosphate%2520synthase%2520inhibitors%2520with%2520unique%2520ligand-binding%2520geometries%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D349%26epage%3D354%26doi%3D10.1021%2Fml500528x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matralis, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacbay, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsakos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández De Troconiz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berghuis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span> <span> </span><span class="NLM_article-title">Pharmacophore mapping of thienopyrimidine-based monophosphonate (ThP-MP) inhibitors of the human farnesyl pyrophosphate synthase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2119</span>– <span class="NLM_lpage">2134</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01888</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01888" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivFSru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2119-2134&author=J.+Parkauthor=C.+Y.+Leungauthor=A.+N.+Matralisauthor=C.+M.+Lacbayauthor=M.+Tsakosauthor=G.+Fern%C3%A1ndez+De+Troconizauthor=A.+M.+Berghuisauthor=Y.+S.+Tsantrizos&title=Pharmacophore+mapping+of+thienopyrimidine-based+monophosphonate+%28ThP-MP%29+inhibitors+of+the+human+farnesyl+pyrophosphate+synthase&doi=10.1021%2Facs.jmedchem.6b01888"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore Mapping of Thienopyrimidine-Based Monophosphonate (ThP-MP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase</span></div><div class="casAuthors">Park, Jaeok; Leung, Chun Yuen; Matralis, Alexios N.; Lacbay, Cyrus M.; Tsakos, Michail; Fernandez De Troconiz, Guillermo; Berghuis, Albert M.; Tsantrizos, Youla S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2119-2134</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The human farnesyl pyrophosphate synthase (hFPPS), a key regulatory enzyme in the mevalonate pathway, catalyzes the biosynthesis of the C-15 isoprenoid farnesyl pyrophosphate (FPP).  FPP plays a crucial role in the post-translational prenylation of small GTPases that perform a plethora of cellular functions.  Although hFPPS is a well-established therapeutic target for lytic bone diseases, the currently available bisphosphonate drugs exhibit poor cellular uptake and distribution into non-skeletal tissues.  Recent drug discovery efforts have focused primarily on allosteric inhibition of hFPPS and the discovery of non-bisphosphonate drugs for potentially treating non-skeletal diseases.  Hit-to-lead optimization of a new series of thienopyrimidine-based monosphosphonates (ThP-MPs) led to the identification of analogs with nanomolar potency in inhibiting hFPPS.  Their interactions with the allosteric pocket of the enzyme were characterized by crystallog. and the results provide further insight into the pharmacophore requirements for allosteric inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyhrW7fwd66bVg90H21EOLACvtfcHk0liB1T-U4P5rUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivFSru74%253D&md5=ac44083a7b20a199cd1cfb59bec71be1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01888%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DC.%2BY.%26aulast%3DMatralis%26aufirst%3DA.%2BN.%26aulast%3DLacbay%26aufirst%3DC.%2BM.%26aulast%3DTsakos%26aufirst%3DM.%26aulast%3DFern%25C3%25A1ndez%2BDe%2BTroconiz%26aufirst%3DG.%26aulast%3DBerghuis%26aufirst%3DA.%2BM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DPharmacophore%2520mapping%2520of%2520thienopyrimidine-based%2520monophosphonate%2520%2528ThP-MP%2529%2520inhibitors%2520of%2520the%2520human%2520farnesyl%2520pyrophosphate%2520synthase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2119%26epage%3D2134%26doi%3D10.1021%2Facs.jmedchem.6b01888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span> For a recent review see:<span class="NLM_contrib-group"><span class="NLM_string-name">Mucha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kafarski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berlicki, Ł.</span></span> <span> </span><span class="NLM_article-title">Remarkable potential of the α-aminophosphonate/phosphinate structural motif in medicinal chemistry</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">5955</span>– <span class="NLM_lpage">5980</span>, <span class="refDoi"> DOI: 10.1021/jm200587f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200587f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVWlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5955-5980&author=A.+Muchaauthor=P.+Kafarskiauthor=%C5%81.+Berlicki&title=Remarkable+potential+of+the+%CE%B1-aminophosphonate%2Fphosphinate+structural+motif+in+medicinal+chemistry&doi=10.1021%2Fjm200587f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry</span></div><div class="casAuthors">Mucha, Artur; Kafarski, Pawel; Berlicki, Lukasz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5955-5980</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Potential of the α-aminophosphonate/phosphinate structural motif in medicinal chem. is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPPeUBOTalirVg90H21EOLACvtfcHk0liB1T-U4P5rUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVWlsrs%253D&md5=0683f7f9ff6269b7d93ee27e623c21c5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm200587f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200587f%26sid%3Dliteratum%253Aachs%26aulast%3DMucha%26aufirst%3DA.%26aulast%3DKafarski%26aufirst%3DP.%26aulast%3DBerlicki%26aufirst%3D%25C5%2581.%26atitle%3DRemarkable%2520potential%2520of%2520the%2520%25CE%25B1-aminophosphonate%252Fphosphinate%2520structural%2520motif%2520in%2520medicinal%2520chemistry%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5955%26epage%3D5980%26doi%3D10.1021%2Fjm200587f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pompei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Francesco, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liverton, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summa, V.</span></span> <span> </span><span class="NLM_article-title">Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2574</span>– <span class="NLM_lpage">2578</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.03.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.bmcl.2009.03.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=19328685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslyiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2574-2578&author=M.+Pompeiauthor=M.+E.+Di+Francescoauthor=U.+Kochauthor=N.+J.+Livertonauthor=V.+Summa&title=Phosphorous+acid+analogs+of+novel+P2-P4+macrocycles+as+inhibitors+of+HCV-NS3+protease&doi=10.1016%2Fj.bmcl.2009.03.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease</span></div><div class="casAuthors">Pompei, Marco; Di Francesco, Maria Emilia; Koch, Uwe; Liverton, Nigel J.; Summa, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2574-2578</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HCV-NS3 protease is essential for viral replication and NS3 protease inhibitors have shown proof of concept in clin. trials.  Novel P2-P4 macrocycle inhibitors of NS3/4A comprising a P1 C-terminal carboxylic acid have recently been disclosed.  A series of analogs, in which the carboxylic residue is replaced by phosphorous acid functionalities were synthesized and inhibitors of the NS3 protease.  Among them the methylphosphinate analog showed nanomolar level of enzyme inhibition and sub-micromolar potency in the replication assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF5paPaPlwc7Vg90H21EOLACvtfcHk0lgKJC-YHfd5Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslyiu70%253D&md5=beab4e3f05a3497e4e5ae7ee78df2ed5</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.03.038%26sid%3Dliteratum%253Aachs%26aulast%3DPompei%26aufirst%3DM.%26aulast%3DDi%2BFrancesco%26aufirst%3DM.%2BE.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DSumma%26aufirst%3DV.%26atitle%3DPhosphorous%2520acid%2520analogs%2520of%2520novel%2520P2-P4%2520macrocycles%2520as%2520inhibitors%2520of%2520HCV-NS3%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2574%26epage%3D2578%26doi%3D10.1016%2Fj.bmcl.2009.03.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pyun, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Synthesis and resolution of diethyl(1<i>S</i>,2<i>S</i>)-1-amino-2-vinylcyclopropane-1-phosphonate for HCV NS3 protease inhibitors</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3833</span>– <span class="NLM_lpage">3835</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2009.04.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.tetlet.2009.04.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtlKmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=3833-3835&author=H.-J.+Pyunauthor=K.+Chaudharyauthor=J.+R.+Somozaauthor=X.+C.+Shengauthor=C.+U.+Kim&title=Synthesis+and+resolution+of+diethyl%281S%2C2S%29-1-amino-2-vinylcyclopropane-1-phosphonate+for+HCV+NS3+protease+inhibitors&doi=10.1016%2Fj.tetlet.2009.04.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and resolution of diethyl (1S,2S)-1-amino-2-vinylcyclopropane-1-phosphonate for HCV NS3 protease inhibitors</span></div><div class="casAuthors">Pyun, Hyung-Jung; Chaudhary, Kleem; Somoza, John R.; Sheng, X. Christopher; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3833-3835</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The authors herein describe an efficient synthesis of optically active di-Et 1-amino-2-vinylcyclopropane-1-phosphonate (analogous to 1-amino-2-vinylcyclopropane-1-carboxylate).  The racemic phosphonate di-Et ester was obtained from an imine derived from aminomethylphosphonate diester and trans-1,4-dibromo-2-butene.  Crystns. of the dibenzoyl-L-tartaric acid salt allowed for the sepn. of enantiomers.  The enantiomerically pure material was used to synthesize an extremely potent tripeptide phosphonate inhibitor of HCV NS3 protease.  X-ray crystal structure of the inhibitor bound to the HCV NS3 protease confirmed the abs. stereochem. of the title compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppj_DLTixJfLVg90H21EOLACvtfcHk0lgKJC-YHfd5Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtlKmsb4%253D&md5=f03f2de96dbdae562db5f85c68011eb8</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.04.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.04.044%26sid%3Dliteratum%253Aachs%26aulast%3DPyun%26aufirst%3DH.-J.%26aulast%3DChaudhary%26aufirst%3DK.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSheng%26aufirst%3DX.%2BC.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DSynthesis%2520and%2520resolution%2520of%2520diethyl%25281S%252C2S%2529-1-amino-2-vinylcyclopropane-1-phosphonate%2520for%2520HCV%2520NS3%2520protease%2520inhibitors%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D3833%26epage%3D3835%26doi%3D10.1016%2Fj.tetlet.2009.04.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyun, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaudhary, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleury, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMurtrie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaney, W. E.,  IV</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. U.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3453</span>– <span class="NLM_lpage">3457</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1016%2Fj.bmcl.2009.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=19477126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvFGju7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3453-3457&author=X.+C.+Shengauthor=H.-J.+Pyunauthor=K.+Chaudharyauthor=J.+Wangauthor=E.+Doerfflerauthor=M.+Fleuryauthor=D.+McMurtrieauthor=X.+Chenauthor=W.+E.+Delaneyauthor=C.+U.+Kim&title=Discovery+of+novel+phosphonate+derivatives+as+hepatitis+C+virus+NS3+protease+inhibitors&doi=10.1016%2Fj.bmcl.2009.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors</span></div><div class="casAuthors">Sheng, X. Christopher; Pyun, Hyung-Jung; Chaudhary, Kleem; Wang, Jianying; Doerffler, Edward; Fleury, Melissa; McMurtrie, Darren; Chen, Xiaowu; Delaney, William E.; Kim, Choung U.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3453-3457</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel class of phosphonate derivs. contg. amino acid and thiazolylquinoline units was designed to mimic the interaction of product-like carboxylate based inhibitors of HCV NS3 protease.  A phosphonic acid I was demonstrated to be a potent HCV NS3 protease inhibitor, and a potential candidate for treating HCV infection.  The syntheses and preliminary biol. evaluation of this phosphonate class of inhibitor are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJLUzzADl8_rVg90H21EOLACvtfcHk0lgKJC-YHfd5Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvFGju7Y%253D&md5=19903f9636361fe7603f51792bd5af2b</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DX.%2BC.%26aulast%3DPyun%26aufirst%3DH.-J.%26aulast%3DChaudhary%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DFleury%26aufirst%3DM.%26aulast%3DMcMurtrie%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DDelaney%26aufirst%3DW.%2BE.%26aulast%3DKim%26aufirst%3DC.%2BU.%26atitle%3DDiscovery%2520of%2520novel%2520phosphonate%2520derivatives%2520as%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3453%26epage%3D3457%26doi%3D10.1016%2Fj.bmcl.2009.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Burk, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammers, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straub, J. A.</span></span> <span> </span><span class="NLM_article-title">Enantioselective synthesis of α-hydroxy and α-amino phosphonates via catalytic asymmetric hydrogenation</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">387</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1021/ol9906099</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9906099" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADyaK1MXkt1SjtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1999&pages=387-390&author=M.+J.+Burkauthor=T.+A.+Stammersauthor=J.+A.+Straub&title=Enantioselective+synthesis+of+%CE%B1-hydroxy+and+%CE%B1-amino+phosphonates+via+catalytic+asymmetric+hydrogenation&doi=10.1021%2Fol9906099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective Synthesis of α-Hydroxy and α-Amino Phosphonates via Catalytic Asymmetric Hydrogenation</span></div><div class="casAuthors">Burk, Mark J.; Stammers, Timothy A.; Straub, Judith A.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">387-390</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cationic Rh catalysts of the C2 sym. DuPHOS (o-bis(2,5-R2-1-phospholidinyl)benzene; R = Me, Et, Pr, iPr) and BPE (1,2-bis(2,5-R2-1-phospholidinyl)ethane; R = Me, iPr) ligands demonstrated the ability to asym. hydrogenate enol phosphonates, e.g. (MeO)2P(O)C(OBz):CH2, in good to excellent enantiomeric excess under mild conditions.  Initial studies toward the catalytic asym. hydrogenation of enamido phosphonates, e.g. (MeO)2P(O)C(NHAc):CH2, using the DuPHOS-Rh+ catalysts are also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkGWm4Sk13vrVg90H21EOLACvtfcHk0lgIEtEgO3TEvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkt1SjtLY%253D&md5=92cba8ba4963fcfd58a56b9fb5d5af40</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fol9906099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9906099%26sid%3Dliteratum%253Aachs%26aulast%3DBurk%26aufirst%3DM.%2BJ.%26aulast%3DStammers%26aufirst%3DT.%2BA.%26aulast%3DStraub%26aufirst%3DJ.%2BA.%26atitle%3DEnantioselective%2520synthesis%2520of%2520%25CE%25B1-hydroxy%2520and%2520%25CE%25B1-amino%2520phosphonates%2520via%2520catalytic%2520asymmetric%2520hydrogenation%26jtitle%3DOrg.%2520Lett.%26date%3D1999%26volume%3D1%26spage%3D387%26epage%3D390%26doi%3D10.1021%2Fol9906099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, Z.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Z.</span></span> <span> </span><span class="NLM_article-title">Modular phosphine-aminophosphine ligands based on chiral 1,2,3,4-tetrahydro-1-naphthyamine backbone: a new class of practical ligands for enantioselective hydrogenations</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">2683</span>– <span class="NLM_lpage">2689</span>, <span class="refDoi"> DOI: 10.1002/adsc.200800418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fadsc.200800418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFSntrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2008&pages=2683-2689&author=M.+Qiuauthor=X.-P.+Huauthor=J.-D.+Huangauthor=D.-Y.+Wangauthor=J.+Dengauthor=S.-B.+Yuauthor=Z.-C.+Duanauthor=Z.+Zheng&title=Modular+phosphine-aminophosphine+ligands+based+on+chiral+1%2C2%2C3%2C4-tetrahydro-1-naphthyamine+backbone%3A+a+new+class+of+practical+ligands+for+enantioselective+hydrogenations&doi=10.1002%2Fadsc.200800418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Modular phosphine-aminophosphine ligands based on chiral 1,2,3,4-tetrahydro-1-naphthylamine backbone: a new class of practical ligands for enantioselective hydrogenations</span></div><div class="casAuthors">Qiu, Min; Hu, Xiang-Ping; Huang, Jia-Di; Wang, Dao-Yong; Deng, Jun; Yu, Sai-Bo; Duan, Zheng-Chao; Zheng, Zhuo</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2683-2689</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">New chiral phosphine-aminophosphine ligands [(R)-HW-Phos] were prepd. from (R)-1,2,3,4-tetrahydro-1-naphthylamine through a two-step procedure, and successfully applied in the Rh-catalyzed asym. hydrogenation of various functionalized olefins such as α-enol ester phosphonates, α-enamido phosphonates, (Z)-β-(acylamino)acrylates and so on.  Excellent enantioselectivities were achieved in the hydrogenation of most substrates tested, demonstrating the high potential of these newly developed phosphine-aminophosphine ligands in asym. catalysis.  The present research also discloses that these newly developed phosphine-aminophosphine ligands are more efficient than that derived from (S)-1-phenylethylamine, suggesting that the increased rigidity conferred by a cyclohexyl fragment in these phosphine-aminophosphine ligands has a pos. effect in the asym. induction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNtuTAJkoWErVg90H21EOLACvtfcHk0lgIEtEgO3TEvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFSntrvN&md5=78d6eaa462c2f66240fb4b8b3590e930</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1002%2Fadsc.200800418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.200800418%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DX.-P.%26aulast%3DHuang%26aufirst%3DJ.-D.%26aulast%3DWang%26aufirst%3DD.-Y.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.-B.%26aulast%3DDuan%26aufirst%3DZ.-C.%26aulast%3DZheng%26aufirst%3DZ.%26atitle%3DModular%2520phosphine-aminophosphine%2520ligands%2520based%2520on%2520chiral%25201%252C2%252C3%252C4-tetrahydro-1-naphthyamine%2520backbone%253A%2520a%2520new%2520class%2520of%2520practical%2520ligands%2520for%2520enantioselective%2520hydrogenations%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2008%26volume%3D350%26spage%3D2683%26epage%3D2689%26doi%3D10.1002%2Fadsc.200800418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span> <span> </span><span class="NLM_article-title">Asymmetric hydrogenation of α- and β-enamido phosphonates: rhodium(I)/monodentate phosphoramidite catalyst</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">11743</span>– <span class="NLM_lpage">11747</span>, <span class="refDoi"> DOI: 10.1002/anie.201104912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fanie.201104912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12qtrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=11743-11747&author=J.+Zhangauthor=Y.+Liauthor=Z.+Wangauthor=K.+Ding&title=Asymmetric+hydrogenation+of+%CE%B1-+and+%CE%B2-enamido+phosphonates%3A+rhodium%28I%29%2Fmonodentate+phosphoramidite+catalyst&doi=10.1002%2Fanie.201104912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric hydrogenation of α- and β-enamido phosphonates: rhodium(I)/monodentate phosphoramidite catalyst</span></div><div class="casAuthors">Zhang, Jinzhu; Li, Yang; Wang, Zheng; Ding, Kuiling</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">11743-11747, S11743/1-S11743/92</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Chiral α- and β-aminophosphonates RCH2CH(NHR1)PO(O)(OR)2 (2a-e, R1 = PhCO, R = 4-halophenyl; 4a-o, R1 = Cbz, R = substituted Ph, piperonyl, 2-naphthyl, 2-thienyl, cyclohexyl, alkyl) and RCH(NHPG)CH2P(O)(OEt)2 (PG = PhCO, MeCO; R = halophenyl, 2-naphthyl, 3-thienyl, cyclohexyl, 2-pyridyl, tolyl) were prepd. by asym. hydrogenation of the corresponding unsatd. phosphonates RCH:C(NHR1)PO(O)(OR)2 and RC(NHPG):CHP(O)(OEt)2 at ambient conditions catalyzed by rhodium cyclic phosphoramidite systems, Rh/Ln (Ln shown as I, R1-R3 = PhCH2, Me, H, iPr).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH41BwCIEGo7Vg90H21EOLACvtfcHk0lgIEtEgO3TEvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12qtrrM&md5=a7925931de3c085d2570a105c73a3722</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1002%2Fanie.201104912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201104912%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DAsymmetric%2520hydrogenation%2520of%2520%25CE%25B1-%2520and%2520%25CE%25B2-enamido%2520phosphonates%253A%2520rhodium%2528I%2529%252Fmonodentate%2520phosphoramidite%2520catalyst%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2011%26volume%3D50%26spage%3D11743%26epage%3D11747%26doi%3D10.1002%2Fanie.201104912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.-G.</span></span> <span> </span><span class="NLM_article-title">Enantioselective synthesis of α-amino phosphonates via Pd-catalyzed asymmetric hydrogenation</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">695</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.5b03664</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.5b03664" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVynsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=692-695&author=Z.+Yanauthor=B.+Wuauthor=X.+Gaoauthor=M.-W.+Chenauthor=Y.-G.+Zhou&title=Enantioselective+synthesis+of+%CE%B1-amino+phosphonates+via+Pd-catalyzed+asymmetric+hydrogenation&doi=10.1021%2Facs.orglett.5b03664"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective Synthesis of α-Amino Phosphonates via Pd-Catalyzed Asymmetric Hydrogenation</span></div><div class="casAuthors">Yan, Zhong; Wu, Bo; Gao, Xiang; Chen, Mu-Wang; Zhou, Yong-Gui</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">692-695</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A highly enantioselective palladium-catalyzed hydrogenation of a series of linear and cyclic α-iminophosphonates has been achieved, providing efficient access to optically active α-aminophosphonates with up to 99% ee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Uh0L4-v01rVg90H21EOLACvtfcHk0lhVo2l0kTallQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVynsL4%253D&md5=7102c58194f26a5baa63d7b7f9343238</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.5b03664&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.5b03664%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DM.-W.%26aulast%3DZhou%26aufirst%3DY.-G.%26atitle%3DEnantioselective%2520synthesis%2520of%2520%25CE%25B1-amino%2520phosphonates%2520via%2520Pd-catalyzed%2520asymmetric%2520hydrogenation%26jtitle%3DOrg.%2520Lett.%26date%3D2016%26volume%3D18%26spage%3D692%26epage%3D695%26doi%3D10.1021%2Facs.orglett.5b03664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goulioukina, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shergold, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rybakov, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beletskaya, I. P.</span></span> <span> </span><span class="NLM_article-title">One-pot two-step synthesis of optically active α-aminophosphonates by palladium-catalyzed hydrogenation/hydrogenolysis of α-hydrazono phosphonates</span>. <i>Adv. Synth. Catal.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>359</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1002/adsc.201600945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fadsc.201600945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVGht7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2017&pages=153-162&author=N.+S.+Goulioukinaauthor=I.+A.+Shergoldauthor=V.+B.+Rybakovauthor=I.+P.+Beletskaya&title=One-pot+two-step+synthesis+of+optically+active+%CE%B1-aminophosphonates+by+palladium-catalyzed+hydrogenation%2Fhydrogenolysis+of+%CE%B1-hydrazono+phosphonates&doi=10.1002%2Fadsc.201600945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">One-Pot Two-Step Synthesis of Optically Active α-Amino Phosphonates by Palladium-Catalyzed Hydrogenation/Hydrogenolysis of α-Hydrazono Phosphonates</span></div><div class="casAuthors">Goulioukina, Nataliya S.; Shergold, Ilya A.; Rybakov, Victor B.; Beletskaya, Irina P.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Synthesis & Catalysis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">359</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-162</span>CODEN:
                <span class="NLM_cas:coden">ASCAF7</span>;
        ISSN:<span class="NLM_cas:issn">1615-4150</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">An efficient and convenient 1-pot procedure for the stereoselective catalytic synthesis of ring-substituted [amino(phenyl)methyl]phosphonates was developed.  The enantioselective hydrogenation of easily available diisopropyl (Z)-[aryl(phenylhydrazono)methyl]phosphonates using Pd(II) acetate as a precatalyst, (R)-2,2'-bis(diphenylphosphino)-5,5'-dichloro-6,6'-dimethoxy-1,1'-biphenyl [(R)-Cl-MeO-BIPHEP] as a ligand, and (1S)-(+)-10-camphorsulfonic acid as an activator in a mixt. of 2,2,2-trifluoroethanol and CH2Cl2 at ambient temp. gave corresponding [aryl(2-phenylhydrazino)methyl]phosphonates.  The subsequent cleavage of the N-N bond was accomplished with H2 after the addn. of Pd on C and MeOH into crude reaction mixt. to afford the optically active [amino(aryl)methyl]phosphonates.  The method is operationally simple and provides an appreciable enantioselectivity up to 98% ee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPkGWO1E-oxrVg90H21EOLACvtfcHk0lhVo2l0kTallQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVGht7nI&md5=aceb980169d5a33daa4ee37a7019d590</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fadsc.201600945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadsc.201600945%26sid%3Dliteratum%253Aachs%26aulast%3DGoulioukina%26aufirst%3DN.%2BS.%26aulast%3DShergold%26aufirst%3DI.%2BA.%26aulast%3DRybakov%26aufirst%3DV.%2BB.%26aulast%3DBeletskaya%26aufirst%3DI.%2BP.%26atitle%3DOne-pot%2520two-step%2520synthesis%2520of%2520optically%2520active%2520%25CE%25B1-aminophosphonates%2520by%2520palladium-catalyzed%2520hydrogenation%252Fhydrogenolysis%2520of%2520%25CE%25B1-hydrazono%2520phosphonates%26jtitle%3DAdv.%2520Synth.%2520Catal.%26date%3D2017%26volume%3D359%26spage%3D153%26epage%3D162%26doi%3D10.1002%2Fadsc.201600945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Joly, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, E. N.</span></span> <span> </span><span class="NLM_article-title">Thiourea-catalyzed enantioselective hydrophosphonylation of imines: practical access to enantiomerically enriched α-amino phosphonic acids</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">4102</span>– <span class="NLM_lpage">4103</span>, <span class="refDoi"> DOI: 10.1021/ja0494398</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0494398" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVals7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=4102-4103&author=G.+D.+Jolyauthor=E.+N.+Jacobsen&title=Thiourea-catalyzed+enantioselective+hydrophosphonylation+of+imines%3A+practical+access+to+enantiomerically+enriched+%CE%B1-amino+phosphonic+acids&doi=10.1021%2Fja0494398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Thiourea-Catalyzed Enantioselective Hydrophosphonylation of Imines: Practical Access to Enantiomerically Enriched α-Amino Phosphonic Acids</span></div><div class="casAuthors">Joly, Guy D.; Jacobsen, Eric N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4102-4103</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chiral thiourea (I) catalyzes the highly enantioselective hydrophosphonylation of a wide range of N-benzyl imines.  For example, (o-NO2C6H4CH2O)2P(O)H reacted with PhCH:NCH2Ph in the presence of I giving (o-NO2C6H4CH2O)2P(O)CH(Ph)NHCH2Ph (87% yield, 98% ee).  The hydrophosphonylation products are readily deprotected by hydrogenolysis, providing access to free α-amino phosphonic acids in highly enantioenriched form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqlGWeNIVz9LVg90H21EOLACvtfcHk0lhVo2l0kTallQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVals7o%253D&md5=c0c2502329be7c6020077a8191e412e6</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1021%2Fja0494398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0494398%26sid%3Dliteratum%253Aachs%26aulast%3DJoly%26aufirst%3DG.%2BD.%26aulast%3DJacobsen%26aufirst%3DE.%2BN.%26atitle%3DThiourea-catalyzed%2520enantioselective%2520hydrophosphonylation%2520of%2520imines%253A%2520practical%2520access%2520to%2520enantiomerically%2520enriched%2520%25CE%25B1-amino%2520phosphonic%2520acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26spage%3D4102%26epage%3D4103%26doi%3D10.1021%2Fja0494398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egami, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuki, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis of an optically active Al(salalen) complex and its application to catalytic hydrophosphonylation of aldehydes and aldimines</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">1978</span>– <span class="NLM_lpage">1986</span>, <span class="refDoi"> DOI: 10.1021/ja0651005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0651005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlemsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=1978-1986&author=B.+Saitoauthor=H.+Egamiauthor=T.+Katsuki&title=Synthesis+of+an+optically+active+Al%28salalen%29+complex+and+its+application+to+catalytic+hydrophosphonylation+of+aldehydes+and+aldimines&doi=10.1021%2Fja0651005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of an Optically Active Al(salalen) Complex and Its Application to Catalytic Hydrophosphonylation of Aldehydes and Aldimines</span></div><div class="casAuthors">Saito, Bunnai; Egami, Hiromichi; Katsuki, Tsutomu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1978-1986</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optically active aluminum(salalen) complex I was newly synthesized in a modular synthetic manner, and it was found to serve as an efficient catalyst for hydrophosphonylation of aldehydes and aldimines, giving the corresponding α-hydroxy and α-amino phosphonates with high enantioselectivity, resp.  Thus, I-catalyzed hydrophosphonylation of PhCHO in THF at -15° gave 87% (S)-PhCHOHP(O)(OMe)2 in 48h and 90% enantiomeric excess.  The scope of the hydrophosphonylation was wide, and both aliph. and arom. aldehydes and aldimines were successfully used as substrates for the reaction.  The potent catalysis of the complex is attributed to its unique structure: it adopts a distorted trigonal bipyramidal configuration which allows the salalen ligand to take a cis-β-like structure wherein the chiral amino group is located close to the metal center.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI6IdQ0gvDJLVg90H21EOLACvtfcHk0lhVo2l0kTallQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlemsb4%253D&md5=f1f5a02bfb9454f1828ebb3c4d553a2d</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1021%2Fja0651005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0651005%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DB.%26aulast%3DEgami%26aufirst%3DH.%26aulast%3DKatsuki%26aufirst%3DT.%26atitle%3DSynthesis%2520of%2520an%2520optically%2520active%2520Al%2528salalen%2529%2520complex%2520and%2520its%2520application%2520to%2520catalytic%2520hydrophosphonylation%2520of%2520aldehydes%2520and%2520aldimines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D1978%26epage%3D1986%26doi%3D10.1021%2Fja0651005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, B.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis and bioselective activities of α-aminophosphonates based on the dufulin motif</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">4207</span>– <span class="NLM_lpage">4213</span>, <span class="refDoi"> DOI: 10.1021/acs.jafc.6b01256</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jafc.6b01256" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsF2qtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2016&pages=4207-4213&author=G.+Zhangauthor=G.+Haoauthor=J.+Panauthor=J.+Zhangauthor=D.+Huauthor=B.+Song&title=Asymmetric+synthesis+and+bioselective+activities+of+%CE%B1-aminophosphonates+based+on+the+dufulin+motif&doi=10.1021%2Facs.jafc.6b01256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis and Bioselective Activities of α-Amino-phosphonates Based on the Dufulin Motif</span></div><div class="casAuthors">Zhang, Guoping; Hao, Gefei; Pan, Jianke; Zhang, Jian; Hu, Deyu; Song, Baoan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4207-4213</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The asym. synthesis of enantiomerically pure α-aminophosphonates with high and bioselective activities is a challenge.  Here, we report that both enantiomers of α-aminophosphonates bearing the N-benzothiazole moiety can be prepd. in high yields (up to 99%) and excellent enantioselectivities (up to 99% ee) by using chiral thiourea organocatalysts.  Evaluation of the antiviral activities of our reaction products against cucumber mosaic virus (CMV) led to promising hits with high and selective biol. activities, wherein (R)-enantiomers exhibit higher biol. activities than the corresponding (S)-enantiomers.  Esp., compd. (I) with excellent anti-CMV activity (curative activity, 72.3%; protection activity, 56.9%; and inactivation activity, 96.9%) at 500 μg/mL emerged as a potential inhibitor of the plant virus.  The difference in the selective bioactivity could be affected by the combination mode of the three-dimensional space between the enantiomers of α-aminophosphonate and cucumber mosaic virus coat protein (CMV-CP) via florescence spectroscopy and mol. docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqvkIetROq-rVg90H21EOLACvtfcHk0lg4wdulY4eGmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsF2qtrY%253D&md5=437a6e273c845af2110d19eadb55222b</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1021%2Facs.jafc.6b01256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jafc.6b01256%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DHao%26aufirst%3DG.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DSong%26aufirst%3DB.%26atitle%3DAsymmetric%2520synthesis%2520and%2520bioselective%2520activities%2520of%2520%25CE%25B1-aminophosphonates%2520based%2520on%2520the%2520dufulin%2520motif%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2016%26volume%3D64%26spage%3D4207%26epage%3D4213%26doi%3D10.1021%2Facs.jafc.6b01256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit15d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span> <span> </span><span class="NLM_article-title">Asymmetric synthesis of α-amino phosphonates by using cinchona alkaloids chiral phase transfer catalyst</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>2018</i></span>,  <span class="NLM_fpage">5422</span>– <span class="NLM_lpage">5426</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201801013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fejoc.201801013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVOrtbvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2018&publication_year=2018&pages=5422-5426&author=W.+Liauthor=Y.+Wangauthor=D.+Xu&title=Asymmetric+synthesis+of+%CE%B1-amino+phosphonates+by+using+cinchona+alkaloids+chiral+phase+transfer+catalyst&doi=10.1002%2Fejoc.201801013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15dR"><div class="casContent"><span class="casTitleNuber">15d</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric Synthesis of α-Amino Phosphonates by Using Cinchona Alkaloid-Based Chiral Phase Transfer Catalyst</span></div><div class="casAuthors">Li, Weihua; Wang, Yifeng; Xu, Danqian</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">2018</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">5422-5426</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A highly enantioselective nucleophilic addn. of phosphite esters to imines catalyzed by a chiral phase-transfer catalyst has been developed.  The process affords the hydrophosphonylation of imine products with quaternary stereocenters in good to high yields (up to 95 % yield) and excellent enantioselectivities (up to 99 % ee).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofCr0e4AZYSbVg90H21EOLACvtfcHk0lg4wdulY4eGmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVOrtbvL&md5=478b2d0d1aa6c295d68c60b240b080d0</span></div><a href="/servlet/linkout?suffix=cit15d&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201801013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201801013%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DD.%26atitle%3DAsymmetric%2520synthesis%2520of%2520%25CE%25B1-amino%2520phosphonates%2520by%2520using%2520cinchona%2520alkaloids%2520chiral%2520phase%2520transfer%2520catalyst%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2018%26volume%3D2018%26spage%3D5422%26epage%3D5426%26doi%3D10.1002%2Fejoc.201801013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">Transition-metal-free [3 + 2] cycloaddition of dehydroaminophosphonates and <i>N</i>-tosylhydrazones: access to aminocyclopropanephossphonates with ajacent quaternary tetrasubstituted carbon centers</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">12746</span>– <span class="NLM_lpage">12756</span>, <span class="refDoi"> DOI: 10.1021/acs.joc.7b01862</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.7b01862" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVejs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2017&pages=12746-12756&author=W.+Wuauthor=Z.+Linauthor=C.+Zhuauthor=P.+Chenauthor=J.+Liauthor=H.+Jiang&title=Transition-metal-free+%5B3+%2B+2%5D+cycloaddition+of+dehydroaminophosphonates+and+N-tosylhydrazones%3A+access+to+aminocyclopropanephossphonates+with+ajacent+quaternary+tetrasubstituted+carbon+centers&doi=10.1021%2Facs.joc.7b01862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Transition-Metal-Free [3+2] Cycloaddition of Dehydroaminophosphonates and N-Tosylhydrazones: Access to Aminocyclopropanephosphonates with Adjacent Quaternary-Tetrasubstituted Carbon Centers</span></div><div class="casAuthors">Wu, Wanqing; Lin, Zhiming; Zhu, Chuanle; Chen, Pengquan; Li, Jiawei; Jiang, Huanfeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">12746-12756</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel 1-step strategy for the synthesis of aminocyclopropanephosphonates contg. adjacent quaternary-tetrasubstituted C centers under transition-metal-free catalysis via [3 + 2] cycloaddn. process was developed.  Aminocyclopropanephosphonates with adjacent quaternary-tetrasubstituted C centers including spirocyclopropyl adducts were obtained in moderate to excellent yields under mild reaction conditions.  This protocol would find the potential applications in biochem. and medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMC_E2-C1TgrVg90H21EOLACvtfcHk0lg4wdulY4eGmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVejs7vP&md5=dd5a34d2928cdc0ca4e19152553eea4f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.7b01862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.7b01862%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DTransition-metal-free%2520%255B3%2520%252B%25202%255D%2520cycloaddition%2520of%2520dehydroaminophosphonates%2520and%2520N-tosylhydrazones%253A%2520access%2520to%2520aminocyclopropanephossphonates%2520with%2520ajacent%2520quaternary%2520tetrasubstituted%2520carbon%2520centers%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2017%26volume%3D82%26spage%3D12746%26epage%3D12756%26doi%3D10.1021%2Facs.joc.7b01862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goddard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">List, B.</span></span> <span> </span><span class="NLM_article-title">Direct catalytic asymmetric three-component Kabachnik-Fields reaction</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5079</span>– <span class="NLM_lpage">5081</span>, <span class="refDoi"> DOI: 10.1002/anie.200801173</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fanie.200801173" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslajtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5079-5081&author=X.+Chengauthor=R.+Goddardauthor=G.+Buthauthor=B.+List&title=Direct+catalytic+asymmetric+three-component+Kabachnik-Fields+reaction&doi=10.1002%2Fanie.200801173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Direct catalytic asymmetric three-component Kabachnik-Fields reaction</span></div><div class="casAuthors">Cheng, Xu; Goddard, Richard; Buth, Gernot; List, Benjamin</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">5079-5081</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Chiral α-amino-β-branched 2-arylethylphosphonates were prepd. by in situ hydrophosphonylation of α-branched aldimines by di-3-pentyl hydrophosphonate catalyzed by a chiral Bronsted acid, 9-anthracenylphenyl-substituted BINOL hydrogen phosphate.  Reaction of rac-ArCHR1CHO (1; R1 = cyclopentyl) with 4-MeOC6H4NH2 and HP(O)(O-3-pentyl)2 catalyzed by hydrogen phosphate I (7) gave α-aminophosphonates (R,R)-ArCHR1CH(NHC6H4OMe-4)P(O)(O-3-pentyl)2 (4a-o; Ar = Ph, MeC6H4, MeOC6H4, ClC6H4, 4-BrC6H4, 2-naphthalenyl, 2-thienyl) with 6:1 to 28:1 d.r. and 88-96% ee.  Esters 4a-o were converted into free α-aminophosphonic acids (R,R)-ArCHR1CH(NH2)P(O)(OH)2 by subsequent treatment by CAN and TMSBr.  As mimics of α-amino acids, α-amino phosphonates have great promise as antibacterial and anti-HIV agents as well as protease inhibitors.  Racemic α-branched aldehydes react, in the presence the new chiral phosphoric acid catalyst I, directly with p-anisidine and a dialkyl phosphite to furnish β-branched α-amino phosphonates highly diastereoselectively and enantioselectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9qNT_GZCxBLVg90H21EOLACvtfcHk0lgwOxgZrq1Zng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslajtrc%253D&md5=a7ca09fd6d1cc299d74fbfcd178a498f</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1002%2Fanie.200801173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200801173%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DGoddard%26aufirst%3DR.%26aulast%3DButh%26aufirst%3DG.%26aulast%3DList%26aufirst%3DB.%26atitle%3DDirect%2520catalytic%2520asymmetric%2520three-component%2520Kabachnik-Fields%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2008%26volume%3D47%26spage%3D5079%26epage%3D5081%26doi%3D10.1002%2Fanie.200801173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span> <span> </span><span class="NLM_article-title">Enantioselective three-component Kabachnik-Fields reaction catalyzed by chiral scandium(III)-<i>N,N</i>′-dioxide complexes</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1401</span>– <span class="NLM_lpage">1404</span>, <span class="refDoi"> DOI: 10.1021/ol9000813</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol9000813" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1eltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=1401-1404&author=X.+Zhouauthor=D.+Shangauthor=Q.+Zhangauthor=L.+Linauthor=X.+Liuauthor=X.+Feng&title=Enantioselective+three-component+Kabachnik-Fields+reaction+catalyzed+by+chiral+scandium%28III%29-N%2CN%E2%80%B2-dioxide+complexes&doi=10.1021%2Fol9000813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective Three-Component Kabachnik-Fields Reaction Catalyzed by Chiral Scandium(III)-N,N'-Dioxide Complexes</span></div><div class="casAuthors">Zhou, Xin; Shang, Deju; Zhang, Qi; Lin, Lili; Liu, Xiaohua; Feng, Xiaoming</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1401-1404</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The N,N'-dioxide-Sc(III) complex has been applied in the three-component Kabachnik-Fields reaction of aldehydes (e.g. PhCHO), 2-aminophenol, and di-Ph phosphite, giving the corresponding α-amino phosphonates (e.g. 86% 2-HOC6H4NHCHPhP(O)(OPh)2 in 84% enantiomeric excess) in good yields with high enantioselectivities (up to 87% ee).  The direct Kabachnik-Fields reaction proceeded with extremely high reactivity under mild reaction conditions and could be used for large-scale synthesis of the α-amino phosphonates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFeCms8kkVL7Vg90H21EOLACvtfcHk0lgwOxgZrq1Zng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1eltr4%253D&md5=fee5edbbf32961b8a26696e398637768</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fol9000813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol9000813%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DShang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DX.%26atitle%3DEnantioselective%2520three-component%2520Kabachnik-Fields%2520reaction%2520catalyzed%2520by%2520chiral%2520scandium%2528III%2529-N%252CN%25E2%2580%25B2-dioxide%2520complexes%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D1401%26epage%3D1404%26doi%3D10.1021%2Fol9000813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefevre, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brayer, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folléas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darses, S.</span></span> <span> </span><span class="NLM_article-title">Chiral α-amino phosphonates via rhodium-catalyzed asymmetric 1,4-addition reactions</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4274</span>– <span class="NLM_lpage">4276</span>, <span class="refDoi"> DOI: 10.1021/ol402059w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol402059w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2ru7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=4274-4276&author=N.+Lefevreauthor=J.-L.+Brayerauthor=B.+Foll%C3%A9asauthor=S.+Darses&title=Chiral+%CE%B1-amino+phosphonates+via+rhodium-catalyzed+asymmetric+1%2C4-addition+reactions&doi=10.1021%2Fol402059w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Chiral α-Amino Phosphonates via Rhodium-Catalyzed Asymmetric 1,4-Addition Reactions</span></div><div class="casAuthors">Lefevre, Nicolas; Brayer, Jean-Louis; Folleas, Benoit; Darses, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4274-4276</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new approach for the prepn. of enantioenriched α-amino phosphonates and derivs. is described.  Indeed, the Rh-catalyzed asym. 1,4-addn. of K organotrifluoroborates to dehydroaminophosphonates afforded α-amino phosphonates in good yields and high enantioselectivities (up to 96%) using Difluorphos as a chiral ligand.  E.g., reaction of di-Et (1-acetamidovinyl)phosphonate with K phenyltrifluoroborate in the presence of 1.5 mol% [RhCl(CH2:CH2)2]2 and 3.3 mol% (S)-Difluorphos with NaHCO3 in iPrOH at 90° to give 91% yield of (-)-di-Et (1-acetamido-2-phenylethyl)phosphonate (94% ee).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2LLspZNjzCrVg90H21EOLACvtfcHk0lgwOxgZrq1Zng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2ru7nO&md5=ef6d475e46049ffd8bb43cafd116f2b3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fol402059w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol402059w%26sid%3Dliteratum%253Aachs%26aulast%3DLefevre%26aufirst%3DN.%26aulast%3DBrayer%26aufirst%3DJ.-L.%26aulast%3DFoll%25C3%25A9as%26aufirst%3DB.%26aulast%3DDarses%26aufirst%3DS.%26atitle%3DChiral%2520%25CE%25B1-amino%2520phosphonates%2520via%2520rhodium-catalyzed%2520asymmetric%25201%252C4-addition%2520reactions%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D4274%26epage%3D4276%26doi%3D10.1021%2Fol402059w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Key, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. J.</span></span> <span> </span><span class="NLM_article-title">Site- and stereoselective chemical editing of thiostrepton by Rh-catalysed conjugate arylation: new analogues and collateral enantioselective synthesis of amino acids</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">15460</span>– <span class="NLM_lpage">15466</span>, <span class="refDoi"> DOI: 10.1021/jacs.7b08775</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.7b08775" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Slur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2017&pages=15460-15466&author=H.+M.+Keyauthor=S.+J.+Miller&title=Site-+and+stereoselective+chemical+editing+of+thiostrepton+by+Rh-catalysed+conjugate+arylation%3A+new+analogues+and+collateral+enantioselective+synthesis+of+amino+acids&doi=10.1021%2Fjacs.7b08775"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Site- and stereoselective chemical editing of thiostrepton by Rh-catalyzed conjugate arylation: New analogues and collateral enantioselective synthesis of amino acids</span></div><div class="casAuthors">Key, Hanna M.; Miller, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">15460-15466</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of complex, biol. active mols. by catalyst-controlled, selective functionalization of complex mols. is an emerging capability.  We describe the application of Rh-catalyzed conjugate arylation to the modification of thiostrepton, a complex mol. with potent antibacterial properties for which few analogs are known.  By this approach, we achieve the site- and stereoselective functionalization of one subterminal dehydroalanine residue (Dha16) present in thiostrepton.  The broad scope of this method enabled the prepn. and isolation of 24 new analogs of thiostrepton, the biol. testing of which revealed that the antimicrobial activity of thiostrepton tolerates the alteration of Dha16 to a range of amino acids.  Further anal. of this Rh-catalyzed process revealed that use of sodium or potassium salts was crucial for achieving high stereoselectivity.  The catalyst system was studied further by application to the synthesis of amino esters and amides from dehydroalanine monomers, a process which was found to occur with up to 93:7 er under conditions milder than those previously reported for analogous reactions.  Furthermore, the addn. of the same sodium and potassium salts as applied in the case of thiostrepton leads to a nearly full reversal of the enantioselectivity of the reaction.  As such, this study of site-selective catalysis in a complex mol. setting also delivered synergistic insights in the arena of enantioselective catalysis.  In addn., these studies greatly expand the no. of known thiostrepton analogs obtained by any method and reveal a high level of functional group tolerance for metal-catalyzed, site-selective modifications of highly complex natural products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroBlJ0cEpJarVg90H21EOLACvtfcHk0lh_tIkQ49bCcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Slur3I&md5=28a8558907ba84caf6a9413f44b797f8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjacs.7b08775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.7b08775%26sid%3Dliteratum%253Aachs%26aulast%3DKey%26aufirst%3DH.%2BM.%26aulast%3DMiller%26aufirst%3DS.%2BJ.%26atitle%3DSite-%2520and%2520stereoselective%2520chemical%2520editing%2520of%2520thiostrepton%2520by%2520Rh-catalysed%2520conjugate%2520arylation%253A%2520new%2520analogues%2520and%2520collateral%2520enantioselective%2520synthesis%2520of%2520amino%2520acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2017%26volume%3D139%26spage%3D15460%26epage%3D15466%26doi%3D10.1021%2Fjacs.7b08775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trost, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span> <span> </span><span class="NLM_article-title">A direct catalytic enantioselective Aldol reaction via a novel catalyst design</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">12003</span>– <span class="NLM_lpage">12004</span>, <span class="refDoi"> DOI: 10.1021/ja003033n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja003033n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVyhsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=12003-12004&author=B.+M.+Trostauthor=H.+Ito&title=A+direct+catalytic+enantioselective+Aldol+reaction+via+a+novel+catalyst+design&doi=10.1021%2Fja003033n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">A direct catalytic enantioselective aldol reaction via a novel catalyst design</span></div><div class="casAuthors">Trost, Barry M.; Ito, Hisanaka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">12003-12004</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An enantioselective catalyst for aldol addn. reactions was prepd. in situ from amino acid-derived pyrrolidinyldiphenylmethanol I and diethylzinc in the presence of triphenylphosphine sulfide; in the presence of I, aldehydes RCHO [R = EtCH2, Me2CHCH2, Me2CH, c-C6H11, Ph2CH, Me3CSi(Me)2OCH2CMe2] and ketones R1COMe (R1 = Ph, 2-furanyl, 2-MeOC6H4, 4-MeOC6H4, 2-naphthyl) reacted to give the 3-hydroxyketones RCH(OH)CH2COR1 in 24-79% yields and with 56-99% ee.  E.g., diethylzinc was added to a soln. of 0.20 equiv. I in THF under argon to yield a catalyst soln.; 2-methylpropanal, 5-10 equiv. acetophenone, and 15 mol% triphenylphosphine sulfide were dissolved in THF to which was added a soln. with 5 mol% catalyst; after stirring at 5° for 2 days and workup to give (S)-Me2CHCH(OH)CH2COPh in 62% yield and in 98% ee.  Calcns. of a complex of I and two equiv. of zinc diethoxide indicate that the lowest energy complex is one with each zinc atom coordinated to both the phenol oxygen and one of the pyrrolidinyldiphenylmethanol moieties rather than a structure with one zinc atom coordinated to all three alc. moieties and a second zinc atom coordinated to the two pyrrolidinyldiphenylmethanol moieties and an ethoxide ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9oOIIrPuzV7Vg90H21EOLACvtfcHk0lh_tIkQ49bCcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVyhsLY%253D&md5=3bbdc7bfc8384ea03b630bbc22ae0efc</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fja003033n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja003033n%26sid%3Dliteratum%253Aachs%26aulast%3DTrost%26aufirst%3DB.%2BM.%26aulast%3DIto%26aufirst%3DH.%26atitle%3DA%2520direct%2520catalytic%2520enantioselective%2520Aldol%2520reaction%2520via%2520a%2520novel%2520catalyst%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D12003%26epage%3D12004%26doi%3D10.1021%2Fja003033n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trost, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silcoff, E. R.</span></span> <span> </span><span class="NLM_article-title">Asymmetric Aldol reaction via a dinuclear zinc catalyst: α-hydroxyketones as donors</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">3367</span>– <span class="NLM_lpage">3368</span>, <span class="refDoi"> DOI: 10.1021/ja003871h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja003871h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslClur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=3367-3368&author=B.+M.+Trostauthor=H.+Itoauthor=E.+R.+Silcoff&title=Asymmetric+Aldol+reaction+via+a+dinuclear+zinc+catalyst%3A+%CE%B1-hydroxyketones+as+donors&doi=10.1021%2Fja003871h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Asymmetric aldol reaction via a dinuclear zinc catalyst: α-Hydroxy ketones as donors</span></div><div class="casAuthors">Trost, Barry M.; Ito, Hisanaka; Silcoff, Elliad R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3367-3368</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A dinuclear zinc compd., formed in situ by reaction of the bis(pyrrolidino)cresol I with Et2Zn, catalyzed asym. aldol reactions of α-hydroxy ketones with aldehydes to give α,β-dihydroxy ketones with high diastereoselectivity and enantioselective.  Thus, the catalyst was prepd. by reaction of I with Et2Zn in THF and then added to a near stoichiometric mixt. of cyclohexanecarboxaldehyde and HOCH2COPh in THF at -35° to give, after a reaction time of 24 h, the syn-dihydroxypropiophenone II in 83% yield with a 30:1 diastereoisomer ratio and 92% enantiomeric excess.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfZ28SqVhzFLVg90H21EOLACvtfcHk0lh_tIkQ49bCcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslClur8%253D&md5=2180b77ce617f7c1655559460dc8cbd4</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fja003871h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja003871h%26sid%3Dliteratum%253Aachs%26aulast%3DTrost%26aufirst%3DB.%2BM.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DSilcoff%26aufirst%3DE.%2BR.%26atitle%3DAsymmetric%2520Aldol%2520reaction%2520via%2520a%2520dinuclear%2520zinc%2520catalyst%253A%2520%25CE%25B1-hydroxyketones%2520as%2520donors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D3367%26epage%3D3368%26doi%3D10.1021%2Fja003871h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trost, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnanamani, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalnmals, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C.-I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, J. S.</span></span> <span> </span><span class="NLM_article-title">Direct enantio- and diastereoselective vinylogous addition of butenolides to chromones catalyzed by Zn-ProPhenol</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">1489</span>– <span class="NLM_lpage">1493</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b13367</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b13367" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFGrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2019&pages=1489-1493&author=B.+M.+Trostauthor=E.+Gnanamaniauthor=C.+A.+Kalnmalsauthor=C.-I.+J.+Hungauthor=J.+S.+Tracy&title=Direct+enantio-+and+diastereoselective+vinylogous+addition+of+butenolides+to+chromones+catalyzed+by+Zn-ProPhenol&doi=10.1021%2Fjacs.8b13367"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20cR"><div class="casContent"><span class="casTitleNuber">20c</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Enantio- and Diastereoselective Vinylogous Addition of Butenolides to Chromones Catalyzed by Zn-ProPhenol</span></div><div class="casAuthors">Trost, Barry M.; Gnanamani, Elumalai; Kalnmals, Christopher A.; Hung, Chao-I. "Joey"; Tracy, Jacob S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1489-1493</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the first enantio- and diastereoselective 1,4-addn. of butenolides to chromones.  Both α,β- and β,γ-butenolide nucleophiles are compatible with the Zn-ProPhenol catalyst, and preactivation as the siloxyfurans is not required.  The scope of electrophiles includes a variety of substituted chromones, as well as a thiochromone and a quinolone, and the resulting vinylogous addn. products, e.g. I, are generated in good yield (31 to 98%), diastereo- (3:1 to >30:1), and enantioselectivity (90:10 to 99:1 er).  These Michael adducts allow rapid access to several natural product analogs, and can be easily transformed into a variety of other interesting scaffolds as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlPd4H2qr6CLVg90H21EOLACvtfcHk0lh_tIkQ49bCcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFGrsA%253D%253D&md5=dd02804feee30ae94506e8adc44ba44e</span></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b13367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b13367%26sid%3Dliteratum%253Aachs%26aulast%3DTrost%26aufirst%3DB.%2BM.%26aulast%3DGnanamani%26aufirst%3DE.%26aulast%3DKalnmals%26aufirst%3DC.%2BA.%26aulast%3DHung%26aufirst%3DC.-I.%2BJ.%26aulast%3DTracy%26aufirst%3DJ.%2BS.%26atitle%3DDirect%2520enantio-%2520and%2520diastereoselective%2520vinylogous%2520addition%2520of%2520butenolides%2520to%2520chromones%2520catalyzed%2520by%2520Zn-ProPhenol%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2019%26volume%3D141%26spage%3D1489%26epage%3D1493%26doi%3D10.1021%2Fjacs.8b13367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Trost, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, C.-I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnanamani, E.</span></span> <span> </span><span class="NLM_article-title">Tuning the reactivity of ketones through unsaturation: Construction of cyclic and acyclic quaternary stereocenters via Zn-ProPhenol catalyzed Mannich reaction</span>. <i>ACS Catal.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1549</span>– <span class="NLM_lpage">1557</span>, <span class="refDoi"> DOI: 10.1021/acscatal.8b04685</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscatal.8b04685" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvFGmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1549-1557&author=B.+M.+Trostauthor=C.-I.+J.+Hungauthor=E.+Gnanamani&title=Tuning+the+reactivity+of+ketones+through+unsaturation%3A+Construction+of+cyclic+and+acyclic+quaternary+stereocenters+via+Zn-ProPhenol+catalyzed+Mannich+reaction&doi=10.1021%2Facscatal.8b04685"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20dR"><div class="casContent"><span class="casTitleNuber">20d</span><div class="casTitle"><span class="NLM_cas:atitle">Tuning the Reactivity of Ketones through Unsaturation: Construction of Cyclic and Acyclic Quaternary Stereocenters via Zn-ProPhenol Catalyzed Mannich Reactions</span></div><div class="casAuthors">Trost, Barry M.; Hung, Chao-I. Joey; Gnanamani, Elumalai</div><div class="citationInfo"><span class="NLM_cas:title">ACS Catalysis</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1549-1557</span>CODEN:
                <span class="NLM_cas:coden">ACCACS</span>;
        ISSN:<span class="NLM_cas:issn">2155-5435</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Introduction of unsatn. adjacent to the carbonyl drastically improves the reactivity of the Zn-ProPhenol catalyzed Mannich reactions between N-carbamoyl imines and a-branched ketones.  Despite only a small change in the substrate acidity, the bimetallic catalyst can preferentially recognize and activate unsatd. ketones over their fully satd. counterparts, providing a chemo-, diastereo-, and enantioselective route to valuable β-aminoketones bearing both cyclic and acyclic quaternary stereocenters, which are common motifs in numerous biol. active alkaloids.  Unsatd. ketones and imines with various substitution patterns are viable substrates, and the reaction can be performed on multi-millimole scale at low catalyst loading without impacting its efficiency.  More importantly, the unsatn. introduced via the nucleophile provides a useful platform for structural diversification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFbSt4-9N8kLVg90H21EOLACvtfcHk0lhcETSC9pC0yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvFGmsw%253D%253D&md5=5852b3a309ed2f9d05008fd536eb5237</span></div><a href="/servlet/linkout?suffix=cit20d&amp;dbid=16384&amp;doi=10.1021%2Facscatal.8b04685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscatal.8b04685%26sid%3Dliteratum%253Aachs%26aulast%3DTrost%26aufirst%3DB.%2BM.%26aulast%3DHung%26aufirst%3DC.-I.%2BJ.%26aulast%3DGnanamani%26aufirst%3DE.%26atitle%3DTuning%2520the%2520reactivity%2520of%2520ketones%2520through%2520unsaturation%253A%2520Construction%2520of%2520cyclic%2520and%2520acyclic%2520quaternary%2520stereocenters%2520via%2520Zn-ProPhenol%2520catalyzed%2520Mannich%2520reaction%26jtitle%3DACS%2520Catal.%26date%3D2019%26volume%3D9%26spage%3D1549%26epage%3D1557%26doi%3D10.1021%2Facscatal.8b04685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Highly enantioselective conjugated addition of phosphite to α,β-unsaturated <i>N</i>-acylpyrroles and imines: a practical approach to enantiomerically enriched amino phosphate</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">10983</span>– <span class="NLM_lpage">10987</span>, <span class="refDoi"> DOI: 10.1002/chem.200901901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fchem.200901901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=19739227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ymt7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=10983-10987&author=D.+Zhaoauthor=Y.+Wangauthor=L.+Maoauthor=R.+Wang&title=Highly+enantioselective+conjugated+addition+of+phosphite+to+%CE%B1%2C%CE%B2-unsaturated+N-acylpyrroles+and+imines%3A+a+practical+approach+to+enantiomerically+enriched+amino+phosphate&doi=10.1002%2Fchem.200901901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Enantioselective Conjugate Additions of Phosphites to α,β-Unsaturated N-Acylpyrroles and Imines: A Practical Approach to Enantiomerically Enriched Amino Phosphonates</span></div><div class="casAuthors">Zhao, Depeng; Wang, Yuan; Mao, Lijuan; Wang, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">10983-10987, S10983/1-S10983/193</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The first highly enantioselective phosphonylation of α,β-unsatd. N-acylpyrroles has been developed.  Excellent yields (91-99 %) and enantioselectivities (up to >99 % enantiomeric excess (ee)) were obsd. for a broad spectrum of both phosphites and N-acylpyrroles under mild conditions.  In particular, when di-Et phosphite was employed to test the scope of the N-acylpyrroles, almost optically pure products (98 to >99 % ee) were obtained for 20 examples of N-acylpyrroles.  Moreover, optically pure α-substituted β- or γ-amino phosphonates can be obtained by several simple transformations of the pyrrolyl phosphonates.  The versatility of the N-acylpyrrole moiety makes the phosphorus adducts powerful chiral building blocks that enable the synthesis of various phosphonate-contg. compds.  Finally, the present strategy can also be applied to the asym. hydrophosphonylation of N-acylimines with high enantioselectivities (93 to >99 % ee).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvoS1qKjpGkLVg90H21EOLACvtfcHk0lhcETSC9pC0yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ymt7nM&md5=d1fbc5c65145cb934920545808351a85</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fchem.200901901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200901901%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DHighly%2520enantioselective%2520conjugated%2520addition%2520of%2520phosphite%2520to%2520%25CE%25B1%252C%25CE%25B2-unsaturated%2520N-acylpyrroles%2520and%2520imines%253A%2520a%2520practical%2520approach%2520to%2520enantiomerically%2520enriched%2520amino%2520phosphate%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2009%26volume%3D15%26spage%3D10983%26epage%3D10987%26doi%3D10.1002%2Fchem.200901901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonnella, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senanayake, C. H.</span></span> <span> </span><span class="NLM_article-title">Direct titanium-mediated conversion of ketones into enamides with ammonia and acetic anhydride</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1400</span>– <span class="NLM_lpage">1404</span>, <span class="refDoi"> DOI: 10.1002/anie.201107601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fanie.201107601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFKhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=1400-1404&author=J.+T.+Reevesauthor=Z.+Tanauthor=Z.+S.+Hanauthor=G.+Liauthor=Y.+Zhangauthor=Y.+Xuauthor=D.+C.+Reevesauthor=N.+C.+Gonnellaauthor=S.+Maauthor=H.+Leeauthor=B.+Z.+Luauthor=C.+H.+Senanayake&title=Direct+titanium-mediated+conversion+of+ketones+into+enamides+with+ammonia+and+acetic+anhydride&doi=10.1002%2Fanie.201107601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Titanium-Mediated Conversion of Ketones to Enamides with Ammonia and Acetic Anhydride</span></div><div class="casAuthors">Reeves, Jonathan T.; Tan, Zhulin; Han, Zhengxu S.; Li, Guisheng; Zhang, Yongda; Xu, Yibo; Reeves, Diana C.; Gonnella, Nina C.; Ma, Shengli; Lee, Heewon; Lu, Bruce Z.; Senanayake, Chris H.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1400-1404, S1400/1-S1400/84</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The direct conversion of ketones to enamides with ammonia and acetic anhydride catalyzed by Ti(OCHMe2)4 is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCM8Ss1s2hHbVg90H21EOLACvtfcHk0lhcETSC9pC0yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFKhsw%253D%253D&md5=52bc22182efc93703ed29c979f61c00e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fanie.201107601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201107601%26sid%3Dliteratum%253Aachs%26aulast%3DReeves%26aufirst%3DJ.%2BT.%26aulast%3DTan%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DZ.%2BS.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DReeves%26aufirst%3DD.%2BC.%26aulast%3DGonnella%26aufirst%3DN.%2BC.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DB.%2BZ.%26aulast%3DSenanayake%26aufirst%3DC.%2BH.%26atitle%3DDirect%2520titanium-mediated%2520conversion%2520of%2520ketones%2520into%2520enamides%2520with%2520ammonia%2520and%2520acetic%2520anhydride%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26spage%3D1400%26epage%3D1404%26doi%3D10.1002%2Fanie.201107601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Burk, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. G.</span></span> <span> </span><span class="NLM_article-title">A mild amide to carbamate transformation</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7054</span>– <span class="NLM_lpage">7057</span>, <span class="refDoi"> DOI: 10.1021/jo970903j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo970903j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADyaK2sXmtVersrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1997&pages=7054-7057&author=M.+J.+Burkauthor=J.+G.+Allen&title=A+mild+amide+to+carbamate+transformation&doi=10.1021%2Fjo970903j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">A Mild Amide to Carbamate Transformation</span></div><div class="casAuthors">Burk, Mark J.; Allen, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7054-7057</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A general method for the conversion of benzamides and acetamides to tert-butoxycarbamates in one pot was optimized.  Short reaction times and high yields without racemization were demonstrated for a range of amino acids.  Tolerance of the conditions by various functional groups was found allowing amide cleavage in the presence of different esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8RC3FbaG907Vg90H21EOLACvtfcHk0lj1LEU8fPY1Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtVersrc%253D&md5=25c190e8319287753948d673624edb93</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fjo970903j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo970903j%26sid%3Dliteratum%253Aachs%26aulast%3DBurk%26aufirst%3DM.%2BJ.%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26atitle%3DA%2520mild%2520amide%2520to%2520carbamate%2520transformation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1997%26volume%3D62%26spage%3D7054%26epage%3D7057%26doi%3D10.1021%2Fjo970903j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Faucher, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duceppe, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferland, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiro, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorys, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llinàs-Brunet, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2901</span>– <span class="NLM_lpage">2904</span>, <span class="refDoi"> DOI: 10.1021/ol0489907</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0489907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVSkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=2901-2904&author=A.-M.+Faucherauthor=M.+D.+Baileyauthor=P.+L.+Beaulieuauthor=C.+Brochuauthor=J.-S.+Duceppeauthor=J.-M.+Ferlandauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=S.+H.+Kawaiauthor=M.+Poirierauthor=B.+Simoneauauthor=Y.+S.+Tsantrizosauthor=M.+Llin%C3%A0s-Brunet&title=Synthesis+of+BILN+2061%2C+an+HCV+NS3+protease+inhibitor+with+proven+antiviral+effect+in+humans&doi=10.1021%2Fol0489907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans</span></div><div class="casAuthors">Faucher, Anne-Marie; Bailey, Murray D.; Beaulieu, Pierre L.; Brochu, Christian; Duceppe, Jean-Simon; Ferland, Jean-Marie; Ghiro, Elise; Gorys, Vida; Halmos, Ted; Kawai, Stephen H.; Poirier, Martin; Simoneau, Bruno; Tsantrizos, Youla S.; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2901-2904</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of BILN 2061 (I), a hepatitis C virus (HCV) NS3 protease inhibitor with proven antiviral effect in humans, was accomplished in a convergent manner from four building blocks.  The procedure described here was suitable for the prepn. of multigram quantities of BILN 2061 for preclin. pharmacol. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3e_dv4CxKirVg90H21EOLACvtfcHk0lj1LEU8fPY1Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVSkur0%253D&md5=cfc1b877b24dc5df86fe3ea7f8996f9c</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fol0489907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0489907%26sid%3Dliteratum%253Aachs%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DDuceppe%26aufirst%3DJ.-S.%26aulast%3DFerland%26aufirst%3DJ.-M.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520BILN%25202061%252C%2520an%2520HCV%2520NS3%2520protease%2520inhibitor%2520with%2520proven%2520antiviral%2520effect%2520in%2520humans%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D2901%26epage%3D2904%26doi%3D10.1021%2Fol0489907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Navarre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genet, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darses, S.</span></span> <span> </span><span class="NLM_article-title">Access to enantioenriched α-amino esters via rhodium-catalyzed 1,4-addition/enantioselective protonation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">6159</span>– <span class="NLM_lpage">6169</span>, <span class="refDoi"> DOI: 10.1021/ja710691p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja710691p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BD1cXksVShur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=6159-6169&author=L.+Navarreauthor=R.+Martinezauthor=J.-P.+Genetauthor=S.+Darses&title=Access+to+enantioenriched+%CE%B1-amino+esters+via+rhodium-catalyzed+1%2C4-addition%2Fenantioselective+protonation&doi=10.1021%2Fja710691p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Access to enantioenriched α-amino esters via rhodium-catalyzed 1,4-addition/enantioselective protonation</span></div><div class="casAuthors">Navarre, Laure; Martinez, Remi; Genet, Jean-Pierre; Darses, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6159-6169</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conjugate addn. of potassium trifluoro(organo)borates to dehydroalanine derivs., mediated by a chiral rhodium catalyst and in situ enantioselective protonation, afforded straightforward access to a variety of protected α-amino esters with high yields and enantiomeric excesses up to 95%.  Among the tested chiral ligands and proton sources, Binap, in combination with guaiacol (2-methoxyphenol), an inexpensive and nontoxic phenol, afforded the highest asym. inductions.  Organostannanes have also shown to participate in this reaction.  By a fine-tuning of the ester moiety, and using Difluorophos as chiral ligand, increased levels of enantioselectivity, generally close to 95%, were achieved.  Deuterium labeling expts. revealed, and DFT calcn. supported, an unusual mechanism involving a hydride transfer from the amido substituent to the α carbon explaining the high levels of enantioselectivity attained in controlling this α chiral center.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqHXV_W9YJ7Vg90H21EOLACvtfcHk0lj1LEU8fPY1Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXksVShur0%253D&md5=f2c743b43aaf64bc4137920c5bfb6089</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fja710691p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja710691p%26sid%3Dliteratum%253Aachs%26aulast%3DNavarre%26aufirst%3DL.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DGenet%26aufirst%3DJ.-P.%26aulast%3DDarses%26aufirst%3DS.%26atitle%3DAccess%2520to%2520enantioenriched%2520%25CE%25B1-amino%2520esters%2520via%2520rhodium-catalyzed%25201%252C4-addition%252Fenantioselective%2520protonation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D6159%26epage%3D6169%26doi%3D10.1021%2Fja710691p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoń, J.</span></span> <span> </span><span class="NLM_article-title">A simple preparation of diethyl 1-acylamino-1-ethenephosphonates</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>1981</i></span>,  <span class="NLM_fpage">324</span>, <span class="refDoi"> DOI: 10.1055/s-1981-29440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1055%2Fs-1981-29440" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1981&publication_year=1981&pages=324&author=J.+Zo%C5%84&title=A+simple+preparation+of+diethyl+1-acylamino-1-ethenephosphonates&doi=10.1055%2Fs-1981-29440"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1055%2Fs-1981-29440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1981-29440%26sid%3Dliteratum%253Aachs%26aulast%3DZo%25C5%2584%26aufirst%3DJ.%26atitle%3DA%2520simple%2520preparation%2520of%2520diethyl%25201-acylamino-1-ethenephosphonates%26jtitle%3DSynthesis%26date%3D1981%26volume%3D1981%26spage%3D324%26doi%3D10.1055%2Fs-1981-29440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vedejs, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrimpf, M. R.</span></span> <span> </span><span class="NLM_article-title">Conversion of arylboronic acids into potassium aryltrifluoroborates: convenient precursors of arylboron difluoride Lewis acids</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3020</span>– <span class="NLM_lpage">3027</span>, <span class="refDoi"> DOI: 10.1021/jo00115a016</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00115a016" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADyaK2MXlsFCjsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=3020-3027&author=E.+Vedejsauthor=R.+W.+Chapmanauthor=S.+C.+Fieldsauthor=S.+Linauthor=M.+R.+Schrimpf&title=Conversion+of+arylboronic+acids+into+potassium+aryltrifluoroborates%3A+convenient+precursors+of+arylboron+difluoride+Lewis+acids&doi=10.1021%2Fjo00115a016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Conversion of Arylboronic Acids into Potassium Aryltrifluoroborates: Convenient Precursors of Arylboron Difluoride Lewis Acids</span></div><div class="casAuthors">Vedejs, E.; Chapman, R. W.; Fields, S. C.; Lin, S.; Schrimpf, M. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3020-7</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Reaction of ArB(OH)2 (Ar = Ph, 1-naphthyl, 4-F3CC6H4, etc.) with KHF2 affords cryst. salts KArBF3 (I).  In the presence of TMSCl in acetonitrile, I (R = Ph) reacts to give NMR signals typical of PhBF2 in acetonitrile soln.  When the reaction of I + TMSCl is performed in the presence of potential Lewis bases, the trivalent borane is intercepted, resulting in organoboron complexes.  Thus, the oxazaborolidinones, e.g. II, have been prepd. from amino acid-derived amidine carboxylates NaO2CCH(R)N:CHNMe2 (R = H or phenyl).  Complexes, e.g. III, derived from 1,3-diketones are also easily prepd.  The KHF2 fluoride exchange coupled with the TMSCl activation method allows in situ generation of ArBF2 without having to handle corrosive trivalent boron halides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIrPrKhcU6UbVg90H21EOLACvtfcHk0lg-jtZEcBtvhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlsFCjsL0%253D&md5=0b641b7b7b0f070925a72a60e3dbea95</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo00115a016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00115a016%26sid%3Dliteratum%253Aachs%26aulast%3DVedejs%26aufirst%3DE.%26aulast%3DChapman%26aufirst%3DR.%2BW.%26aulast%3DFields%26aufirst%3DS.%2BC.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DSchrimpf%26aufirst%3DM.%2BR.%26atitle%3DConversion%2520of%2520arylboronic%2520acids%2520into%2520potassium%2520aryltrifluoroborates%253A%2520convenient%2520precursors%2520of%2520arylboron%2520difluoride%2520Lewis%2520acids%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D3020%26epage%3D3027%26doi%3D10.1021%2Fjo00115a016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, J. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupton, D. W.</span></span> <span> </span><span class="NLM_article-title">Enantioselective <i>N</i>-heterocyclic carbene catalysis that exploits imine umpolung</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">4007</span>– <span class="NLM_lpage">4011</span>, <span class="refDoi"> DOI: 10.1002/anie.201812585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1002%2Fanie.201812585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFGhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=4007-4011&author=J.+E.+M.+Fernandoauthor=Y.+Nakanoauthor=C.+Zhangauthor=D.+W.+Lupton&title=Enantioselective+N-heterocyclic+carbene+catalysis+that+exploits+imine+umpolung&doi=10.1002%2Fanie.201812585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Enantioselective N-Heterocyclic Carbene Catalysis that Exploits Imine Umpolung</span></div><div class="casAuthors">Fernando, Jared E. M.; Nakano, Yuji; Zhang, Changhe; Lupton, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4007-4011</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">An enantioselective aza-Stetter reaction that proceeds via imine umpolung using N-heterocyclic carbene catalysis was reported.  The reaction proceeded with high levels of enantioselectivity (all ≥96:4 er) and good generality (21 examples).  Mechanistic studies are reported and are consistent with turnover-limiting addn. of the NHC to the imine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEzPyfNZR3LVg90H21EOLACvtfcHk0lg-jtZEcBtvhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFGhurk%253D&md5=facd43a2a8888b2a10fce118e5028f27</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fanie.201812585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201812585%26sid%3Dliteratum%253Aachs%26aulast%3DFernando%26aufirst%3DJ.%2BE.%2BM.%26aulast%3DNakano%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLupton%26aufirst%3DD.%2BW.%26atitle%3DEnantioselective%2520N-heterocyclic%2520carbene%2520catalysis%2520that%2520exploits%2520imine%2520umpolung%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26spage%3D4007%26epage%3D4011%26doi%3D10.1002%2Fanie.201812585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobley, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, S. M.</span></span> <span> </span><span class="NLM_article-title">Decision making in xia2</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1260</span>– <span class="NLM_lpage">1273</span>, <span class="refDoi"> DOI: 10.1107/S0907444913015308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1107%2FS0907444913015308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=23793152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1260-1273&author=G.+Winterauthor=C.+M.+Lobleyauthor=S.+M.+Prince&title=Decision+making+in+xia2&doi=10.1107%2FS0907444913015308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Decision making in xia2</span></div><div class="casAuthors">Winter, Graeme; Lobley, Carina M. C.; Prince, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1260-1273</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Xia2 is an expert system for the automated redn. of macromol. crystallog. (MX) data employing well trusted existing software.  The system can process a full MX data set consisting of one or more sequences of images at one or more wavelengths from images to structure-factor amplitudes with no user input.  To achieve this many decisions are made, the rationale for which is described here.  In addn., it is crit. to support the testing of hypotheses and to allow feedback of results from later stages in the anal. to earlier points where decisions were made: the flexible framework employed by xia2 to support this feedback is summarized here.  While the decision-making protocols described here were developed for xia2, they are equally applicable to interactive data redn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMCxz3Jkl1CrVg90H21EOLACvtfcHk0lg-jtZEcBtvhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsro%253D&md5=48d02842ee5967636a5f6042cfd90b25</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444913015308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913015308%26sid%3Dliteratum%253Aachs%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DLobley%26aufirst%3DC.%2BM.%26aulast%3DPrince%26aufirst%3DS.%2BM.%26atitle%3DDecision%2520making%2520in%2520xia2%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1260%26epage%3D1273%26doi%3D10.1107%2FS0907444913015308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lgY13jZXufJyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A.</span></span> <span> </span><span class="NLM_article-title">A REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+Vagin&title=A+REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lgY13jZXufJyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%26atitle%3DA%2520REFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doak, G. O.</span></span> <span> </span><span class="NLM_article-title">The preparation and properties of phosphonic acids</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1957</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1021/cr50015a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr50015a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;key=1%3ACAS%3A528%3ADyaG2sXptVCmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1957&pages=479-523&author=L.+D.+Freedmanauthor=G.+O.+Doak&title=The+preparation+and+properties+of+phosphonic+acids&doi=10.1021%2Fcr50015a003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The preparation and properties of phosphonic acids</span></div><div class="casAuthors">Freedman, Leon D.; Doak, G. O.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1957</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">479-523</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    </div><div class="casAbstract">Review, 253 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonwI1ZgKdM3LVg90H21EOLACvtfcHk0lgY13jZXufJyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG2sXptVCmug%253D%253D&md5=d46a5c11d0399b42741173fcf0baaa77</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fcr50015a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr50015a003%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DL.%2BD.%26aulast%3DDoak%26aufirst%3DG.%2BO.%26atitle%3DThe%2520preparation%2520and%2520properties%2520of%2520phosphonic%2520acids%26jtitle%3DChem.%2520Rev.%26date%3D1957%26volume%3D57%26spage%3D479%26epage%3D523%26doi%3D10.1021%2Fcr50015a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Z','PDB','6N7Z'); return false;">PDB: 6N7Z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Y" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Y','PDB','6N7Y'); return false;">PDB: 6N7Y</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAG','PDB','6OAG'); return false;">PDB: 6OAG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAH','PDB','6OAH'); return false;">PDB: 6OAH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N82" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N82','PDB','6N82'); return false;">PDB: 6N82</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N83" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N83','PDB','6N83'); return false;">PDB: 6N83</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XQR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XQR','PDB','4XQR'); return false;">PDB: 4XQR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H5C" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4H5C','PDB','4H5C'); return false;">PDB: 4H5C</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i43"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01104">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_38763"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01104">10.1021/acs.jmedchem.9b01104</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H, <sup>13</sup>C, <sup>31</sup>P NMR spectra, and chiral HPLC chromatograms. X-ray data collection and structure refinement for cocrystal structures of both (<i>R</i>)- and (<i>S</i>)-enantiomers of inhibitors <b>6d</b>, <b>6f</b>, and <b>6g</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01104/suppl_file/jm9b01104_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01104/suppl_file/jm9b01104_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01104/suppl_file/jm9b01104_si_001.pdf">jm9b01104_si_001.pdf (12.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01104/suppl_file/jm9b01104_si_002.csv">jm9b01104_si_002.csv (2.7 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The PDB accession code for the X-ray cocrystal structures of hFPPS with inhibitors bound (<i>S</i>)-<b>6d</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Z">6N7Z</a>), (<i>R</i>)-<b>6d</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N7Y">6N7Y</a>), (<i>S</i>)-<b>6f</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAG">6OAG</a>), (<i>R</i>)-<b>6f</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OAH">6OAH</a>), (<i>S</i>)-<b>6g</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N82">6N82</a>), (<i>R</i>)-<b>6g</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6N83">6N83</a>). Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01104&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01104%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-21%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01104" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799923a8b1221e9","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
